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Summary
Glutamate-gated chloride channels (GluCI) are related to GABAa receptors and are 
the target sites for the avermectin/milbemycin (AM) anthelmintics, drugs that cause 
paralysis of the somatic and pharyngeal muscles in nematodes. Four GluCI 
subunits: HcGluCIa, HcGluClp, HcGluCla3A & HcGluCla3B, have been previously 
identified from the sheep parasite Haemonchus contortus. In the present work, 
specific antisera were raised against all of these subunits and used in 
immunofluorescence experiments, to study their distribution on adult parasites. All 
of the subunits were expressed in the motor nervous system, especially motor 
neuron commissures. Double immunostaining experiments suggested that 
HcGluCIa and HcGluClp were expressed on the same commissures: these were 
also stained with an anti-GABA antibody, suggesting that they may correspond to 
inhibitory motor neurons. The HcGluClp subunit was also detected in lateral and 
sub-lateral nerve cords. The HcGluCla3A & -B subunits, products of an alternatively 
spliced gene, were expressed in different neurons. In addition to the motor neuron 
commissures, the HcGluClaA was found in a pair of sensory, possibly amphid, 
neurons in the head. HcGluCla3B was detected in three cell bodies, probably of 
pharyngeal neurons, and in ventral and lateral cords. These results indicate that the 
GluCI are widely distributed in the H. contortus nervous system and suggest that 
they have critical roles controlling locomotion, pharyngeal function and possibly 
sensory processing in parasitic nematodes. These data were supported by 
behavioural studies carried out in the free-living nematode Caenorhabditis elegans. 
Ultimately, the present work provides an explanation for the observed effects of the 
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Members of the phylum Nematoda (‘round worms’) are numerous and diverse; of 
every five animals on the planet, four are nematodes (Platt, 1994). The vast 
majority are free-living microbivores, but many species include parasites of plants 
and animals mostly from terrestrial habitats (Smyth, 1994). The apparently basic 
anatomy of nematodes masks a complex pattern of diversity and estimates of 
species number within the phylum range from 40 000 to 100 million (Dorris et al., 
1999). Nematodes, despite their diverse habitats and life-styles are consistent in 
their morphology and anatomy, which distinguish them easily from other helminths 
(derived from the Greek word helmins or herminthos, which means worm). They are 
vermiform, unsegmented and bilaterally symmetrical with two concentric tubes 
separated by a space, the pseudocoelom (Bird and Bird, 1991). In the adult, the 
pseudocoelomic space also contains one or two tubular gonads, which open 
through the vulva in the female and into the rectum in the male. The inner tube 
contains the intestine; the outer tube consists of cuticle, hypodermis, musculature 
and nerve cells. The cuticle is secreted by the hypodermis. In some members of the 
order Trichostrongyloidea, such as the parasitic nematode Haemounchus 
contortus, cuticle ridges running the length on the body on the sub-median as well 
as the lateral surface, are clearly observed. The hypodermis consists of a 
syncytium of cells with four longitudinal thick structures: the lateral, ventral and 
dorsal hypodermal ridges or lines. The lateral lines contain the excretory canals and 
lateral nerve cords and the dorsal and ventral hypodermal ridges carry the dorsal 
and ventral nerve cords, respectively (the nematode nervous system will be 
described in section 1.5).
The pharynx is one of the most characteristic features of nematode morphology. It 
varies considerably between orders and species, a diversity largely correlated with 
feeding habits. For example, in the free-living nematode Caenorhabditis elegans, 
the pharynx is swollen into two muscular bulbs (metacarpus and terminal bulb) and 
in the parasite H. contortus it has a conoid shape (Bird and Bird, 1991). Since 
nematodes generally have a high internal pressure, and because the nematode 
intestinal wall is only one cell thick (and therefore liable to collapse under turgor 
pressure), the intestine can only be filled by a pumping organ. The pharynx is a 
cellular structure with distinct cell types: muscular, supporting, neuronal and
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glandular cells. When pharyngeal muscles contract, intrapharyngeal pressure builds 
up and food particles (normally semi-liquid contents) are propelled into the lumen. 
Upon muscle relaxation, the contents pass into the intestine through the pharyngeal 
intestinal valve. The intestine opens posteriously through the anus.
1.2 Parasitic infections
It is believed that the reasons for the success of the phylum Nematoda as parasites 
probably include the presence of an environmentally protective cuticle, facultative 
diapause (like the dauer stage of C. elegans, section 1.4) and biochemical 
adaptations to existence in extreme conditions. The parasitic forms have substantial 
impact on human welfare, through diseases of both humans and domestic animals, 
and crop damage.
As far as human parasites are concerned, more than 1.5 billion people are infected 
with geohelminths such as Ascaris lumbricoides and hookworms (Necator 
americanus and Ancylostoma duodenale) (Crompton, 1999). These infections can 
interfere with appetite, growth, physical fitness, physical activity, work capacity, and 
cognitive development. Hookworm anaemia, if untreated, is especially pernicious 
during pregnancy and in young children can lead to a vicious cycle of low birth 
weight and malnutrition sequelae (Stephenson et al., 2000). Lymphatic filiariasis 
(LF) is also a major public health problem. Worldwide, 120 million people suffer 
from this disease caused by species such as Wuchereria bancrofti and Brugia 
malayi (Cox, 2000). Athough LF is rarely fatal in itself, 43 million of those infected 
are seriously incapacitated or disfigured due to the gross swellings of limbs, breasts 
and genitalia. Also, about 18 million are infected with Onchocerca volvulus, a filarial 
nematode that produces impaired sight or blindness (Foege, 1998).
Nematodes such as H. contortus and Ostertagia ostertagi are of veterinary 
importance. They are gastrointestinal parasites of ruminants which cause 
economically important losses to the livestock industry, such as meat and wool loss 
and animal mortality (McLeod, 1995).
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Parasitic nematodes are the subject of extensive research efforts, often aimed to 
understand their lifestyle and ecology, so as to control or manage them better. The 
following sections will be mainly focused in H. contortus and the model nematode 
C. elegans, which are the organisms studied in this project.
1.3 Haemonchus contortus
Classification: Phylum, Nematoda; Order, Strongylida; Family, Trichostrongylidae.
H. contortus is one of the most common parasites of sheep and goats in both the 
southern and northern hemispheres. It is a dioecious haematophagous parasite 
whose adult stage is found in the fourth stomach (abomasum) of sheep, and other 
ruminants. Adult females are 18-30 mm in length and 0.55 mm diameter and males 
10-20 mm and 0.4 mm respectively (Veglia, 1915). They present a clear sexual 
dimorphism. The female has a remarkable appearance of red and white stripes 
because of its white ovaries wrapped around the red blood filled intestine (Fig. 1.1). 
The characteristic of the male is its external reproductive structure: copulatory 
bursa and brown spicules that form an umbrella-like expansion surrounding the 
cloaca.
Fig. 1.1 Morphology of Haemonchus contortus
The anterior end of the worms are to the right, a: female; i: intestine; o: ovaries; v: vulva, b: 
male; cb: copulatory bursa. Scale bar, 2 mm.
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The life cycle involves an external non-parasitic phase on the grass and soil, 
followed by a parasitic phase in the host (Smyth, 1994). A scheme of it is shown in 
figure 1.2. Adult worms mate in the abomasum producing fertile eggs that are 
released into the faeces. Females can lay up to 20,000 eggs per day. Eggs hatch to 
release first stage L1 larvae. After 14-17 hours they moult to give the second stage 
L2 larvae. L1 and L2 are both free-living microbivores. L2 larvae resume feeding for 
a further 40 hours and moult, but unlike the previous moults the L3 larvae retain 
their sheaths. Ensheathed L3 larvae, the non-feeding infective stage, survive by 
slow metabolism of stored reserves. L3 larvae are about 750 pm in length. They are 
unable to penetrate host skin, but they show positive geotrophism and climb up 
blades of grass, where they are accidentally ingested by ruminants.
In vertebrate
L4 moult to adult in the 
abomasum
L3 larvae burrow into abomasum, 
moult to L4 larvae
Infection upon direct ingestion of 
L3 larvae, followed by 





Eggs passed in faeces
L1 larvae feeding on faeces 
moult to L2 larvae
L2 larvae moult to L3 larvae but 
retain sheath (non-feeding 
infective stage)
Fig. 1.2 Schematic representation of H. contortus life cycle
L3 exsheathment occurs during passage to the abomasum. In this organ, the L3 
larvae burrow into gastric pits and start feeding. A third moult gives rise to the L4 
larva. The early L4 larvae can arrest development in the host (Armour and Duncan, 
1987). This diapause is induced by the onset of winter. The larvae must sense 
environmental cues in their host to allow then to re-enter the growth cycle after 
overwintering, and thus reinfect pasture and new lambs in the first flush of spring. 
Finally, a fourth moult is initiated and worms became sexually mature. Adults live 
buried in the host abomasum wall attached by their mouths to suck blood, but their 
bodies move actively, possibly to overcome the peristaltic action of the host
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gastrointestinal tract. A single sheep may be infected with many thousands of H. 
contortus and it has been estimated that 4000 worms suck about 60 cm3 of blood 
per day. This feeding can produce haemorrhaging of the abomasum and therefore 
blood plasma and proteins are lost in addition to the haemoglobin and iron from red 
blood cells. A loss of these components can cause anaemia and 
hypoalbuminaemia (Crompton and Joyner, 1980). As a result, production of milk, 
wool and meat becomes reduced, and in severe cases the sheep die.
1.4 Caenorhabditis elegans
Classification; Phylum, Nematoda; Order, Rhabditida; Family, Rhabditidae.
C. elegans is a small, free-living, soil nematode of 1 mm long. Hermaphrodites can 
be distinguished by the presence of a vulva, males by the fan-like tail (Fig. 1.3a). 
Hermaphrodites produce oocytes and sperm and can reproduce by self-fertilisation; 
they cannot fertilise each other. Males, which appear at a frequency of about 0.1 %, 
are capable of mating with hermaphrodites.
The C. elegans life cycle has a three-day generation time at 25°C. A single 
hermaphrodite can produce about 300-350 eggs. The embryo develops through a 
series of cell divisions that occur during the first 5 hours of embryonic development 
at 25°C (Fig. 1.3b). After about 14 hours of development in the case, the L1 larva 
hatches from the eggshell. The four larval stages (L1-L4) are each separated by a 
moult, during which the animal sheds its old cuticle. Under crowded conditions and 
with limited food, the L2 larva can enter an alternative developmental programme 
(dauer stage), in which the animal can survive long periods under harsh conditions. 
When those conditions improve and food becomes available, dauer larvae moult to 
L4 to later become adults.
21
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Fig. 1.3 Morphology and life cycle of Caenorhabditis elegans
A: Hermaphrodites can be distinguished by the presence of a vulva (arrowhead) and 
males by the fan-like tail (arrow). B: Schematic representation of the life cycle, d, 
dauer. Adapted from Jorgensen and Mango, 2002.
Since 1974, when Brenner published the first genetic screen in C. elegans, this 
worm has been a powerful model for the study of different biological process of 
multicellular organisms. Some of the features that have made of C. elegans such a 
good model include small size; rapid life-cycle; the choice of keeping strains as 
frozen stocks; transparent body and simple anatomy; identification of all somatic 
nuclei (959 in hermaphrodites); easy culturing and manipulation in the laboratory; 
the possibility of doing genetic analyses, molecular transfections and laser cell- 
ablation, and the completed genome sequence (The C. elegans Sequencing 
Consortium, 1998), etc. The choice of C. elegans as a model for metozoan biology 
has been fortunate for the study of parasitic nematodes. In particular, C. elegans
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has served as a reasonable model for the discovery of anthelmintic drugs and for 
studying their mechanism of action (Geary and Thompson, 2001). Moreover, in the 
molecular phylogeny of nematodes (Blaxter et al., 1998), a study based on 
nucleotide sequence, the orders Rhabditida, which includes C. elegans and 
Strongylida, the order containing important trichostrongyloid parasites of ruminants 
such as H. contortus, are included in the same Clade V. The close association of 
these two nematodes supports the use of C. elegans as a model for the study of H. 
contortus.
1.5 C. elegans Nervous System
The most studied nematode nervous system is that of C. elegans. This nematode 
has only 302 neurons in the adult hermaphrodite, but despite this small number it 
has a rich variety of neuronal types. Regarding the nervous system anatomy, the 
most complete data has been obtained from reconstructions from electron 
micrographs (EM) of serial sections (White et al., 1986). It has been assumed, 
beyond possible ambiguities of the method, that the EM reconstructions showed all 
the neuronal connections in the hermaphrodite nervous system. Analysis of the 
wild-type circuitry, coupled with laser ablation and genetic tools that disrrupt the 
function of a particular cell, have been used to identify the functional interactions 
between neurons in an identified circuit (Chalfie et al., 1985). For example, these 
approaches allowed the description of detailed models of how neurons function 
together to generate behaviour (Driscoll and Kaplan, 1997), and provided tools to 
interpret the spatial development and function of neurotransmitters (Rand and 
Nonet, 1997). Other approaches such as histochemistry and studies of the 
behavioural consequences of pharmacological agents have been used to 
investigate how this system works. Moreover, the recent development of 
electrophysiological techniques in C. elegans, such as patch clamping and voltage- 
and calcium-sensitive dyes, have contributed to the determination of the function of 
individual elements of a circuit (Kerr et al., 2000; Goodman et al., 1998).
C. elegans neurons differentiate, send out processes that migrate to their targets, 
form synapses with the correct targets and synthesize, package and release 
neurotransmitters. Synapses can be electrical (by gap junctions) or chemical.
23
Chemical synapses are en passant between adjacent processes within bundles, 
therefore no classic synaptic endings or synaptic terminals are present (White et al., 
1986). Many synaptic contacts are multiple with two or more postsynaptic elements. 
Appropriate receptors on postsynaptic neurons directly or indirectly activate ion 
channels to transmit the signal to their terminals. Much of the cellular machinery 
used by C. elegans to carry out these processes is homologous to that known in 
other organisms (Kenyon, 1988). C. elegans uses acetylcholine, GABA (y- 
aminobutyric acid), glutamate, 5-HT (serotonin), dopamine, the invertebrate 
catecholamine octopamine and neuropeptides as neurotransmitters (Bargmann and 
Kaplan, 1998; Brownlee and Fairweather, 1999). There are no predicted voltage- 
activated sodium channel genes in the C. elegans genome (Bargmann, 1998). 
However, C. elegans neurons have high membrane resistance, therefore they are 
able to propagate signals efficiently without the large-scale amplification provided 
by sodium channels (Davis and Stretton, 1989; Goodman et al., 1998). On the other 
hand, voltage-activated calcium channels and potassium channels participate on 
the regulation of nematode excitability.
1.5.1 Pharyngeal and Main Nervous System
The C. elegans nervous system (Chalfie and White, 1988) includes two almost 
independent units: the pharyngeal and the main nervous system that are only 
connected by a pair of ring interneurons (RIP). The processes of the RIP neurons 
penetrate the basement membrane in the anterior region of the pharynx (procorpus) 
and make gap junctions with two of the pharyngeal neurons (M1 and 11). In this 
case it seems that information flow runs from the sub-ventral nerve cords to the 
pharynx (Albertson and Thomson, 1976; White et al., 1986).
The C. elegans pharyngeal nervous system is composed of 20 cells: five classes of 
motor neurons (7 cells), six classes of interneurons (8 cells) and 5 other neurons (2 
neurosecretory-motor neurons, 1 motor-interneuron and 2 marginal cells). The 
topography and connectivity of these cells were described by Albertson and 
Thomson (1976). Updated information about all C. elegans pharyngeal neurons 
which includes: description, location, lineage and neuronal function (if it is known) 
can be found on Leon Avery’s web page: http://eatworms.swmed.edu
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The main nervous system includes all the remaining neurons found throughout the 
animal. Most of C. elegans neurons have their cell bodies in the anterior end 
around the pharynx. Neuronal processes run in longitudinal or circumferential tracts 
adjacent to the hypodermis (the hypodermis is the external epithelium). The major 
areas of neuropil are the nerve ring and the ventral and dorsal cords (Figs. 1.4 and
1.5). The nerve ring encircles the centre region of the pharynx (isthmus) in an 
oblique disposition and consists of processes of sensory neurons, interneurons and 
motor neurons that innervate head muscles. In most of cases these processes are 





Fig 1.4 Schematic representation of C. elegans main nervous system
Lateral view of the right side of the worm; anterior is right, nr: nerve ring. Nerve cords: 
dc: dorsal; vc: ventral; die: dorsal lateral; vie: ventral lateral; dslc: dorsal sub-lateral; vslc: 
ventral sub-lateral, p: pharynx. Note the sidedness of the motor neuron commissures 
(mnc); more are present on the right side than on the left (full and dotted circumferential 
lines, respectively).
The ventral nerve cord, the main process bundle, runs along the ventral mid-line 
extending from the ventral region of the nerve ring. This cord is made up of 
interneurons, and motor neurons that innervate body muscles. It is worth 
mentioning that all the cell bodies of these motor neurons lie on the ventral cord. 
Some motor neurons innervate ventral muscles and others dorsal muscles. This 
latter class send processes round to the dorsal mid-line via commissures, the motor 
neuron commissures. These then turn either anteriorly or posteriorly and together 
make up the dorsal nerve cord (Fig. 1.4). The nerve cords run adjacent to swellings 
of the hypodermis (hypodermal ridges). Because the hypodermal ridges are 
situated on the left of the process bundle, it may present a barrier on that side to 
commissures leaving the cord and might be the reason why most of the motor 
neuron commissures run round the right-hand side of the animal (Figs. 1.4 and 1.5).
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In addition to the main cords, lateral cords (dorsal and ventral) and sub-lateral cords 
(dorsal and ventral) are present, containing nerve processes from nerve ring 
interneurons and some mechanosensory neurons. They are located in small 
hypodermal swellings, the lateral lines. The sub-lateral cords run along the anterior 
and middle portion of the worm. The dorsal lateral cord extends through the entire 
animal, but the ventral lateral cord is present only in the posterior region (Fig. 1.4)
1.5.2 Sensory organs
Sensory receptors are arranged in groups of sense organs, named sensilla. Each 
sensillum contains one or a number of ciliated nerve endings (cilia) and two non­
neuronal cells: a sheath and a socket cell. A socket cell is an interfacial hypodermal 
cell that joins the sensillum to the hypodermis and a sheath cell is a glial-like cell 
that envelops the endings of neurons (Chalfie and White, 1988). Sensilla open 
through a hole in the overlying cuticle, giving the cilia access to the external 
environment. Such organs, generally considered to be chemosensory, include the 
two amphid sensilla and the six inner labial sensilla in the head, and the two 
phasmid sensilla in the tail. In contrast to C. elegans, the inner labial neurons of L3 
larvae of the parasitic nematodes Strongyloides stercoralis and Haemonchus 
contortus end beneath the cuticle, and, consequently, are thought to be 
mechanosensory neurons (Fine et al., 1997; Li et al., 2000a). The amphid sensilla 
are described in section 1.5.2.1.
Some ciliated endings do not penetrate the cuticle and are, therefore, thought to 
mediate mechanosensation. These include the following sensilla: the six outer 
labial, the four cephalic, the two deirid sensilla and the two postdeirid sensilla. Other 
receptors with a characterised mechanosensory modality are the touch receptors: 
ALM, PLM, and AVM (Chalfie and Sulston, 1981). Their sensory processes are not 
organised as sensilla but are differentiated in prominent microtubules and extend 
along the length of the lateral lines and ventral midline.
The nerve ring receives sensory input from the anterior tip of the nematode through 
the anterior sensilla. The processes for the non-amphidial sensilla have their cell 
bodies in front of the nerve ring in the anterior ganglion, whereas fibres from the 
amphids run past the nerve ring to their bipolar cell bodies in the lateral ganglia
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from which axonal processes turn back and enter the nerve ring (White et al., 
1986).
1.5.2.1 Am phids
The amphid sensilla are the main chemoreceptive organs of the anterior end of the 
worm. They consist of two bilaterally symmetric sensilla (left and right) containing 
the ending of 12 types of sensory neurons. These neurons can be distinguished 
from each other by their morphology and by their connections to other neurons. 
Each neuron is bipolar, with one sensory process (dendrite) and one presynaptic 
process (axon) emerging from the cell body. The dendrites extend to the nose and 
terminate in sensory cilia. All the axons extend to the nerve ring, where they make 
connections with other neurons and each other. The amphidial process tracts are 
represented in the diagram of figure 1.5.
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Fig. 1.5 C. elegans anterior nerve bundles.
a: left lateral view with the anterior of the worm towards the left, b-d: cross-sections at 
different regions, showing in circles axons of different neurons. Blue arrows indicate the 
bilateral symmetry of nerve processes. Notice amphidial nerves, nerve ring, the dorsal, 
ventral and sublateral nerve processes as a right-side motor neuron commissure (mnc). hr: 
hypodermal ridge. Adapted from Hobert et al., 2002.
Based on their dendritic morphology and function, amphidial neurons can be 
grouped into three classes: exposed, wing and finger cells (Ward et al., 1975). The
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exposed cells have one or two long cilia open to the environment through the 
amphidial pore and include: ADF, ADL, ASE, ASG, ASH, ASI, ASJ and ASK 
neurons. These cells detect mostly water-soluble chemicals (Bargmann et al., 1990; 
Bargmann and Horvitz 1991 a,b; Kaplan and Horvitz 1993; Troemel et al., 1995). 
The wing cells have flattened branched cilia near the pore but enclosed by the 
sheath cell. They include the AWA, AWB and AWC neurons, which detect volatile 
odorants (Bargmann et al., 1993; Troemel et ai., 1997). Finally the finger cell, AFD, 
has a complex brush-like dendritic membrane structure embedded in the sheath 
cell, and detects thermal cues (Mori and Ohshima, 1995). Neurons from different 
groups do not share sensory functions, excepting the ASH neurons which are 
particularly broad in their function. They detect water-soluble repellents: high 
osmotic strength (Bargmann et al., 1990), volatile repellents such as octanol 
(Troemel et al., 1995), and a mechanical repellent, light touch to the nose (Kaplan 
and Horvitz, 1993).
As far as H. contortus amphidial neurons are concerned, they do not take up 
fluorescent label fluorescein isothiocyanate (FITC), 1,1’ dioctadecyl-3,3,3’- 
tetramethylindocarbocyanine perchlorate (Dil), or 3,3'-dioctadecyloxacarbocyanine 
perchlorate (DiO), as do those of C. elegans (Hedgecock et al., 1985); therefore 
dye filling cannot be used in the parasite as a tool to identify amphidial neurons (Li 
et al., 2000a). The sensory neuron anatomy of H. contortus first stage larva (L1), 
has been studied by neuronal laser microbeam ablation coupled to three- 
dimensional reconstructions from electron micrographs of serial transverse sections 
of the anterior sensilla (Ashton et al., 1999; Li et al., 2000a). On L1 and L3 larva, 
the stage-to-stage constancy of the amphidial neuronal number, position and 
structure in H. contortus, was confirmed (Li et al., 2000a). Amphidial structure in H. 
contortus is similar for the described on C. elegans, suggesting that the sensory 
functions controlled by these neurons might be also comparable. As in C. elegans, 
each amphid of H. contortus is innervated by 12 neurons. However, whereas the 
position of cell bodies is conserved between these nematodes, they differ on the 
number of neurons included in the amphid channel (ten in H. contortus instead of 
eight), and in that three of these neurons rather than two, end in double processes. 
Recently a comparison of amphidial structure between H. contortus ivermectin- 
resistant and susceptible strains, revealed a dramatic decrease in the length of 
sensory cilia in the resistant strains (Freeman et al., 2003). Whether such structural
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modification of the dendrites facilitates survival of nematodes exposed to 
macrocyclic lactones remains unclear.
The structure of amphidial neurons has also been described for two other 
gastrointestinal nematode parasites: Ancylostoma caninum, the hookworm of dogs, 
and Strongyloides stercoralis, which normally parasitises humans, other primates 
and dogs (Ashton at al., 1999). Whereas in A. caninum the amphidial structure is 
very similar to that of H. contortus, in S. stercoralis is slightly different from that of 
C. elegans, A. caninum and H. contortus (Ashton et al., 1995 and 1999). Thirteen 
neurons instead of 12 are associated with the amphid. In each amphid, eleven 
neurons extend nearly to the amphidial pore as single ciliated dendritric processes. 
A twelfth dendrite terminates at the base of the amphidial channel. One specialised 
neuron (ALD) enters the base of the amphidial channel along with the other 
dendirtes, but leaves the channel and forms a complex of lamellae within the body 
of the amphidial sheath cell. The shape of it dendritic process is similar to the wing 
cell AWC in C. elegans, but it is much more complex. The large number of lamellae 
of ALD greatly increase the surface area of the process as do the microvilli of the C. 
elegans thermoreceptor neuron AFD, absent in S. stercoralis. It has been described 
that the neurons ALD mediate thermotaxis in this parasite, and would play an 
important role in host-finding behaviour (Lopez et al., 2000). Although some 
structural differences have been found between amphidial dendrites of C. elegans 
and parasitic nematodes, the position of the amphidial cell bodies are found to be 
quite similar (Ashton et al., 1999). Ashton et al (1998) demonstrated that C. elegans 
can serve as a model for predicting the function of amphidial neurons in S. 
stercoralis, based on similarities in the positions and morphological characteristics 
of the amphidial neurons of the two species. In S. stercoralis ASI and ASF (=ADF in 
C. elegans), two apparently C. elegans homologous amphidial neurons that control 
the process of becoming environmental resistant dauer larvae in the free-living 
nematode, also control the direction of larval development in the parasite.
The neurons of the amphid sensilla have synaptic outputs predominantly focused 
onto four nerve ring interneurons and the output of this circuit connects to ventral 
cord interneurons, providing a link to the motor nervous system (White et al., 1986).
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1.5.3 Motor neurons and locomotion
In C. elegans and in Ascaris suum, a parasitic nematode whose motor nervous 
system has been widely studied (Stretton et al., 1978; Warlond et al., 1985; 
Johnson and Stretton, 1985 and 1987; Stretton et al., 1992), seven main classes of 
motor neurons are present along the ventral cord, arrayed in repeating units. C. 
elegans motor neurons VAn, VBn and VDn innervate ventral muscle and DAn, DBn, 
ASn and DDn, innervate dorsal muscle. The D-type of neurons and their analogous 
cells in Ascaris possess y-aminobutyric acid (GABA)-like immunoreactivity and 
therefore, are thought to utilise GABA as their neurotransmitter (Mclntire et al., 
1993; Johnson and Stretton 1987). The other type of ventral cord motor neurons 
contains the vesicular acetylcholine transporters (VAChT) and choline 
acetyltransferase (ChAT), therefore use the neurotransmitter acetylcholine 
(Erickson et al., 1994; Johnson and Stretton, 1985).
Motor neurons innervate dorsal and ventral muscles. Body wall muscles are 
organised into two dorsal and two ventral rows. An unusual feature of nematode 
muscle is the manner in which it is innervated. Motor neurons do not extend axons 
peripherally to innervate muscles; instead, muscles send neuron-like processes 
(muscle arms) to the dorsal or ventral cords in which the axons of motor neurons 
reside (Chalfie and White, 1988). At neuromuscular junctions, motor neurons 
release either acetylcholine or GABA causing at a particular area and at the same 
time, contraction of muscle cells in one side of the animal and relaxation on the 
opposite side (Fig. 1.6). This model of cross-inhibition would prevent the 
simultaneous contraction of the dorsal and ventral muscles (White et al., 1986). 
This, coupled to the activation of cholinergic motor neurons by the command 
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Fig. 1.6 Motor neurons and locomotory circuitry
The GABA-ergic motor neurons (red circles) synapse onto muscles situated opposite to 
those innervated by their presynaptic partners, the cholinergic motor neurons (grey circles), 
as indicated with triangles on the dorsal (d) and ventral (v) cords. The VB and VA motor 
neurons do not send processes to the dorsal cord. Cholinergic motor neuron commissures 
(Cm) emerge from motor neuron cell bodies, whereas the GABA-ergic motor neuron 
commissures (Gm) do not. The Gm are right handed but the Cm can be right or left handed. 
Command interneurons (I) synapse onto cholinergic motor neurons directing forward or 
backward movement. Full arrows indicate neuronal synapses (Adapted form Chalfie and 
White, 1988).
1.6 Control of H. contortus infection
1.6.1 Chemical control
The use of antiparasitic chemicals appears to be the most effective and is the most 
widely used method to tackle parasitic infections. Drugs isolated from natural 
botanic and microbiological resources or synthetic compounds have been applied 
(Thompson et al., 1996). However, there is a serious problem of anthelmintic 
resistance in nematode populations in the field. Up to date information on the 
chemotherapy used to treat nematode infections is reviewed by Harder (2002). The 
latest and most potent drugs to treat H. contortus infections belong to the family of 
avermectins and milbemicins (section 1.7).
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1.6.2 Other methods
Alternative methods to chemotherapeutics include grazing management (Strong 
and Wall, 1990). Pasture resting counteracts the possibility of transmission by 
rotating livestock to clean pastures and by alternation grazing between species. 
Dung removal, by sweeping or vacuuming infected dung from the fields, is also 
recommended. Due to differences in management, pasture infectivity, climate, etc, 
it is difficult to establish which programme is to be preferred to control nematode 
infections in livestock. Grazing strategies, when possible, should be combined with 
drug treatment (Coop et al., 2002).
Biological control methods have also been implemented. They are based on the 
use of fungi with nematophagous activity, which are able to reduce the number of 
larvae of sheep and cattle nematodes while they are undergoing the free-living 
stages of their life cycle. Some fungal species are more efficient predators of 
infective larvae in sheep faeces (Waller and Larsen, 1993; Waller and Faedo,
1993). A disadvantage of this approach is that they mostly depend on climatic 
conditions. However, other fungal species have a greater capacity to survive 
passage through the gastrointestinal tract of ruminants and were used to feed 
nematode infected calves. Those assays showed a reduction on the levels of eggs 
from faecal deposits obtained from those calves (Gronvold et al., 1993).
Finally, vaccines could be another alternative used as a method of control. The 
development of vaccines has mainly depended on the identification of novel 
parasite antigen molecules able to elicit a protective immune response in the host 
(Meeusen, 1996). For H. contortus a vaccine based on an intestinal protein, 
contortin, showed a significant reduction in worm burden and egg count in sheep 
(Munn et al., 1987). Also H. contortus excretory-secretory products induced 
protective immunity against the parasite in the host (Schalling et al., 1997). 
However, no H. contortus vaccines are available. A commercially available vaccine 
must need to target multiple species of gastrointestinal nematodes, be cost- 
effective and be accepted into farm management strategies (Knox, 2000).
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1.7 Ivermectin
The avermectins (AVMs) and milbemycins are structurally related classes of 16- 
membered macrocyclic lactones, a group of very hydrophobic compounds, which 
have potent anthelmintic, insecticide, and acaricide properties. Both were isolated 
in the 1970s from soil-dwelling Streptomyces species and remain at the forefront of 
control for a range of endo- and ecto-parasites, including nematodes. The first 
commercial member of the AVMs/milbemycins (AMs), ivermectin (IVM), was 
introduced in 1981. Ivermectin (22,23-dihydro-avermectin Bia), is a semi-synthetic 
derivative of avermectin Bia, the most potent of the 8  natural AVMs originally 
isolated, developed for use in animals (Chabala et al., 1980). The high potency of 
IVM against nematodes of sheep was first reported by Egerton et al (1980). They 
found that oral dosing of IVM to sheep at dosages almost 100 times less that 
thiabendazole (an anthelmintic drug that binds to p-tubulin and inhibits microtubule 
polymerisation (Lacey, 1990), eliminated nematode species from the 
gastrointestinal tract such as H. contortus, Ostertagia circumcincta and 
Trichostrongylus spp.
Other AMs anthelmintics used to control parasitic infections in small ruminants 
include doramectin, moxidectin and abamectin. All AMs are effective against the 
same spectrum of biologically diverse invertebrate parasites, they kill these 
organisms through hyperpolarisation and flaccid paralysis and they are efficacious 
at similar dosages (Shoop et al., 1995). Given the similarity in structure and action 
between the AVMs and milbemycins, it is often assumed that data obtained with 
one member of the family is generally applicable to all. Though this may be true, it 
is probably sensible to note that this may not always be the case and therefore it 
will be noted which compounds were actually used in the experiments reviewed 
here.
Like the other AMs, IVM has a broad spectrum of activity and has also been widely 
used to combat nematode parasitism of humans, other domesticated animals, and 
crops (Campbell, 1989). In man IVM has become the cornerstone of the mass drug 
administration program to eradicate onchocercasis (river blindness) (Dull and 
Meredith, 1998) and is used in part for a similar program to eliminate lymphatic 
filariasis (Brown et al., 2000).
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1.7.1 Safety of AMs
The selective effect of action of AMs in the host, can be explained by their action on 
the glutamate-gated chloride channels (GluCIs), present only in invertebrates 
(section 1.8). AMs generally show very low host toxicity. It is believed that the 
blood-brain barrier prevents access of IVM to the central nervous system (Fisher et 
al., 1992). Since at higher concentrations (100-fold more than therapeutic dosage) 
IVM can potentiate GABA-gated chloride channels and a7 nicotinic acetylcholine 
receptors (Adelsberger et al., 2000; Krause et al., 1998), it has been suggested that 
IVM and related drugs can be toxic for vertebrates that possess a deficiency in their 
blood barrier (Etter et al., 1999). This is supported by data from Kwei et al (1999) 
and Mealey et al (2001), which found that the side effects seen in vertebrates 
following IVM treatment may be due to the lack or functional deficiency of a P- 
glycoprotein membrane pump (mdr) in their blood barrier.
1.7.2 Ivermectin Resistance
In nematodes that infect small ruminants, particularly in H. contortus, anthelmintic 
resistance has reached enormous proportions in many parts of the world (Prichard, 
1994; Sangster, 1999; Jackson and Coop, 2000). Genes involved in drug 
resistance may, but will not necessarily, be involved in the mechanism of action of 
an anthelmintic. Resistance mechanisms can broadly be considered as due to 
changes in the drug receptor, or modulation of drug concentration. However, genes 
that code for transport or metabolism, for example, can be involved in drug 
resistance but have no direct role in the mechanism of action. Population genetic 
studies have suggested that during the development of AMs resistance in H. 
contortus, there is selection at a P-glycoprotein (Pgp) gene (Blackhall et al.,1998a), 
at the HcGluCIa (Blackhall et al., 1998b), which encodes a glutamate-gated 
chloride channel (section 1.8) and at HG1 (Feng et al., 2002), a putative member of 
the amino acid-gated anion channel subunit family (Laughton et al., 1994). Studies 
from Le Jambre et al (1999) showed that the Pgp gene is not the major gene 
responsible for resistance, at least in the H. contortus CAVRS IVM-resistant strain. 
Further work is required to characterise whether the function of any of the other two 
is relevant for AM resistance. As far as HcGluCIa is concerned, full-length cDNA
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sequences from H. contortus IVM-resistant and IVM-sensitive isolates were 
analysed (Cheeseman et al., 2001). No consistent coding differences were found 
between both isolates, which led to the suggestion that if there are any changes in 
this gene associated with IVM resistance, they might be present in the non-coding 
regions and possibly result in alterations in the expression of the HcGluCIa subunit 
rather than to its amino acid sequence.
C. elegans has been used to study the effects of gene knockouts and mutations on 
resistance to anthelmintics such as IVM. These studies have lead to the isolation of 
multiple IVM-resistant mutant strains. The genes known to be involved in IVM- 
resistance include genes encoding for GluCI subunits (avr-15, avr-14 and glc-1), 
two innexin genes (subunits of invertebrate gap junctions) and dye filling defective 
(Dyf) genes (Dent et al., 2000). It seems that the development of resistance in C. 
elegans requires the simultaneous mutation of several of those genes to develop 
high level of resistance. IVM resistance in C. elegans does not necessary replicate 
the mechanisms of resistance in parasitic worms. However, C. elegans can help to 
identify orthologous genes in parasitic nematodes, which might provide insights into 
the possible mechanisms of resistance in parasitic nematodes.
1.7.3 Biological effects
A number of in vitro studies have shown that the AMs inhibit pharyngeal pumping 
(and hence feeding), motility and fecundity in susceptible nematodes. In H. 
contortus, pharyngeal pumping is the most sensitive of the processes affected by 
these anthelmintics (Gill et al, 1991, 1995; Geary et al., 1993; Paiement et 
al.,1999). IVM concentrations >0.1 nM paralyse the pharynx of adult H. contortus, 
whereas a reduction in motility leading to overall paralysis requires >10 nM IVM. 
Interestingly paralysis is confined to the mid-body region of the worm, with the head 
and tail regions still able to move normally (Geary et al., 1993). It is believed that 
inhibition of pharyngeal pumping would lead to a depletion of energy reserves as 
the parasite would no longer be feeding, while inhibition of motility would be 
expected to have a more immediate effect as gastrointestinal parasites would be 
swept away by digesta. AVMs exert similar effects at comparable concentrations on 
H. contortus larvae (Gill et al., 1991,1995) and C. elegans (Kass et al., 1980; Avery 
and Horvitz, 1990; Arena et al., 1995). In some species, particularly the filaria, the
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most important effect on the adult worm is to suppress new microfilariae production 
(Awadzi et al., 1985; Duke et al., 1991) without directly killing the resident 
macrofilariae; similar effects on fecundity are seen in H. contortus and C. elegans 
(Le Jambre et al., 1995; Grant, 2000). It remains unclear which mechanism is 
responsible for the overall potency of the AMs in vivo towards H. contortus and 
other parasitic nematodes. Since H. contortus and Trichostrongylus colubriformis, 
both gastrointestinal sheep parasites, may be expelied very rapidly after IVM 
treatment (within 8 - 1 0  hours), it has been suggested that parasite body wall 
paralysis rather than inhibition of feeding may be the crucial event for initial removal 
of those nematodes from the host (Gill and Lacey, 1998; Sangster and Gill, 1999). 
However, in O. circumcincta (a gastrointestinal cattle parasite) AMs effects on 
pharyngeal pumping may be crucial for the elimination of this nematode from the 
host. It seems likely that the relative importance of each of these major effects may 
differ between species and even developmental stages.
1.7.4 Molecular targets
It was apparent from early experiments that the AVMs interacted with ligand-gated 
chloride channels from both target and non-target species (Kass et al., 1980; 
Supavilai and Karobath 1981; Graham et al., 1982; Pong and Wang 1982) and so 
perhaps it was not surprising that it was thought that their main target could be the 
GABA receptor present at the nematode neuromuscular junction, though 
micromolar concentrations were required to elicit the blocking effects observed 
(Holden-Dye et al., 1988; Holden-Dye and Walker 1990). A patch-clamp study by 
Martin and Pennington (1989) on A. suum muscle also demonstrated that IVM 
antagonised GABA receptors, reducing the single-channel conductance and the 
frequency of channel openings. The same study showed that IVM activated both 
non-GABA chloride channels and cation-selective channels.
Older studies have also indicated that AVM Bia could also block transmission 
between interneurons and excitatory motorneurons in the ventral cord and ventral 
inhibitory neuromuscular transmission (Kass et al., 1980,1984). Delany et al (1998) 
proposed that this could be explained by the presence of glutamate-gated chloride 
channels (GluCIs) on motor neurons innervating the somatic muscles. Today it is 
clear that the AMs can interact with a wide variety of channels, including
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mammalian glycine and GABAa receptors (Adelsberger et al., 2 0 0 0 ; Dawson et al., 
2000; Shan et al., 2001), a7 nicotinic acetylcholine receptors (Krause et al., 1998) 
and P2 X4  receptors (Khakh et al., 1999).
The first direct evidence for an AM interaction with GluCIs was revealed in insect 
muscle. IVM was shown to activate a chloride channel, which was sensitive to the 
glutamate analogue ibotenate but insensitive to GABA (Duce and Scott, 1985; Scott 
and Duce, 1985). In nematodes, IVM was shown to bind a site in membranes 
prepared from C. elegans with a 1 0 0 -fold higher affinity than binding to membranes 
from rat brain. The relative binding affinities of IVM and a number of derivatives 
were shown to correlate well with their ability to inhibit motility in C. elegans, i.e. the 
higher the binding affinity the more potent the effect on motility (Schaeffer and 
Haines, 1989). High affinity binding by a series of AM analogues has also been 
demonstrated to membranes prepared from H. contortus (Rohrer et al., 1994; 
Hejmadi et al., 2000; Cheeseman et al., 2001). When avermectin-sensitive chloride 
currents were produced in Xenopus oocytes injected with C. elegans mRNA, they 
were found to be GABA-insensitive (Arena et al., 1991) but, later, to be sensitive to 
glutamate (Arena et al., 1992). This, and the subsequent cloning of cDNAs 
encoding avermectin sensitive GluCI subunits from C. elegans, parasitic nematodes 
and insects (Cully et al., 1994, 1996a; Dent et al. 1997, 2000; Laughton et al., 
1997a; Forrester et al., 1999, 2002; Jagannathan et al., 1999; Cheeseman et al. 
2001; Horoszok et al., 2001) has led to the belief that the GluCIs are the principle 
targets through which the AMs exert their biological effects on nematodes.
Electrophysiological studies of pharyngeal preparations from both C. elegans and 
A. suum have shown that the AMs act on GluCIs to inhibit pumping (Martin 1996; 
Adelsberger et al., 1997; Pemberton et al., 2001), though Brownlee et al (1997) 
also suggested a possible interaction with GABA receptors in the A. suum pharynx. 
In insects the situation has been recently complicated by the suggestion that the 
Drosophila avermectin receptor may contain both the GluCI subunit and the GABA 
receptor subunit, RDL (Ludmerer et al., 2002) and by the discovery of avermectin- 
sensitive histamine-gated chloride channels (HisCIs) (Gisselmann et al., 2002; 
Zheng et al., 2002). Mutations in the ort gene, which encodes one of the HisCI 
subunits, alter the susceptibility of the flies to the avermectins (Georgiev et al., 
2002; lovchev et al., In Press) suggesting that these channels may be important
37
targets in vivo. In nematodes, where no HisCIs have been demonstrated, the 
evidence remains strongly in favour of the GluCIs as the clinically relevant AM 
target.
1.8 Glutamate-gated chloride channel (GluCI) 
subunits
The initial isolation of the C. elegans GluClal and GluCip cDNAs by the Merck 
group, was carried out by subfractionation of clones from a cDNA library, screened 
by expression in Xenopus oocytes of mRNA pools that elicited responses to low 
concentrations of glutamate (1 mM) and/or IVM (1 pM) (Cully et al., 1994). 
Phylogenetic analyses indicated that these subunits belong to a discrete ligand- 
gated ion channel family that may represent genes orthologous to the vertebrate 
glycine channels (Vassilatis et al., 1997a). GluCI channels (GluCIs) have been also 
described from neuronal and muscular tissues of insects (Cully-Candy and 
Usherwood, 1973), crustaceans (Cleland and Selverston, 1995) and molluscs 
(Ikemoto and Akaike, 1988).
The GluCI subunits share about 40 % and 30-35 % amino-acid identity with the
vertebrate glycine and GABAa receptor subunits, respectively (reviewed by Cleland,
1996). The individual subunit sequences show all the characteristics of the ligand-
gated ion channel family, with a long N-terminal extracellular domain followed by
four membrane-spanning domains (Fig. 1.7). The N-terminal domain possesses a
second pair of cysteine residues and carries the ligand-binding site. The
intracellular loop between the third and fourth transmembrane domains contains
consensus sequences for protein kinases: in other members of the family protein
phosphorylation has been shown to affect the channel properties (Porter et al.,
1990; Wafford and Whiting, 1992; Moss et al., 1995; Filippova et al., 2000). By
analogy with other ligand-gated ion channels, the mature receptor is presumed to
be a pentamer, made up of different types of subunit and with the second
membrane-spanning domains lining the ion pore. To date there is no direct
evidence on the subunit composition of any nematode GluCI. The ‘a subunits were
named based on their ability to respond to IVM when expressed in a heterologous
system, usually the Xenopus oocytes for C. elegans (Cully et al., 1994; Dent et al.,
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1997; Vassilatis et al., 1997b; Dent et al., 2000; Horoszok et al., 2001). The ‘P’ 






Fig. 1.7 Diagram of a putative GluCI receptor
Pentameric structure of the GluCI transmembrane channel. The subunits cluster around a 
central ion pore composed of their second transmembrane domains (TM), the TM2 regions. 
The lower panel ilustrates the composition of a single subunit showing a long N-terminal 
region, the four TM regions (TM1-TM4), and the cytoplasmic loop between TM3 and TM4 
which contains consensus phosphorylation sites (P). The agonist binding sites are in the N- 
(t) domain and cross the interface between the p- subunit and the adjacent subunit (top 
view, green triangles). As the C. elegans GluCIa and p subunits form heteromeric functional 
receptors when expressed in Xenopus oocytes (Cully et al., 1994), they were 
representatively chosen for this diagram.
Further cloning studies, together with the complete C. elegans genomic sequence, 
have led to the identification of a small family of six GluCI genes in this species 
(Table 1.1). At least two of these genes, avr-14 and avr-15, are alternatively spliced 
(Dent et al., 1997, 2000; Laughton et al., 1997a; Vassilatis et al., 1997b) to yield at 
least eight possible subunits. Since the native GluCIs are presumed to be 
pentamers, it is clear simply from the number of GluCI subunit genes that multiple 
forms of this channel must exist in worms, and there are therefore likely to be 
multiple AM target sites.
COOH
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Table 1.1 GluCI genes and subunits
The current names used for genes and subunits are shown. Other names that have been 
used in the literature are given in brackets.
C. elegans gene C. elegans subunit H. contortus gene H. contortus subunit
glc-1 GluClal
glc-2 GluClp Hcglc-2 (hg4) HcGluCip (HG4)
gic-3 GluCla4
glc-4 (C27H5.8) GLC-4
avr-14 (gbr-2) GluCla3A (GBR-2A) 
GluCla3B (GBR-2B)





The alternative splicing of avr-14 is intriguing: both mRNAs encode the same N- 
terminal domain, which would include the glutamate binding site, but are attach to 
different membrane-spanning domains, which form the chloride ion channel 
(Laughton et al., 1997b). The parasitic species about which we have most 
information is H. contortus. So far, three genes encoding four GluCI subunits have 
been identified in this organism (Delany et al., 1998; Forrester et al. 1999; 
Jagannathan et al., 1999; Cheeseman et al., 2001) (Table 1.1). Figure 1.8 shows a 
neighbour-joining tree of the GluCI subunits so far identified in C. elegans, H. 
contortus and D. melanogaster. Three of the H. contortus subunits are clearly 
orthologues of ones in C. elegans, the HcGluCip and a3 subunits; in the absence of 
a complete genome sequence it is impossible to know whether or not orthologues 
of the other C. elegans genes await discovery. Similar to C. elegans GluCIs, 
HcGluCIa was defined as an ‘a subunit based on it capability to bind IVM when 
expressed in cultured mammalian cells (Forrester et al., 1999; Cheeseman et al., 
2001; Forrester et al., 2002). This subunit does not seem to be orthologous to any 
of the C. elegans genes (Cheeseman et al., 2001), indicating that there are 
differences in the genetics of the GluCIs between even quite closely related
nematode species: H. contortus and C. elegans (Blaxter et al., 1998). Sequences 
corresponding to avr-14 have also been isolated from A. suum and the filarial 
species Onchocerca volvulus and Dirofilaria immitis (Cully et al., 1996b; 
Jagannathan et al., 1999; Yates and Wolstenholme, pers. commun.): the alternative 
splicing of this gene is conserved in all the nematodes where this has been 
examined (Jagannathan et al., 1999; Yates and Wolstenholme, pers. commun.). 
The final member of the C. elegans GluCI family, glc-4, is somewhat divergent from










-  HcGluCip 
■ GLC-4
Fig 1.8 Neighbour-joining tree to illustrate the relationships between the identified 
C. elegans, H. contortus and D. melanogaster GluCI subunits
Amino-acid sequences were analysed. Taken from Yates et al., 2003.
the a and p subunits and may therefore represent a y  subunit. Related sequences 
are present in the Brugia malayi genome, as yet we do not known whether this is 
also true for H. contortus.
The nomenclature of some of the GluCI genes and subunits is rather confusing, as 
may be obvious from Table 1.1. Some of this confusion stems from the original 
isolation of C. elegans avr-14 by both genetic (Dent et al., 2000) (avr= avermectin 
resistance) and molecular cloning (Laughton et al., 1997a) methods: originally avr- 
14 was referred as gbr (GABA-receptor related)-2 in the absence of any functional 
data and the name has continued to be used for the parasite orthologues. In C. 
elegans the subunits encoded by this gene have been referred to as GluCla3A & -B 
(Dent et al., 2000). A possible source of confusion in applying this nomenclature to 
the H. contortus subunits is that no ‘a2’ subunit has been identified to date and the
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H. contortus a  subunit is clearly different from C. elegans a1 (Cheeseman et al.,
2001). In this work, and in order to clarify the present nomenclature, where clear 
orthologues of identified C. elegans genes are identified in parasites, equivalent 
names (avr-14, GluCla3) will be used. Where the evolutionary relationship between 
the genes is more uncertain (HcGluCIa), we will use the names originally given in 
the literature.
I.8.1 Pharmacology of GluCI channels
The current understanding of nematode GluCI pharmacology has been derived 
from the following experimental approaches: two-electrode voltage clamp 
recordings from Xenopus oocytes expressing C. elegans GluCI subunits, 
radioligand binding studies on membranes from either whole worms or cell-lines 
expressing GluCI subunits, and electrophysiological assays using nematode tissue 
preparations. Pharmacological evidences suggest that the GluCIs are the high- 
affinity binding sites for the AMs in nematodes. The current pharmacology data 
from all C. elegans GluCI subunits expressed in X. laevis oocytes, are summarised 
in table form in Pemberton et al (Pemberton et al., 2001).
Interestingly, the concentrations of IVM required to gate C. elegans GluCIs 
expressed in Xenopus oocytes are high when compared to the concentrations able 
to paralyse pharyngeal pumping and motility in worms in vitro. Besides, a recent 
electrophysiological study on C. elegans pharynx, demonstrated that the native 
pharyngeal GluCIs from C. elegans were considerably more sensitive to IVM than 
GluCIs expressed in Xenopus oocytes (Pemberton et al., 2001). In this work the 
inhibitory response observed on the C. elegans pharynx was caused by a 
depolarisation of the membrane and not the previously suggested hyperpolarisation 
(Dent et al., 2000). IVM elicited a chloride-dependent depolarisation of the muscle: 
this response was typically irreversible and highly potent, with an EC5o=2 . 7  nM 
(Pemberton et al., 2001). The potency of the IVM response was comparable with 
concentrations shown to paralyse the pharynx in vitro (Avery and Horvitz, 1990; 
Geary et al., 1993). This could be explained by potentiation of the IVM response by 
endogenous glutamate (Pemberton et al., 2001). In support of this, a recent study 
has shown that glutamate potentiated AM binding to the H. contortus HcGluCIa 
subunit (Forrester et al., 2002). Alternatively the observed differences of IVM
42
sensitivities could be explained by the native subunit composition of the IVM 
receptor. So far only a limited number of C. elegans GluCI subunit combinations 
have been successfully expressed in oocytes and none of these seemed to reflect 
the composition of native GluCIs. Therefore, the elucidation of the subunits that 
form the native avermectin/GluCI receptor is vital to understand the pharmacology 
of AMs in this therapeutical relevant receptor.
Studies of H. contortus GluCI pharmacology have largely taken a radioligand 
binding assay approach. IVM has been shown to bind a high affinity site in H. 
contortus whole worm membrane preparations with a Kd ranging from 0.07-0.6 nM 
(Rohrer et al., 1994; Hejmadi et al., 2000; Cheeseman et al., 2001). This is 
comparable to the high affinity IVM binding site (Kd = 0.26 nM) described in C. 
elegans (Schaeffer and Haines, 1989) and to the concentrations of the drug that 
exhibit anthelmintic activity. Further binding studies were conducted with 
membranes prepared from COS-7 cells, a mammalian cell-line, expressing 
individual H. contortus GluCI subunits (Cheeseman et al., 2001; Forrester et al.,
2002). As predicted by functional data from the C. elegans orthologues, the 
HcGluCIa and HcGluCla3B subunits were shown to bind [3 H]-IVM with Kd values of 
26-110 pM and 70 pM respectively. These data implicate the high-affinity IVM 
binding site to be a GluCI. Binding of [3H]-IVM to the individual subunits and whole 
worm membranes was inhibited by a variety of AVMs, implying they all bound the 
same site. However glutamate, GABA and PTX failed to compete for the IVM 
binding site. The recombinant HcGluCla3A and HcGluCip subunits exhibited no 
specific [3 H]-IVM binding, as predicted from the properties of their C. elegans 
orthologues expressed in Xenopus oocytes. Finally, radioligand binding assays 
indicate that glutamate and AMs do not share the same binding sites, as glutamate 
does not compete for IVM binding-sites in membrane preparations.
Table 1.2 summarises the pharmacology of the C. elegans and H. contortus GluCI 
subunits.
43
Table 1.2 Pharmacology of C. elegans and H. contortus GluCI subunits
C. elegans H. contortus
GluClal Forms ivermectin-gated channels
(gic-1) (Cully et al., 1994; Etter et al., 1996)
GluClp Forms glutamate-gated channels HcGluCip Does not bind ivermectin
(gic-2) (Cully etal., 1994) (Cheeseman et al., 2001)
GluCla4 Forms glutamate- and ivermectin- gated channels
(glc-3) (Horoszok et al.,2001)
GluCla2A/a2B Forms glutamate- and ivermectin-gated channels
(avr-15) (Dent et al., 1997; Vassilatis et al., 1997) ? ?
GluCla3A Forms glutamate- and ivermectin- gated channels HcGluClot3A High affinity ivermectin binding
(avr-14) (Cheeseman et al., 2001)
GluCla3B Does not form functional channels 
(Dent et al., 2000)
HcGluCla3B Does not bind ivermectin 
(Cheeseman et al., 2001)
X X HcGluCIa High affinity ivermectin binding 
(Cheeseman et al., 2001; Forrester et al., 2002)
GLC-4 (glc-4) Does not form functional channels 
(Cully etal., 1996)
1.8.2 Distribution of GluCI subunits
The expression patterns of the C. elegans GluCI genes have been studied using 
transformation techniques, where a putative promoter is fused to a reporter gene, 
either GFP or lacZ, and then microinjected into worms. Expression of the reporter 
gene in a cell indicates that the ‘promoter’ is active in that cell and the gene will be 
expressed there (Fire et al., 1990; Mello and Fire 1995). However, this technique 
presents some disadvantages such as, it may not indicate the intracellular location 
of the normal gene product and usually it is assume that the promoter used in those 
assays mimics the natural one. In parasitic nematodes, where transformation is 
much more difficult, the expression of the GluCI subunits has been studied using 
affinity-purified anti-subunit antibodies in immunofluorescence experiments.
In C. elegans, reporter gene constructs have shown that avr-14 and avr-15 are 
widely expressed in the nervous system (Dent et al. 1997, 2000) whereas glc-2 
expression is confined to pm4 pharyngeal muscle cells (Laughton et al., 1997b). 
Avr-15 is also expressed in the pm4 and pm5 muscle cells of the pharynx (Dent et 
al., 1997). The relaxation of those muscles is triggered by the M3 pharyngeal motor 
neurons, a pair of fast inhibitory glutamatergic neurons. Also, the IVM effect 
observed in the pharynx of C. elegans was dependent on GluCla2 (Pemberton et 
al., 2001). Threfore, it is likely that the GluCI/IVM pharyngeal muscle receptor is a 
heteromer comprised of GluCla2, GluClp and possibly one other GluCI subunit. To 
date, there have been no reported studies on the expression patterns of the glc-1, 
glc-3 or glc-4 genes.
In H. contortus, HcGluCip was detected on motor neuron commissures but not on 
pharyngeal muscle (Delany et al., 1998). The HcGluCla3 subunits were detected in 
motor neuron commissures, nerve cords and the nerve ring (Jagannathan et al., 
1999). In that work the same antibody, stained A. suum dorsal and ventral cords. 
As far as HcGluCIa is concerned, no spatial data was described but RT-PCR 
studies showed the level of expression of this subunit was found to be adult > L3 > 
eggs (Forrester et al., 1999).
The distribution of GluCI subunits from C. elegans and H. contortus known at the 
time I started this project is summarised in Table 1.3.
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Table 1.3 Early data of the distribution of the GluCI subunits in C. elegans and their orthologous in H. contortus




GluClp pharyngeal muscleb HcGluCip motor neuron commissures0
(g/c-2 )
GluCla4 ? ? ?
(alc-3)
GLC-4 ? ? ?
(glc-4)
GluCla2 pharyngeal muscle, some motor
(avr-15) neurons in the head and ventral 
corda
? ?
GluCla3 extrapharyngeal neurons in the HcGluCla3 motor neuron commissures, lateral
(avr-14) head, sensory neurons and 
ventral cord motor neurons®
(GluCla3A & 
GluCla3B)
and ventral nerve cords and nerve 
ringd
X X HcGluCIa ?
a Dent et al., 1997. bLaughton et al., 1997a.cDelany et al, 1998.d Jagannathan et al, 1999. Note that the antibodies 
used in this work did not distinguish between the two alternative spliced variants HcGluC!a3A and a3B. 6 Dent et al., 
personal communication (now Dent et al., 2000) ?=not yet identified; x=not present
As indicated by the number of question marks and crosses, a considerable amount 
remains to be discovered about the expression pattern of the H. contortus GluCI 
subunits. Besides, the antibody used to study the distribution of the HcGluCla3 
subunits did not discriminate between the expression pattern of the alternatively- 
spliced products of the H. contortus avr-14 gene, HcGluCla3A and HcGluCla3B.
1.9 Project Aims
A full understanding of the functions of the nematode glutamate-gated chloride 
channels (GluCIs) and the effect of the avermectins/milbemycins (AMs), requires 
that we know where the receptors are expressed, their subunit composition and 
their physiological roles within the worm. Since the native GluCIs are presumed to 
be pentamers, simply from the number of nematode GluCI subunit genes isolated 
so far, multiple forms of this channel must exist in worms. However, there was no 
direct evidence on the subunit composition of any nematode GluCI receptor. It was 
known that the GluCIs are the target sites for the AMs, and that these drugs inhibit 
pharyngeal pumping (and hence feeding), motility and fecundity in nematodes. 
However, the nematocidal mechanism of the AMs still remained unknown.
The general aim of this project was to get insights into the composition and function 
of the native avermectin/GluCI receptor of Haemonchus contortus. In particular, I 
wished to map the distribution of all the GluCI subunits isolated for H. contortus and 
to study possible functions of GluCIs using Caenorhabditis elegans as a model 
nematode.
The specific aims of the first part of the project included: the production of subunit- 
specific polyclonal antibodies raised against the HcGluCIa, HcGluCip, HcGluCla3A 
and HcGluCla3B subunits, and the immunolocalisation of these subunits in whole 
mount preparations of H. contortus adult worms. The results obtained from this 
work suggested that the H. contortus GluCIs might have a role in locomotion and 
nematode sensory functions. This led to the second part of this project, which was 
to investigate possible roles of nematode GluCIs, through behavioural assays 
conducted in C. elegans such as chemosensation and locomotion.
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CHAPTER 2 
PRODUCTION OF POLYCLONAL ANTIBODIES
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2.1 Introduction
Most of the gene expression patterns described in C. elegans have been identified 
using promoter/reporter gene constructs. In contrast, no genetic transformation 
methods have been developed yet for H. contortus and the closest approach has 
been the use of C. elegans as an expression host for H. contortus genes (Britton et 
al., 1999). Thus, in H. contortus and other parasitic nematodes detection of gene 
expression has been mainly studied through immunocytochemistry (Keating et al., 
1995; Delany et al., 1998; Jagannathan et al. 1999; Johnson and Stretton, 1987; 
Johnson et al., 1996; Maule et al., 1996).
In order to define the expression pattern of the GluCI receptor in H. contortus, 
specific antisera were raised against the currently known HcGluCI subunits. Two 
different approaches were used in this project to raise polyclonal antibodies. The 
first method consisted of the production of a recombinant protein expressed in a 
prokaryotic system, which once purified could be used to raise antibodies in rabbits, 
and the second method, of the use of synthetic peptides as antigens. In the 
following sections I will summarise the crutial steps to consider when producing 
antibodies.
2.1.1 Properties of antigens and antibodies
The term antigen refers to any molecule that can bind to an antibody, while the term 
immunogen is used when it induces an immune response mediated by 
lymphocytes. An immunocompetent animal can produce antibodies with well over 
107 different antigen-combining sites (Harlow and Lane, 1988a). This represents a 
higher diversity of possible antibodies per antigen than using monoclonal antibodies 
where all of the descendants of one hybridoma cell line are identical, recognising 
hence only one epitope. Polyclonal mixtures of antibodies react with multiple 
epitopes on the surface of the antigen, being potentially more tolerant of minor 
changes in the antigen (e.g. heterogeneity of glycosylation, or slight denaturation) 
than will monoclonal antibodies. Although hybridoma cell lines provide an unlimited 
supply of homogeneous antibodies with a defined specificity, the production is time 
consuming and monoclonal antisera against peptide-antigens produce low titres
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(Harlow and Lane, 1988a). For all the reasons mentioned above, polyclonal 
antibodies were preferred rather than producing monoclonal antibodies.
2.1.1.1 Immunogen properties
An ideal immunogen has to have three chemical features: 1) an epitope that can be 
recognised by the cell-surface antibody found on B cells, 2) it must be degradable, 
3) the processed antigen fragments must bind simultaneously to both: the major 
histocompatibility complex (MHC class) II protein and the T-cell receptor to promote 
helper T cells-and B cells communication. This last requirement imposes a 
minimum size limit on an immunogen of M.W: 10 000 Da (Catty and Raykundalia, 
1988). However, physical coupling of small molecules (haptens) to larger 
immunogenic ones (carriers) overcomes this problem (Erlanger, 1980). While the 
haptens serve as epitopes for binding to the antibodies on the B-cell surface, the 
carriers provide the MHC class ll-T cell receptor binding sites.
2.1.1.2 Peptides vs. recombinant proteins
When a cloned DNA sequence is available, peptides or bacterially expressed 
proteins can be used as immunogens. Peptide antigens have advantages over 
whole protein antigens in that the antibodies generated may be targeted to unique 
sequence regions. The major disadvantage of anti-peptide antibodies is that 
because of peptide structural features, they may not recognize the native protein. In 
contrast, because of the larger size of the bacterially expressed protein, there is a 
better chance that the antibodies will bind to the native protein (Harlow and Lane, 
1988a). However, because of possible toxic side effects of over-expression, some 
recombinant proteins are difficult to express in bacteria or, when expressed, they 
may result in inclusion bodies.
The successful production of anti-peptide antibodies often depends on the 
prediction of the peptide location within the proteins three-dimensional structure. 
Peptides with amino acids exposed on the surface of the native protein are more 
likely to be antigenic. When choosing the peptide sequence, the hydrophilicity value 
and the antigenic index for each amino acid should be considered (Kyte and 
Doolittle, 1982; Jameson and Wolf, 1988). Peptide hydrophilic regions are likely to 
be on the outside of the molecule and thus available for reaction. Besides,
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hydrophilic peptides are more likely to be soluble for coupling reactions. Finally, the 
design of a peptide should take into consideration the method of coupling to the 
carrier protein.
2.1.1.3 Coupling of hapten to carrier protein
Most coupling methods depend on the presence of free amino, sulfhydryl, phenolic 
or carboxylic acid groups (Harlow and Lane, 1988a). Free amino groups used for 
coupling will be found on lysine side chains or on the amino-terminal residue. 
Sulfhydryl groups are found on cysteine side chains, phenolic groups on tyrosines 
and carboxylic acid groups on aspartic and glutamic acids and on the carboxy 
terminal residue. Peptides should preferably be linked to the carrier via the carboxy- 
or amino-terminal residue to avoid disruption of putative central epitopes. However, 
this depends on the peptide chosen and coupling through central epitopes can still 
produce good immunogens.
The cross-linkers used in this work were glutaraldehyde and the sulfhydryl-reactive 
cross-linking agents (maleimides): Sulfosuccinimidyl-4-(N-maleimidomethyl)
cyclohexane-1-carboxylate (sulfo-SMCC) and m-Maleimidobenzoyl-N- 
hydroxysulfosuccinimidine ester (sulfo-MBS). Glutaraldehyde is a bifunctional 
cross-linker that reacts with free amino groups found on lysine side chains or on the 
amino-terminal residue. It is used when the synthetic peptide contains preferably 
only a single free amino group at its amino terminus (Reichlin, 1980). The 
maleimides (sulfo-SMCC and sulfo-MBS) are heterofunctional cross-linkers. The 
sulfosuccinimide group reacts with primary amines and the maleimide group reacts 
with free sulfhydryls present in cysteine residues. Since heteroreagents possess 
two selectively reactive groups that allow coupling to be carried out in a stepwise 
manner, better control of the conjugation chemistry is attainable, reducing the 





Since soluble substances are readily cleared from circulation, either by some 
metabolic pathway or by excretion, through routes that largely by-pass reservoirs of 
immunopotent cells, they rarely stimulate the production of effective reagent 
antibodies. This problem is normally overcome by administering the antigen with 
some sort of adjuvant. Even then, they can vary widely in immunogenicity (Hum 
and Chantler, 1980). Adjuvants provoke an immunogen depot effect protecting the 
antigen from rapid dispersal, making antibody responses more persistent. They 
also contain substances that stimulate the secretion of lymphokines, which recruit 
macrophages to the site of antigen deposition, increasing the local rate of antigen- 
processing cells and causing a local inflammatory reaction at the site of injection. 
Two methods of forming a deposit involve using mineral oils such as those present 
in Freund’s or TiterMax® Gold adjuvants, or using aluminium hydroxide precipitates 
such as Imject® Alum. TiterMax® Gold adjuvant produce a more stable emulsion, 
easier to emulsify and is less viscous than Freund’s adjuvant. However, side effects 
of water-in-oil formulations can invoke very aggressive and persistent granulomas 
in the host. This can be avoided by using aluminum hydroxide based adjuvants, 
instead. In this case, the immunogen is either allowed to adsorb to the preformed 
aluminium salt or can be trapped in the salt during precipitation. The final mixture is 
not viscous and is very simple to prepare.
2.1.2.2 Choice of animal, dose, and immunisation timing.
In most cases, rabbits represent the best choice of animals for producing polyclonal 
antibodies. They can yield up to 25 ml of serum from a single bleed and 150 ml 
from the final exanguination. They are also easy to immunise and bleed, giving 
good IgG responses to a variety of immunogens with long-term adjuvant-antigen 
mixtures. Because only small volumes of serum can be obtained from small 
animals such as rats, mice, hamsters and guinea pigs, these are not normally 
chosen for polyclonal antibody production. Although mice and rats are most 
commonly used for producing monoclonal antibodies, they can be very useful when 
polyclonal antibodies raised in different animal species rather than in rabbit are 
required, and when the volume of antiserum to be recover is not that critical.
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Immunisations should be done in animals that are as far as possible, in evolutionary 
distance, from the source of the antigen. The use of chickens provides an 
alternative route when highly conserved mammalian antigens are weakly or not 
immunogenic in rabbits or rodents. The maximal yield of chicken serum is 500 ml. 
Only when large volumes of sera are needed, larger animals such as sheep, pigs, 
donkeys and horses are required. The best yields obtained form sheep antiserum 
are: 300-600 ml from individual bleeds and 5 litres from the final bleed. (Hum and 
Chantler, 1980; Catty and Raykundalia, 1988).
The dose of antigen depends on the form and immunogenicity of the antigen. 
Suggested doses for rabbits, mice and rats vary from 10 to 100 pg. The dosage 
required for larger animals does not increase in proportion to body weight: 0.25-5 
mg is satisfactory for sheep and 0.5-10 mg for donkeys. The choice of injection 
route may be influenced by the physical nature of the injection (e.g. immunogens in 
water in oil adjuvant formulations should be given intradermal or subcutaneously) 
and by the type of animal used (Catty and Raykundalia, 1988). Individual variation 
in response is often very striking; therefore groups of at least 2  animals should be 
started.
Primary immune responses are often very weak. When an animal is boosted, a 
much faster, more potent and more persistent secondary response occurs. A 
minimum of 2  weeks is advised before reintroducing the antigen to a primed animal. 
Because memory cells are long-lived, the secondary response can take place 
months or years after the primary response. The concentration of antibodies 
produced after the second injection increases exponentially and consists mainly of 
the high affinity IgG isotype. Antibody concentration and quality also increases in 
hyperimmunised aimals. As far as timing is concerned, to prevent rapid clearance 
of the newly injected antigen, the circulating level of antibody should be allowed to 
drop enough before injections.
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The aim of the present study was to produce polyclonal antibodies against the H. 
contortus GluCI subunits. Two different approaches were assayed: the attempt to 
use a recombinant protein expressed into a prokaryotic system, and the use of 
synthetic peptides as antigens. The first part of this chapter includes the cloning of 
a HcGluCla3B cDNA fragment into an inducible expression vector, and its 
expression in Escherichia coli. Since the resulting protein was insoluble and once 
solubilised its purification was unsuccessful, subunit-specific synthetic peptides 
were preferred to produce polyclonal antibodies. Thus, the second part describes 
the production and purification of HcGluCla3A, a3B and HcGluClp anti-peptide 
antibodies plus the purification of the anti-HcGluCIa antibodies.
54
2.2 Materials and Methods
2.2.1 Biological materials
2.2.1.1 Bacterial strain genotypes
XL-1 Blue: supE44 hsdR17 recA1 endA1 gyrA46 thi relA1 lac F’ [F’ proAB lacq lacZ 
AM 15 TnlO(tetR)]. Supplied by Stratagene Ltd (Cambridge, UK)
JM105: supE endA sbcB'\5 hsdR4 rpsL thi A{lac-proAB) F’ praD36 proAB+laclq
lacZ AM 15]. Supplied by New England Biolabs (Hitchin, UK)).
BL21: F', ompT, hsdS (rB\  mB'), gal. Supplied by Amersham Biosciences
(Little Chalfort, UK).
TOP10: F' mcrA A(mrr-hsdRN\S-mcrBC)§80lacZAM'\5 A/acX74 cfeoR recA1
araD130 A(ara-/eu)76797 ga/U ga/K rpsL enc/A1 nupG. Supplied by 
Invitrogen (Paisley, UK).
2.2.1.2 Laboratory animals
Rabbits and rats were obtained from the University of Bath, Animal House breeding 
colony.
2.2.2 Plasmid DNA
pCR®-Blunt II and pCR*-Blunt II TOPO vectors (Kanr, Zeor): supplied by Invitrogen 
(Paisley, UK). Vector details can be downloaded from the company web site: 
http ://ww. i n vitrogen. co m.
pGEX-2T vector (Amp1): obtained from Alison Bibbard, University of Bath. Vector 
details can be obtained from Amersham Biosciences web site: 
http://ww.amershambiosciences.com
2.2.3 Buffers & Media
2.2.3.1 Buffers
PBS (phosphate-buffered saline): 140 mM NaCI, 2.7 mM KCI, 10 mM Na2 HP0 4 , 1.8 
mM KH2PO4, pH 7.4). Autoclaved.
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10XTBE: 0.89 M Tris-CI, 0.89 M boric acid, 20 mM EDTA, pH 8.0 
50XTAE:  2 M Tris Acetate, 50 mM EDTA, pH 8.0
2.2.3.2 Bacterial Media
LB: 10 g tryptone, 5 g yeast extract, 5 g NaCI, H20 to 1 I. Autoclaved.
LB agar: 15 g agar per 1 I LB. Autoclaved.
SOC: Disolve 20 g tryptone, 5 g yeast extract and 0.5 g NaCI in 950 ml ddH20. Add 
10 ml of 250 mM KCI, adjust pH to 7.5 with 5 M NaOH, and add ddH20 to 1 I. 
Autoclave and add 10 ml sterile 1M MgCI2.
2.2.4 Reagents and others materials
All chemicals used were of analytical grade and obtained from Sigma Chemical 
Company Ltd. (Poole, UK) and BDH chemicals (Poole, UK). Restriction enzymes 
were obtained from New England Biolabs ((NEB), Hitchin, UK)), Promega 
(Southampton, UK) or Amersham Biosciences (Little Chalfort, UK). DNA molecular 
weight markers were purchased from NEB, Promega and MBI Ferementas (Vilnius, 
Lithuania). Protein molecular weight markers were obtained from Amersham 
Biosciences and Bio-Rad (Cambridge, USA). DNA polymerase Expand ™ High 
Fidelity was obtained from Roche Molecular Biochemicals (Lewes, UK). T4 DNA 
Ligase was purchased from Promega. DNA gel extraction kit was obtained from 
QIAGEN (Crawley, UK) and the CONCERT™ plasmid preparation kit from 
GibcoBRL, now GIBCO-lnvitrogen (Paisley, UK). Zero Blunt® PCR cloning kits were 
supplied by Invitrogen (Paisley, UK). Sources from other particular products will be 
indicated in the following sections.
Plasticware was Sterilin (Bibby Sterilin Ltd., Stone, UK), Nunc (Life Technologies 
Ltd), Paisley, UK) and Falcon (Falcon, New Jersey, USA).
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General DNA Methods
2.2.5 The Polymerase Chain Reaction (PCR)
The polymerase used to amplify DNA by PCR was the Expand High Fidelity PCR 
system (Expand HF). This enzyme is composed of a mix containing thermostable 
Taq DNA and Pwo DNA polymerases. The advantage of this system is given by the 
3’-5’ exonuclease proofreading activity of the Pwo DNA polymerase, which 
increases the fidelity of DNA synthesis compared to Taq. Expand HF generates a 
mixture of 3’ single A overhang and blunt ended PCR products, allowing direct 
ligation into 3 -T  overhangs or Zero Blunt® (Invitrogen) cloning vectors. A typical 
PCR reaction contained 300 pM of each dNTP, 300 nM of each primer, 2.5 units 
(U) of the Expand HF enzyme, Expand HF buffer with 1.5 mM MgCh, 10 ng DNA 
and ddH2 0  to 30 or 50 pi. A reaction where no template was added into the mixture 
was included as a negative control. Amplification conditions consisted of 2 min 
incubation at 94°C followed by the addition of the enzyme and then 35 cycles of 
denaturation at 94°C for 30 s, annealing for 30 s and extension at 72°C for 30 s, 
followed by a final extension of 72°C for 3 min. The annealing temperature (Tm) 
was set according to the primers used in the reaction. All amplifications were 
carried out on a PTC-150 hot-bonnet minicycler (GRI, Braintree, UK). PCR 
reactions were analysed by electrophoresis through a 1-1.5 % (w/v) agarose gel 
(section 2 .2 .6 ).
2.2.6 Agarose gel electrophoresis
Agarose gels were made by the addition of 1-1.5 % (w/v) agarose to 1 x TAE or 
TBE buffer. The agarose was dissolved by heating in a microwave oven at 40 % 
power. Visualisation of DNA was achieved by the addition of 5 pg/ml ethidium 
bromide to this solution. Gels were poured in a gel cast with comb and allowed to 
set before running in 1 X TAE or TBE in a horizontal gel apparatus at 100 V for 1-2 
h. DNA samples were loaded with 6  X loading dye (15 % (w/v) Ficoll, 0.25 % (w/v) 
bromophenol blue, 0.25 % (w/v) xylene cyanol). Molecular weight markers 100 bp 
(NEB) and 1Kb (NEB or Promega) were used. DNA was visualised under UV 
illumination and photographs were taken using a Polaroid camera with a yellow 
filter and Polaroid 667 black and white IS03000/36 film.
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2.2.7 Purification of DNA from agarose gels
The protocol used was the one provided with the QIAquick Gel Extraction Kit. It 
allows the extraction and purification of DNA from 100 bp to 10 kb out of agarose 
gels in TAE or TBE buffer. DNA adsorbs to the silica-membrane contained on spin- 
columns in high salt conditions, while contaminants pass through the column. The 
buffers are a proprietary formulation. All the centrifugation steps were done at 
12000 x g. The DNA band was excised and weighted in a 1.5 ml microfuge tube. 
Four volumes of buffer QX1 were added per volume of gel (100 mg correspond to 
100 pi) and the tube was incubated at 50°C vortexing every 2-3 min. After the 
agarose was dissolved 1 gel volume of isopropanol was added. To bind DNA to the 
column membrane, the sample was applied in a QIAquick spin column placed into a 
2-ml collection tube, and centrifuged for 1 min. To remove all traces of agarose, the 
column was washed with 0.5 ml of buffer QX1. A sample of 0.75 ml of PE buffer 
was added and then let to rest for 2-5 min before centrifugation. Residual ethanol 
from PE buffer was removed by an additional centrifugation step. The DNA was 
eluted in a 1.5 ml microfuge tube with 30-50 pi of ddH20 left standing for 1 min 
before centrifugation. DNA was stored at -20°C.
2.2.8 DNA quantification
Quantification of PCR products or linearised plasmid DNA, was estimated by 
comparison with a molecular weight DNA marker of known concentration (Gene 
Ruler™ 100 bp or 1 kb, MBI Ferementas), analysed by agarose gel electrophoresis.
When required, the amount of DNA was estimated by determining the Absorbance 
at 260 nm of a 1:50 dilution of the sample in water. The concentration was 
calculated using the equation:
[DNA] pg/ml= Absorbance26o x 50 x dilution factor 
Absorbance at 280 nm was also determined to obtain a ratio for O.D26o/O.D28o as 
an indication of DNA preparation purity.
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2.2.9 DNA cloning
2.2.9.1 Preparation of Escherichia coli competent cells
REAGENTS COMPONENTS
TSB medium 1 g Tryptone, 0.5 g Bacto-yeast extract, 0.5 g NaCI and 10 g 
Polyethylene Glycol (M.W: 3000) in 100 ml of ddH20 , pH 6.1 
adjusted with HCI 1N. Autoclaved for 1 hour. Added 5 % (v/v) 
DMSO, 10 mM MgSC>4 , 10 mM MgCI2. Adjusted to pH 6.1 with 3- 
5 drops of 1 mM HCI.
Ten ml of LB medium in a 100 ml flask were inoculated with 3-4 colonies of 
Escherichia coii XL1-Blue, JM105 or BL21 from LB plates and grew by shaking at 
37°C to A 6oo= 0.5 O.D (4 hours aprox.). Upon reaching the required O.D, 1 ml of 
this culture was inoculated to 100 ml of fresh LB in 1 liter flask and grew in the 
same conditions as described above. The flask was chilled on ice and the cells 
were harvested by centrifugation in a Sorvall® RC-5B centrifuge at 4000 rpm in a 
SS-34 rotor for 10 min at 4°C. The pellet was resuspended in 10 ml of TSB medium 
and left on ice for 10 min. Aliquots of 500 pi were prepared and stored at -70°C.
2.2.9.2 Ligation
PCR products were cloned into pCR®-Blunt II or pCR®-Blunt II TOPO vectors using 
50 ng of linearised plasmid. For the cloning into pGEX vector, 100 ng of plasmid 
and a 10:1 molar insert-to-vector ratio were used. Ligation was done in the 
presence of 0.1 volume of 10 X Ligation Buffer (Promega, supplied with 10 mM 
ATP) and 4 units of T4 DNA Ligase (Promega) in a final volume of 10 pi. The 
reaction was mixed gently and incubated overnight at 15°C.
2.2.9.3 Transformation of plasmid DNA into E.coli strains
A tube with 100 pi of E. coli XL1-Blue, JM105 or BL21 strains or 50 pi of One 
Shot™ TOP10 competent cells stored at -70°C, was thawed on ice for 5 min. An 
aliquot of 50-100 ng of plasmid DNA or 2 to 10 pi of the ligation mix was added and 
the tube was placed on ice for 30 min. Cells were heat shocked at 42°C for 30 sec
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followed by immediate transfer to ice for 2min. A sample of 200 pi of SOC or LB 
media (pre-warmed to 37°C) was added and the mixture incubated in a shaker at 
37°C for 1 h. Aliquots of 20, 50 and 100 pi of transformed cells were spread on LB 
agar containing plates in the presence of the selection antibiotic (Kanamycin, 50 
pg/ml or Ampicillin 100 pg/ml). Plates were incubated at 37°C overnight.
2.2.9.4 Screening of transformants
Colonies were picked and grown for 12-16 hours in LB medium containing 50 pg/ml 
Kanamycin or 100 pg/ml of Ampicillin as required, and plasmid DNA was purified 
from bacteria (section 2.2.10). This DNA was analysed initially by restriction 
digestion (section 2.2.11) and then the clones that seemed to contain a DNA 
fragment of the expected size were sequenced (section 2.2.12).
2.2.10 Preparation of plasmid DNA
The alkaline lysis method from the CONCERT™ Rapid Plasmid Purification System 
(GibcoBRL) was used to isolate plasmid DNA from bacterial cultures. For small 
preparations, samples of 3 ml of an overnight bacteria culture were centrifuged at 
14000 x g for 2 min and all medium removed. The resulting pellet was resuspended 
in 250 pi of G1 buffer (50 mM Tris-HCI, pH 8.0; 10 mM EDTA containing RNase A 
20 mg/ml) by vortexing. Cells were lysed with 250 pi of G2 solution (200 mM NaOH, 
1 % (w/v) SDS) and tubes were mixed by inversion before incubation at RT for 5 
min to produce a clear solution. A sample of 350 pi of neutralization buffer (acetate 
and guanidine hydrochloride; proprietary formulation) was added and the solution 
mixed by inversion before centrifugation of samples at 14000 x g for 10 min. The 
resulting supernatant was placed into a spin cartridge, containing silica-based 
membranes where the plasmid DNA is selectively adsorbed, which was contained 
in a 2 ml wash tube. Following removal of the flow-through the column was washed 
with 500 pi of GX buffer (acetate, guanidine hydrochloride, EDTA, ethanol; 
proprietary formulation) followed by a wash with 700 pi of G4 buffer (NaCI, EDTA 
and Tris- HCI, pH 8.0, containing 95-100 % ethanol; proprietary formulation) at 
14000 x g for 1 min. DNA was eluted from the column by the addition of 75 pi of TE 
buffer (10 mM Tris-HCI, pH 8.0; 0.1 mM EDTA) pre-warmed at 65-70°C, incubating 
for 1 min at RT and spinning down for 2 min. When higher concentrations and
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higher purity of plasmid DNA were required, large-scale plasmid DNA preparations 
were obtained using either the High Purity CONCERT™ kit for maxipreps or the 
Qiagen Plasmid Maxikit (QUIAGEN), following the manufacturer instructions.
2.2.11 Endonuclease restriction assays
DNA samples of 1-5 pg were digested with 10 units of restriction enzymes in the 
presence of 0.1 volume of the reaction buffer recommended by the manufacturer. 
Sterile water was added to a volume of 30 pi and the reaction incubated at 37°C for 
2 h. For double digestions, the enzymes that used the same reaction buffer were 
co-incubated into the reaction. When enzymes required different reaction buffers, 
the assay was first set for the one requiring low salt concentration in the reaction 
buffer, and after 1 h of incubation at 37°C, the second enzyme was added adjusting 
the salt concentration to the requirements of the second enzyme. Reaction was 
allowed to continue for 1 h at 37°C.
2.2.12 DNA sequencing and sequence analysis
Approximately 250 ng of DNA preparation was mixed with 10 pmol of primer in 6 pi 
of water and sent to sequence at the University of Bath DNA Autosequencing 
Service. The primers used for sequencing DNA cloned into pCR®-Blunt II or pCR®- 
Blunt II TOPO vectors, were the M13 forward and M13 reverse (Invitrogen) and the 
primers used for sequencing DNA cloned into the pGEX-2T vector were the 5' 
pGEX and 3' pGEX primers (GibcoBRL) (for primer sequences see table 2.1). 
Sequence analysis was carried out on the GCG (Genetic Computer group, 
Wisconsin, USA) suite of programs, accessible via the gnome workstation, for 










5* NNNNNNGGATCCGAATTTCTTCGGAAG 3’ * 55 GibcoBRL
| a3B 3’
(
5’ NNNNNNGAATTC7TAGTCCACCCTACG 3’ ♦ 55 GibcoBRL
pGEX 5’ 5’ GGGCTGGCAAGCCACGTTTGGTG 3’ 57 GibcoBRL
i_______________________
pGEX 3’ 5’ CCGGGAGCTGCATGTGTCAGAGG 3’ 57 GibcoBRL
M13 F(-20) 5’ GTAAAACGACGGCCAG 3’ 46 | Invitrogen
PM13R 5’ CAGGAAACAGCTATGAC 3’ 52 ! Invitrogen
Restriction sites underlined: *  BamH I, ♦ EcoR I. The stop codon included in the 
a3B 3’ primer is indicated in italics. All primers were ordered desalted and at 50 
nmol scale.
2.2.13 Production of HcGluCla3B recombinant protein
2.2.13.1 Construction of the pGEX-GluCla3B plasmid
The pGEX expression system (Amersham Biosciences) was used to obtain a 
GluCla3B recombinant protein, which could then be used to raise polyclonal 
antibodies in rabbits. The DNA encoding the intracellular loop within the 
transmembrane domains III and IV of HcGluCla3B was amplified by PCR and 
cloned in frame into the pGEX-2T expression vector. Plasmid DNA containing the 
Hcavr-14B full-length sequence (obtained from C. Cheeseman, Univeristy of Bath) 
was used as template for PCR (PCR was described in section 2.2.5). 
Oligonucleotides a3B 5’ and a3B 3’ encode the 354-358 and 421-418 amino acids 
of the HcGluCla3B polypeptide sequence, respectively. In their 5’ ends they 
possess 6 random nucleotides and specific restriction sites (Table 2.1) to ensure 
directional cloning into pGEX-2T vector, downstream and in frame with the gst 
gene. On the a3B 3’ primer a stop codon followed the restriction site was also 
introduced.
Amplification conditions consisted of 2 min incubation at 94°C, followed by the 
addition of 2.5 units of the thermostable Expand ™ High Fidelity DNA polymerase 
and then 35 cycles of 94°C for 30 s, 55°C 30 s, 53°C for 30 s and 72°C for 30 s, 
followed by 72°C for 3 min. Amplification products were identified by
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electrophoresis through a 1.5 % (w/v) agarose gel. The amplified DNA was purified 
from the gel, cloned into pCR®-Blunt vector (Invitrogen) and subcloned into pGEX- 
2T vector within the BamH I and EcoR I sites of the vector polylinker.
2.2.13.2 Transformation of E. coli with pGEX plasmids
To get the recombinant plasmid pGEX:GluCla3B into E. coli, two transformation 
steps were required. The JM105 strain, with high transformation efficiency, was 
used first and the BL21 strain, required for the pGEX-2T expression, was used 
second. Therefore, the Hcavr-14B insert cloned into pCR®-Blunt vector was 
digested with BamH I and EcoR I restriction enzymes and ligated into the pGEX-2T 
vector, previously linearised with the same enzymes. The ligation mix was used to 
transform E. coli JM105 cells. Screening of transformants was performed and the 
plasmid DNA isolated from one of these clones was used to transform the E. coli 
BL21 strain. The techniques mentioned above were described in sections 2.2.9 and 
2.2.11.
2.2.13.3 Induction of fusion protein expression
E. coli BL21 cells containing the recombinant (pGEX-GST:GluCla3B) and the wild- 
type (pGEX-2T) plasmids were grown in LB medium containing Ampicillin (100 
(ig/ml) in an orbital shaker at 37°C. When the absorbance at 600 nm reached an 
O.D of 0.6, a sample of 1 ml (non-induced sample) was removed from the culture 
and the expression of the GST or GST:GluCla3B proteins was induced for 2 h by 
the addition of 0.1 mM iso-propyl-p-D-thiogalactopyranoside (IPTG) (final 
concentration) to the remaining culture. Induced and non-induced samples were 
precipitated and resuspended in PBS containing 1 mg/ml lysozyme and 1 mM 
PMSF. Finally, the cells were lysed by sonication on ice for 15 s and the debris 
precipitated by centrifugation at 4000 g for 15 min.
2.2.13.4 Detection of GST: GluCla3B recombinant protein
Aliquots of the IPTG non induced and induced insoluble and soluble material were 
analysed on a 12 % (w/v) SDS-PAGE (section 2.2.14). Proteins were transferred 
onto nitrocellulose membranes and probed with 1:1000, 1:2000 and 1:3000 
antibody dilutions of goat anti-GST (Amersham Biosciences) antiserum and a
63
1:2000 dilution of a horseradish peroxidase (HRP)-conjugated rabbit anti-goat IgG 
secondary antiserum (section 2.2.15).
2.2.13.5 Solubilisation of inclusion bodies
Solubilisation of the GST:GluCla3B was carried out in the presence of a non-ionic 
detergent (NP-40). Bacteria were harvested by centrifugation at 7000 x g for 5 min 
and the cell pellet was resuspended in 100 mM NaCI, 1 mM EDTA, 50 mM Tris-HCI 
(pH 8.0) to a final concentration of 10 % (v/v). 1 mg/ml lysozyme and 1 mM PMSF 
were added and the mixture was incubated at RT for 20 min. Cells were collected 
by centrifugation at 5000 x g for 10 min, the supernatant was discarded and the 
pellet (spheroplasts) was resuspended in ice-cold 100 mM NaCI, 1mM EDTA, 0.1 
% sodium deoxycholate (v/v), 50 mM Tris-HCI pH 8.0. The mixture was incubated 
on ice with occasional mixing for 10 min. Then, a final concentration of 8 mM MgCh 
and 10 pg/ml DNase I were added and the solution was incubated at 4°C until the 
viscosity disappeared. Inclusion bodies were removed from suspension by 
centrifugation at 10000 x g during 10 min and solubilised by resuspending the pellet 
in 1 % NP-40, 100 mM NaCI, 1 mM EDTA, 50 mM Tris-HCI (pH 8.0). This final 
fraction was washed with 100 mM NaCI, 1 mM EDTA, 50 mM Tris-HCI (pH 8.0).
2.2.13.6 Purification of the GST:GluCla3B recombinant protein
The GST:GluCla3B protein was affinity-purified from solubilised bacterial protein 
extracts, prepared as described in section 2.2.13.5. Gutathione-agarose beads 
(Sigma) were swollen as recommended by the manufacturer and equilibrated with 
equilibration buffer: 100 mM NaCI, 1 mM EDTA, 50 mM Tris-HCI (pH 8.0) or PBS. A 
pilot purification assay was performed in 1.5 ml microcentrifuge tubes by mixing 100 
pi of the slurry with 200 pi of protein extracts during 20 min at RT. Three washes of 
1 ml of equilibration buffer or PBS were applied, centrifuging at 5000 x g to discard 
the supernatants. GST-recombinant proteins were eluted incubating the gel mixture 
with glutathione elution buffer (10 mM reduced glutathione (Sigma) prepared in 50 
mM Tris-CI (pH 8.0) or in PBS) during 15 min at RT. Eluted fractions were collected 
following centrifugations at 5000 x g and were analysed on a 12 % (w/v) SDS- 





Proteins were resolved through 12 % (w/v) sodium dodecyl sulphate polyacrylamide 
gel electrophoresis (SDS-PAGE). For the preparation of two 12% (w/v) separating 
gels, 6 ml of acrylamide solution (Sigma) (30% (w/v) acrylamide, 0.8% (w/v) N, N - 
meihylenebisacrylamide) were combined with 3.75 ml of 4X Tris-CI/SDS pH 8.8 
(1.5 M Tris-CI pH 8.8, 0.4% (w/v) SDS; filtered through a 0.45-pm filter (Millipore, 
Bedford, USA) and stored at 4°C) and 5.25 ml of ddH20 . The mixture was 
degassed under vacuum for 10 min and 100 pi of 10 % w/v ammonium persulfate 
(APS) (stored at 4°C for no more than 5 days) plus 10 pi of N, N, N \ N - 
tetramethylethylenediamine (TEMED) (Sigma) were added. The mixture was 
poured into assembled mini-gel glass plates ( 7 x 1 0  cm), overlaid with few drops of 
isopropanol to prevent contact with 0 2 and allowed to polymerise. When gels were 
ready the solvent was removed and the gel interface rinsed with ddH20 . A 4 % 
(w/v) stacking gel was prepared mixing 0.65 ml of acrylamide solution, 1.25 ml of 
4X Tris-CI/SDS pH 6.8 (0.5 M Tris-CI, 0.4 % (w/v) SDS; filtered through a 0.45-pm 
filter and stored at 4°C) 3.05 ml of ddH20 , 25 pi of 10 % (w/v) APS and 5 pi of 
TEMED. The solution was poured over the separating gels, the combs were 
inserted and they were allowed to set. After the stacking gel has polymerised, 
combs were removed and wells were rinsed with ddH20  to remove unpolymerised 
acrylamide. Gels were placed into an electrophoretic chamber and 1 X running 
buffer (5 X stock: 3 g Tris-base, 14.4 g glycine and 0.5 g SDS in 100 ml of dd H20 )  
was added.
Samples were resuspended in loading buffer (6 X stock: 0.35 M Tris-CI, pH 6.8; 10 
% (w/v) SDS, 36 % (v/v) glycerol, 5 % (v/v) p-mercaptoethanol, 0.012 % (w/v) 
bromophenol blue; store at -20°C) and denatured by incubation in a boiling water 
bath for 5 min. Finally, samples were centrifuged at 14000 x g for 3 min just prior to 
loading onto the gel. A rainbow molecular weight marker (10-250 kDa) (Amersham 
Biosciences) was also loaded.
Gels were run at 100 V until the dye front reached the bottom of the gel. They were 
stained by soaking and rotating in Coomasie Blue solution (50 % (v/v) methanol,
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0.05 % (w/v) Coomasie Brillant Blue R, 10 % (v/v) acetic acid in ddH20). For the 
preparation of this solution, the Coomasie Brillant Blue R was first dissolved in 
methanol before adding the acetic acid and the water. Gels were destained with 50 




A non-stained SDS-PAGE gel, two gel sized sets of 3 sheets of 3 MM Whatman 
filter paper (Whatman Ltd., Kent, UK) and a gel sized nitrocellulose membrane 
(Amersham Biosciences) (previously rinsed with ddH20), were soaked for 15 min in 
transfer buffer (25 mM Tris-HCI pH 8.3,150 mM glycine, 0.037 % (w/v) SDS and 20 
% ethanol (added immediately before using). One set of filter papers was aligned 
on the cathode plate of the graphite transfer electrode, followed by the 
nitrocellulose membrane and the gel rolled out on top of the membrane. This stack 
was overlaid with the second set of soaked filter papers and any air bubbles 
between layers were removed by rolling a glass pipette over the top of the 
“sandwich”. The anode graphite plate was put on the top and it was connected to 
the power supply set at 0.8 mA/cm2 of gel for 90 min.
2.2.15.2 Immunoprobing and detection
The nitrocellulose membrane was incubated overnight at 4°C in blocking solution (2 
% (w/v) glycine, 5 % Marvel™ non-fat milk powder in TBST: 10 mM Tris-CI pH 8.0, 
150 mM NaCI, 0.1 % (v/v) Tween 20). The blot was briefly washed in TBST and 
incubated 1 hour at RT or overnight at 4°C with the first antibody diluted in blocking 
solution. The membrane was washed three times in TBST for 5,10 and 15 min on a 
rotating table and incubated 1-2 hours at RT with a horseradish peroxidase- 
conjugated secondary antibody (Amersham Biosciences) diluted 1:1000 in TBST. 
The Electro Chemi- Luminescence (ECL) reagents (Amersham Biosciences) were 
used to detect immunoreactivity in the blot. An equal volume of detection solution 1 
and 2 were mixed and poured onto the surface of the immunoprobed blot for 1 min. 
Excess fluid was drained off and the blot was wrapped in cling film. An X-ray film 
was placed in the dark on top of the blot inside a film cassette. Over a series of
66
exposure times (from 1 min to 5 min), films were developed using an X-Ograph 
Compact X2 processor.
2.2.16 Protein quantification
The Coomassie® Plus Protein Assay Reagent (PIERCE, Tattenhall, UK) was used 
for protein quantification. The method is based on the Bradford method (Bradford, 
1976). The reagent contains: Coomasie® dye, methanol, phosphoric acid and 
solubilizing agents in water. Ninety-six well Nunc microtitre plates were used and 
either 10 or 15 pi of sample or standard protein (BSA) were added per well plus 
300pl of the Coomassie® reagent. Plates were mix on a shaker for 30 sec and the 
absorbance was measured at 595 nm using a microtitre plate reader. A standard 
curve was prepared by plotting the average blank corrected 595 nm reading for 
each BSA standard, versus its concentration in pg/ml. This curve was used to 
determine the protein concentration of the unknown samples.
Anti-peptide antibodies 
2.2.17 Production of polyclonal anti-peptide antibodies
2.2.17.1 Coupling of Peptides to Carrier Protein
The HcGluClp, HcGluCla3A and HcGluCla3B peptides were synthesized on a 
Perseptive Biosystems 9050+ synthesizer and purified by HPLC by Dr. G. 
Bloomberg, Department of Biochemistry, University of Bristol. Peptides, stored at - 
20°C, were coupled to the carrier protein porcine thyroglobulin (Sigma, Poole, UK) 
using either glutaraldehyde (Grade 1, Sigma) or Sulfosuccincinimidyl-4-(N- 
maleidimidomethyl)-cyclohexane-1 -carboxylate (sulfo-SMCC) (Calbiochem®, 
Beeston, UK) as crosslinkers.
2.2.17.1a HcGluClp peptide
The peptide sequence used was the described by Delany et al (1998), designed in 
the N-terminus of the HcGluClp mature polypeptide: RSTGGTQEQEILNELLSN, 
which corresponds to amino acids 24-41.
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Two and a half mg of both freeze-dried porcine thyroglobulin (thyr) and HcGluClp 
peptide were dissolved together in 0.1 M NaHC0 3  to give a final concentration of 2 
mg/ml of thyr-peptide mixture. Glutaraldehyde (stored as a 25 % (w/v) aqueous 
solution at -20°C) from a fresh ampoule was added to a final concentration of 0.05 
% (v/v). The mixture was inverted in a glass vial overnight at room temperature. A 
0.1 volume of 1 M glycine ethyl ester (pH 8.0 with NaOH) was added and rotated as 
described before for 30 min to block unreacted gutaraldehyde. To remove the 
unbound peptide and excess of glutaraldehyde, the mixture was injected into a 
Slide-A-Lyzer® dialysis cassettes (PIERCE, Tattenhall, UK) of nominal molecular 
weight limit 10,000 Da and left to dialyse overnight in 1 I of PBS at 4°C. Finally the 
peptide conjugate solution was quantified using the Coomassie® Plus Protein 
Assay Reagent Kit (PIERCE) and stored in aliquots at -20°C.
2.2.17.1b HcGIuCla3A and HcGluCla3B peptides
The HcGluCla3 peptide sequences used were, HcGluCla3A: 
CRIFVRRYKERSKRID and HcGluCla3B: CSERPALRLDLSNYRRRGWT. They 
correspond to amino acid residues 384-399 of GluCla3A and 373-391 of GluCla3B.
A sample of 3 mg of sulfo-SMCC was dissolved in 1 ml of 20 mM NaHC0 3 . This 
solution was added to a 1.5 ml microcentrifuge tube containing 10 mg of 
thyroglobulin and was left at room temperature for 30 minutes. Unbound cross­
linker was removed by gel filtration through a Sephadex G25 column of 10 ml 
(Amersham Biosciences), using 50 mM sodium phosphate buffer pH 7.0. The 
eluate was monitored at 220 nm, collecting fractions of 3 ml. The first peak, 
containing the SMCC-thyr conjugated, was stored at -20°C.
Samples of 8.6 and 10 mg of HcGluCla3A and 3B peptides were respectively 
activated with 1 mM DTT in sodium phosphate buffer pH 7.0 for 1 hour at room 
temperature. The excess of DTT was removed by gel filtration through a Sephadex 
G10 column of 10 ml (Amersham Biosciences), using 50 mM sodium phosphate 
buffer pH 7.0. The eluate was monitored at 280 nm. Peak fractions were collected 
immediately prior to the coupling reaction.
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SMCC-thyr samples were mixed with half of the volume of the activated peptide 
fractions. The coupling was performed under argon (to prevent oxidation of 
sulfhydryl groups) at room temperature, stirring for 3 hours. The peptide conjugate 
solution was quantified using the Coomassie® Plus Protein Assay Reagent Kit 
(PIERCE) and stored in aliquots at -20°C.
For each peptide, a control coupling reaction using 5 mg of BSA (Sigma) as a 
carrier and 1.5 mg of m-Maleimidobenzoyl-N-hydroxysulfosuccinimidine ester 
(sulfo-MBS) (Calbiochem®) as a cross-linker, was carried out. The coupling reaction 
was performed as described above, using the remaining of the volume from the 
activation of the peptides.
2.2.17.2 Production of antisera 
2.2.17.2a HcGluClp rat antiserum
The antigen mixture was prepared adding dropwise one volume of the 
thyroglobulin-HcGluClp conjugate to one volume of adjuvant (Imject® Alum, 
PIERCE), which was mixed by vortexing. The mixture was left at room temperature 
for 30 minutes, vortexing every 10 minutes for about 1 minute. Two anaesthetised 
male Wistar rats of 320 g were injected subcutaneously with 140 pg of the antigen 
mixture. Further immunisation timings were determined according to serum titres, 
and three doses of 70 pg were given two weeks, a month and four months after the 
first immunisation. A blood sample was taken day 0 (pre-immune serum). Test 
bleeds were done on anaesthetised animals by tail tip amputation.
2.2.17.2b HcGluCla3A and 3B rabbit antisera
For each peptide, two New Zealand white rabbits were immunised subcutaneously 
with thyroglobulin-peptide conjugates prepared as a water in oil emulsion with 
Titremax Gold™ (Sigma) as adjuvant, according to the manufacturer instructions. 
To prepare 1.0 ml of the antigen-adjuvant emulsion, 0.5 ml of antigen (volumen 
completed with PBS) and 0.5 ml of adjuvant were required. After the TiterMax Gold 
was vortexed and loaded in one syringe, two other syringes were loaded with 0.25 
ml of aqueous antigen. The syringe containing the adjuvant and one of the loaded 
with the antigen solution, were connected via one 3-way stopcock. To obtain an 
adequate emulsion it was important to push the antigen into the adjuvant syringe
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first and to push repeatedly the mixture between both syringes for approximately 2 
min. Then, all the emulsion was pushed into one syringe and the empty one 
disconnected. The remaining syringe containing 0.25 ml of the aqueous antigen 
solution was connected end emlusified until a meringue-like emulsion was formed 
(aprox. 5 min).
The concentration of antigens used were 20 pg for the primings and 100 pg for the 
first second and third boosts given, according to serum titres, at weeks 2, 7 and 16 
post-primings. A blood sample was taken the day 0 (pre-immune serum). To 
monitor sera titres, rabbits were preanaesthetised with Hypnorm 0,2 ml/Kg 
(Janssen Pharmaceutica (Beerse, Belgium)) and test bleeds were taken from the 
ear vein. When antibody titres reached a satisfactory level, animals were sacrificed 
by cardiac puncture under terminal anaesthetic. All animal handling was done by 
licensed staff.
2.2.17.3 Harvesting the sera
Collected blood was allowed to clot for 1 h at 37°C. The serum was separated from 
the clotted blood by centrifugation at 4°C, first at 2500 g for 30 min and then at 
1500 g for 20 min. Purified supernatant was aliquoted and frozen at -20°C. Working 
aliquots were kept at 4°C in presence of 0.01 % (w/v) sodium azide.
2.2.17.4 Antibody quantification (ELISA)
Antibody production of isolated sera was assessed by performing enzyme linked 
immunoabsorbent assays (ELISAs).
Ninety-six well microtitre Falcon Pro-bind plates were coated with 10 pg/ml antigen 
in coating buffer (15 mM Na2C0 3 ; 35 mM NaHC0 3 , 0.01 % (w/v) NaN3 , pH 9.6). 
Plates were covered with foil paper and incubated overnight at 4°C. Unbound 
antigen was washed off the plates with wash buffer (PBS pH 7.0, 0.1 % (v/v) 
Tween-20) 3 times during 15 min each wash. The plates were drained of any 
residual solution by inverting and tapping on paper towels. Adsorption sites of the 
wells were blocked with 250pl of blocking buffer (PBS pH 7.0, 0.1 % (v/v) Tween 
20, freshly prepared 1 % (w/v) casein) for 1h at RT. Plates were again washed
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twice with wash buffer whereupon 100 pl/well of sera prediluted to 1/100 in wash 
buffer, was applied in duplicates in serial dilutions resulting in a 1/2 dilution in each 
well. Following an overnight incubation at 4°C, plates were washed four times with 
wash buffer before anti-rabbit Ig-peroxidase conjugated (Amersham Biosciences) or 
anti-rat Ig-peroxidase linked (Sigma) antibodies were applied at 1/1000 dilutions in 
wash buffer. Plates were incubated 1.5-2 hour at RT and washed again three times 
with wash buffer and two times with PBS. Then 100 pi of substrate solution (50 mM 
sodium acetate/citrate buffer pH 6.0, 0.1 mg/ml of 3, 3', 5, 5' tetramethyl benzidine 
(TMB), 0.006 % (v/v) H2O2 ) freshly prepared, was added and allowed to react in the 
dark for 10 min before being completed by the addition of 50 pl/well of 1.84 M 
H2SO4 (1:10 v/v dilution of concentrated stock). Absorbance was measured at 450 
nm using a plate reader.
Antibody titre was determined by plotting absorbance against antiserum dilution, 
using the mean and standard error for each duplicate. The inflection point of the 
post-immune data when interpolated by drawing a line down to the X-axis, resulted 
in the Ab titre of the sera (http://www.perbio.com/pa/340913/html/chap6.html).
2.2.17.5 Antibody Purification 
2.2.17.5a IgG isolation
Total IgG was first purified from the immune serum on Protein A Sepharose CL-4B 
columns (Sigma). A gram of the sepharose was swollen in 10 volumes (40 ml) of 
PBS pH 7.3. The slurry was packed into a column and washed with 10 volumes of 
PBS pH 7.3. Eight to 10 ml of antiserum were 1/10 diluted in PBS pH 7.3 and 
recycled through the column overnight at 4°C. Column was washed with PBS and 
IgG antibodies were eluted with 35 mM NaCI / 35 mM diethylamine pH 11.5 at 4°C. 
Eluted proteins were detected by absorbance at 280 nm, monitored by an uvicord 
(LKB-Optical Unit UV-1, Amersham Biosciences) and plotted on a chart recorder 
connected to the column. The eluants were neutralised by dialysis against PBS 
overnight at 4°C and stored at 4°C in presence of 0.01 % (w/v) sodium azide.
2.2.17.5b Peptide-Affinity Chromatography
Peptides were immobilised on cyanogen bromide (CNBr) -activated Sepharose 4B 
columns (Amersham Biosciences). A gram of CNBr-activated Sepharose 4B was
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hydrated in 100 ml of 1 mM HCI pH 2.0. Swollen sepharose was poured on a 
sintered funnel connected to a vacuum pump and washed with 2 0 0  ml volumes of 1 
mM HCI (pH 2.0-3.0), d d ^ O  and 0.1 M [\laHCO3 pH 8.3 respectively. After the last 
wash, the swollen sepharose beads were mixed with 1 0  mg of peptide previously 
dissolved in 5 ml of 0.5 M NaCI / 0.1 M NaHC0 3  pH 8.3. The peptide-sepharose 
bead mixture was left to rotate end over end overnight at 4°C. Excess peptide was 
removed by washing with three gel volumes (about 15 ml) of 0.5 M NaCI / 0.1 M 
NaHCC>3 pH 8.3. Washes consisted of slow speed centrifugation of 2500 g for 2 min 
followed by removal of supernatants. The remaining active groups were blocked 
with 0.1 M Tris-HCI pH 8.0 rotating end over end overnight at 4°C. The peptide- 
coupled resin was washed with three cycles of alternating pH. Each one consisted 
of a wash with 0.5 M NaCI / 0.1 M sodium acetate/citrate buffer pH 4.0, followed by 
0.5 M NaCI / 0.1 M Tris-HCI pH 8.3. Finally the resin was resuspended in 5 ml of 20 
mM Na2 HP0 4 / 0.5 M NaCI containing 0.01 % (w/v) NaN3 .
The peptide-coupled sepharose was packed into a column. The beads were 
washed with PBS pH 7.3 and any unbound peptide was removed eluting with 50 
mM diethylamine pH 11.5. The column was linked up to an uvicord (LKB-Optical 
Unit UV-1, Amersham Biosciences) and graph plotter at 4°C. Absorbance at 280 
nm was monitored to detect peptides and or proteins passing through the column 
during all the purification steps. The resin was washed and purified IgGs (see 
section 2.2.17.5a) or antisera diluted 1/10 in PBS were recycled through the column 
overnight at 4°C. The column was washed with PBS until reaching the base level at 
280 nm. Anti-peptide antibodies were eluted with 50 mM diethylamine pH 11.5. 
Samples corresponding to plotted peaks were dialysed against PBS overnight at 
4°C and concentrated in centrifugal filter devices Centricon® Plus -2 0  (Millipore 
Bedford, USA) of nominal molecular weight limit of 30,000 Da. Antibody aliquots of 
0.5 mg/ml were stored at -20°C in the presence of 0.01 % (w/v) sodium azide. The 
column was washed with PBS before regenerating with three alternating cycles of 
0.5 M NaCI / 0.1 M Tris-HCI pH 8.3 and 0.5 M NaCI / 0.1 M sodium acetate/citrate 
buffer pH 4.0. Finally it was stored in 20 mM Na2 HP0 4 / 0.01 % (w/v) at 4°C.
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2.3 Results
2.3.1 Production of HcGluCla3B recombinant protein
The Glutathione S-Trasferase (GST) gene fusion system (Smith and Johnson, 
1988) was used to obtain a fragment of the HcGluCla3B subunit expressed in 
bacteria, which could then be used to raise polyclonal antibodies in rabbits. The 
pGEX plasmids provide an inducible and high-level intracellular expression of 
genes or genes fragments as fusions with Schistosoma japonicum GST protein. 
The GST-fusion proteins can be affinity purified from bacterial lysates using 
Glutathione-agarose beads. Cleavage of the desired protein from GST can be 
achieved using a site-specific protease whose recognition sequence is located 
immediately upstream from the multiple cloning site on the pGEX plasmids. Since 
GST is highly immunogenic, the whole purified fusion protein could also be used as 
antigen when small gene fragments are cloned into the pGEX vectors.
2.3.1.1 Construction of the pGEX:HcGluCla3B plasmid
The HcGluCla3B subunit was the first one selected to produce polyclonal 
antibodies. In order to obtain specific antibodies against it, a search for a non­
conserved region in the predicted protein, which was also a putative antigenic 
peptide, was carried out. A sequence alignment between HcGluCla3B and a3A 
subunits showed an area of great diversity on the intracellular loop between the 
transmembrane domains III and IV (TM lll-TM IV) of these subunits (Fig. 2.1). The 
predicted antigenicity of that region was also checked considering the following 
properties: hydrophilicity and antigenic index for each amino acid. The region 
selected comprises 58 amino acids and is indicated in figure 2.1. It has a mean 
hydrophilicity and antigenicity scores of 1.12 and 0.8 respectively. These values 
were obtained using the command peptidestructure in the GCG program suite, on 
the gnome workstation according to Kyte and Doolittle (1982) and Jameson and 
Wolf (1988). Good scores for antigenicity and hydrophilicity are around 1.3. 
Hydrophilicity scores of less than 1.3 mean that the peptide will be more 
hydrophobic, hence the amino acid residues will have less chances to be facing the 
outside of the molecule to be available for reaction.
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1 ♦  100 
GluCla3A MRNSVPLATR IGPMLALICT VSTIMSAVEA KRKLKEQEII QRILNNYDWR VRPRGLNASW PDTGGPVLVT VNIYLRSISK IDDVNMEYSA QFTFREEWVD 
GluCla3B MRNSVPLATR IGPMLALICT VSTIMSAVEA KRKLKEQEII QRILNNYDWR VRPRGLNASW PDTGGPVLVT VNIYLRSISK IDDVNMEYSA QFTFREEWVD
GluCla3A
101
ARLAYGRFED .ESTEVPPFV VLATSENADQ SQQIWMPDTF FQNEKEARRH LIDKPNVLIR IHKDGSILYS VRLSLVLSCP MSLEFYPLDR
200
QNCLIDLASY
GluCla3B ARLAYGRFED .ESTEVPPFV VLATSENADQ SQQIWMPDTF FQNEKEARRH LIDKPNVLIR IHKDGSILYS VRLSLVLSCP MSLEFYPLDR QNCLIDLASY
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GluCla3B AYTTQDIKYE WKEQNPVQQK DGLRQSLPSF ELQDWTKYC TSKTNTGEYS CARVKLLLRR E .YSYYLIQL YIPCIMLLW SWVSFWI^DKD A)VPARVSLGVl
GluCla3A








GluCla3B TTLLTMTTQA SGINSKLPPV SYIKjAVDVWI GVCLAFIFGA LLEYAWNYY GRKEFLRKEK KKKTRLDDCV CPSE.............. . RPALRLDLS NYRRRGWTP.
401 TM IV 450
GluCla3A
GluCla3B
RTSFCCRIFV RRYKERSKRI DVVSRLVFPI GYACFNVLYW AVYLM....
LNRL..LDML GRNADLSRRV DLMSRITFPS LFTAFLVFYY SVYVKQSNLD
Fig. 2.1 Alignment of H. contortus GluCla3A and GluCla3B subunit sequences
Conserved residues are in bold and the predicted membrane-spanning domains (TM) boxed. The underlined region between TM III and TM IV of GluCla3B 
corresponds to the peptide selected for the construction of the recombinant protein. In colour, the peptides selected for synthesis. The putative glycosylation site is 
indicated by (♦ )  and the conserved PKC (■) and cAMP-dependent protein kinase (• )  consensus sites are shown. Accession numbers: Y14233 and Y14234.
The corresponding DNA was amplified by PCR for cloning in frame into the pGEX- 
2T expression vector, downstream from the gst gene. Specific primers, a3B 5’ and 
a3B 3’, were designed to amplify the corresponding DNA of the intracellular TM III- 
TM IV region. The a3B 5’ primer contained a BamH I site and the a3B 3’ an EcoR I 
site for directional cloning into the pGEX-2T vector (for details see methods 2.2.13).
A HcGluCla3B cDNA full-length clone was used as template for PCR and one band 




Fig. 2.2- PCR amplification of the intracellular TM lll-TM IV region of HcGluCla3B
Lane 1, 1 Kb DNA ladder (NEB). Lane 2, no-template control PCR reaction. Lane 3, PCR 
product amplified from plasmid HcGluCla3B DNA. For the PCR mixturelpM of a3B 5’ and 3’ 
primers, 1.2 mM dNTP and 100 ng of template DNA were used in a 50 pi volume reaction. 
Cycling conditions: 94°C for 2 min, followed by the addition of 2.5 U DNA polymerase 
Expand ™ High Fidelity and then 35 cycles of 94°C for 30 s, 58°C for 30 s, 55°C for 30 s and 
72°C for 30 s, terminating with 3 min at 72°C. 15 pi of PCR products were analysed by 
separation via electrophoresis on a 1.5% (w/v) agarose gel in 1X TAE. The arrow indicates 
the product of 200 bp.
The band was excised from the gel and the DNA extracted was cloned into the
pCR®-Blunt vector. Five transformants were isolated and digested with EcoR I and
BamH I. The identity of one of these clones (number 1), was confirmed by
sequencing. Clone 1 DNA was digested with EcoR I and BamH I and the fragment
obtained (-200 bps) was sub-cloned into the pGEX-2T vector. Attempts to ligate
the HcGluCla3B DNA fragment to the pGEX vector and transform directly into E.
coli BL21 (the bacteria strain suitable for pGEX fusion protein expression), were
unsuccessful. Hence, the transformation of the recombinant plasmid was done in
two steps. First, an alternate strain recommended by the manufacturer was used
(E. coli JM105). Eleven transformants were isolated and their plasmid DNA
assayed by restriction digestions with EcoR I and BamH I enzymes. A fragment of
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Fig. 2.3. Restriction analysis of plasmid DNA from E. coli JM105 transformed with
pGEX:GluCla3B
1.5% (w/v) agarose gel in TBE. Lanes 1 and 2 DNA ladders 1 KB and 100 bp with relevant 
band sizes noted on the side. Lanes 3, 8 & 14, clones 1, 4 & 11 uncut. Lanes 4-7, 9-13 & 15- 
16 EcoR I- BamH I digested DNA from clone 1 to 11. The arrow indicates the fragment of 
200 bo released from the transformed clones.
The identity of two of these clones (1 and 2) as well as the conservation of the 
reading frame with the gst gene was confirmed by sequencing. Plasmid DNA from 
clone 1 was used to transform the strain required for the expression of the 
pGEX:GluCla3B plasmid. The EcoR I and BamH I restriction analysis of six 
transformants is shown in the figure 2.4. The expected fragment of 200 bp was 
obtained in all of the clones. Clone number 2 was used for expression assays.
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Fig. 2.4- Restriction analysis of plasmid DNA from transformed E. coli BL21
1.5% (w/v) agarose gel in TBE. Lane 1 and 2, 1 KB and 100 bp DNA ladders with relevant 
band sizes noted on the side. Lanes 3, 5, 7, 9,11 & 13, uncut DNA from clones 1 to 6. Lanes 
4, 6, 8, 10, 12 & 14, clones 1 to 6 digested with EcoR I- BamH I. The arrow indicates the 
fragment of 200 bp released from the clones.
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2.3.1.2 Expression, detection and purification of GST:GluCla3B
The HcGluCla3B intracellular TM lll-TM IV region was expressed as a GST fusion 
protein designated GST:GluCla3B. A few colonies of E. coli transformed with the 
pGEX:GluCla3B or pGEX-2T plasmids (the last one used as the expression 
control), were grown into 3 ml of LB / Ampicillin broth to an A6oo of 0.6. At this point 
a 1 ml sample was removed (uninduced cells) and the remaining culture was 
induced with IPTG. Following induction, cell lysates were separated by SDS-PAGE 
(Fig. 2.5A).
GST GST:GluCla3B B
Fig. 2.5- Expression of GST fusion proteins
A: Cell lysates of E. coli BL21 transformed with pGEX-2T (1-2) and pGEX:GluCla3B (3-6) 
plasmids, separated on a 12% (w/v) SDS-PAGE and stained with Coomasie Blue solution. 
Lanes 1 & 3, soluble fraction of uninduced cells. Lanes 2 and 4-6, 0.1 mM IPTG-induced 
cells showing the pre-sonicated extract (4), the insoluble (5) and the soluble fractions (2 & 
6). B: Western blot of the GST:GluCla3B pre-sonicated (1) and insoluble fractions (2) probed 
with 1:2000 dilution of a goat anti-GST serum, followed by incubation with a 1:2000 anti-goat 
horseradish peroxidase-conjugated antibody. Chemiluminescence was detected using the 
ECL reagents after 5 min of exposure on X-ray film. Relevant molecular weight marker 
bands are noted on the side of the aels.
Two major bands of 26 and 29 kDa were over-expressed on the pGEX IPTG- 
induced cell fraction (lane 2). The apparent molecular weight expected for GST is 
26 kDa. Western blots assays using an anti-GST antibody showed 
immunoreactivity only for the 26 kDa band, confirming the identity of the lower band 
with the GST protein (data not shown). Two novel bands of approximately 32 kDa 
and 34 kDa appeared on the pGEX:GluCla3B induced lysate, on the pre-sonicated 
and insoluble fractions being the lower band more abundant that the upper one 
(lanes 4 and 5). As the expected size of the fusion protein is about 32 kDa (26000 
Da of GST plus 6380 Da of the GluCla3B peptide), the lower band would
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correspond to the GST: GluCla3B protein. To confirm this, the pre-sonicated and 
insoluble fractions of the GST:GluCla3B expressing cell extract were 
immunoprobed with an anti-GST antibody. At 1:2000 dilution of the antibody, the 32 
kDa band was recognised on both extracts (Fig. 2.5B). When high amounts of 
proteins were loaded (see Fig. 2.5A lane 5), immunoreactivity against the 34 kDa 
band was also observed (Fig. 2.5B lane 2), suggesting a non-specific reaction of 
the antiserum.
As the GST:GluCla3B protein was found in the insoluble fraction, different induction 
conditions were tried to solubilise it such as decreasing the induction time and the 
temperature to 20°C, increasing aeration and changing the LB bacterial medium for 
minimal medium. All these attempts were unsuccessful. Finally and in order to 
prevent possible denaturation of the fusion protein, the non-ionic detergent NP-40 
(1 % (v/v)) was used to solubilise it (for details see section 2.2.13.5).
A pilot affinity purification assay of the NP-40 solubilised extract was carried out 
using glutathione-agarose beads and reduced glutathione (10 mM) to elute the 
fusion protein. The analysis of the collected fractions is shown in the figure 2.6A.
B
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Fig. 2.6 Analysis of the purification of GST fusion proteins
12 % (w/v) SDS-PAGE stained with Coomasie Blue solution. A: Purification of 
GST:GluCla3B from a solubilised inclusion body extract. B: Purification of GST from a PBS 
soluble fraction. Lane 1, crude IPTG-induced extracts. Lane 2, proteins not adsorbed to the 
column. Lanes 3-5, PBS washes. Lanes 6-8, fractions eluted with 50 mM TrisCI (pH 8.0)/10 
mM reduced glutathione. MW: Rainbow wide range molecular weight marker (Amersham) 
with relevant bands noted on the side. Arrows indicate the proteins of interest.
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Most of the recombinant protein was not adsorbed to the beads (lane 2) and only a 
small fraction of the GST:GluCla3B protein was recovered on the elution steps 
(lanes 6-8), but contaminated with other proteins. As a control for the purification 
method, the same protocol was performed in parallel using bacterial extracts 
expressing the GST wild-type protein (Fig. 2.6B). In contrast, the GST protein was 
totally adsorbed to the agarose-beads (lane 2) and recovered pure (lanes 6-8).
In view of the difficulties encountered in preparing a suitable recombinant 
immunogen and the length of the procedures involved, the use of synthetic peptides 
was chosen as an alternative route for the production of polyclonal antibodies.
2.3.2 Production of anti-peptide antibodies
2.3.2.1 Peptide design
The ideal peptide antigen is 15-20 amino acids long and hydrophilic. Since most of 
the antigenic sites are located within surface exposed regions of a protein, 
hydrophilic peptides are more likely to be antigenic. Proline and/or tyrosine residues 
can induce structural motifs into the peptide that may mimic more closely the shape 
of the peptide in the naive protein. A cysteine residue should be present at the N- or 
C- terminus if a sulfhydryl-reactive cross-linker is to be used to couple the peptide 
to a carrier protein.
As it was mentioned above when selecting the peptide sequence for the GluCla3B 
recombinant protein, prediction programs suggest that good scores for antigenicity 
and hydrophilicity should be around 1.3. Scores of less than 1.3 for hydrophilicity 
mean that the peptide will be more hydrophobic and also possibly more difficult to 
solubilise it. Overall charges for ideal peptides should be neutral (+/-2); greater 
charges could result in charge interactions of the peptide that could alter 
conformation and affect solubility. To score peptide charges, Lys and Arg are score 
1+; Asp, Gin and Glu 1 -  and His 1/2+ (Cambridge Research Biochemical 
http://www.crb.gb.com).
2.3.2.1a HcGluCIa and p peptides
HcGluCIa and HcGluCip synthetic peptides were designed and used previously in
our lab by S. Jagannathan and N. Delany to raise antibodies in rabbits. The 18
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amino-acid length peptides (HcGluCip: RSTGGTQEQEILNELLSN; HcGluCIa: 
EKLLDEQKIIKHKKESPY) correspond to the predicted extreme N-terminus of the 
full-length mature proteins following the predicted signal peptide cleavage sites 
(Delany et al., 1998; Forrester et al., 1999; Cheeseman et al., 2001).
2.3.2.1b HcGluCla3A and 3B peptides
The alternatively spliced products of the H. contortus gbr-2 (avr-14) gene, 
HcGluCla3A and 3B, were previously shown to be widely distributed in the adult 
nervous system of H. contortus (Jagannathan et al., 1999). In order to distinguish 
between the expression patterns of HcGluCla3A and 3B, subunit-specific rabbit 
antisera were required. A search for the region of greatest sequence diversity 
between the two subunits was carried out and peptides corresponding to such 
sequences within the intracellular loop between transmembrane domains III and IV 
were selected (Fig. 2.1). Measures of hydrophilicity and antigenic index were 
calculated for each amino-acid, using the command “peptidestructure" in the GCG 
program suite according to Kyte and Doolittle (1982) and Jameson and Wolf (1988) 
prediction programs. Hydrophilicity plots for the GluCla3A & 3B full length 
sequences determined which parts of the proteins are likely to be on the outside of 
the molecule and thus available for reaction (Fig. 2.7).
The peptides finally chosen correspond to amino acids 384-399 for GluCla3A and 
373-391 for GluCla3B.
GluCla3A peptide: A/H2-CRIFVRRYKERSKRID-COOH M.W: 2124.2
GluCla3B peptide: A/H2-CSERPALRLDLSNYRRRGWT- COOH M.W: 2449.4
A BLAST search for these peptide sequences was done and they only matched 
with their respective proteins. The mean hydrophilicity and antigenicity index scores 
for these peptides were 1.3 and 0.77 for GluCla3A and 1.32 and 0.95 for GluCla3B 
respectively. Also, an overall charge of +5 and +3 was scored for GluCla3A and 3B 
respectively. Notice that in the GluCla3B peptide a Cys residue was added at the 
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Fig. 3.7- Hydrophilicity profiles of GluCla3A and GluCla3A B proteins
The hydrophilicity plots for the amino-acid full-length sequences of GluCla3A (A) or 3B (B) 
proteins were obtained using the command peptidestructure in the GCG program suite, on 
the gnome workstation according to Kyte and Doolittle (1982) and Goldman et al. (1986). 
The numbers on the x axis represent each amino-acid in the sequences. The y axis 
represents the range of hydrophilicity/hydrophobicity values. The areas below the midpoint 
line indicate the regions predicted to be hydrophilic. The red bars denote the regions from 
which the peptides were chosen.
2.3.2.2 Coupling to carrier protein
In all cases thyroglobulin was selected as the carrier protein as it is not found in 
nematodes making any anti-thyroglobulin antibody less likely to cross-react with 
nematode proteins.
2.3.2.2a HcGluCip
The HcGluCip peptide was coupled to thyroglobulin using glutaraldehyde. The 
concentration of the final peptide-conjugated (Thyr-GluCip) was 0.7 mg/ml.
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Control coupling reactions included the peptides coupled to bovine serum albumin 
(BSA) by sulfo-MBS, cross-linker with the same chemistry of sulfo-SMCC. The use 
of sulfo-MBS to couple peptides to BSA was tested early in our lab, and showed a 
decreased migration of BSA conjugates when resolved on a 7.5% SDS-PAGE and 
a fuzzy doublet (J. Eastlake, pers. commun.). BSA control reactions were 
performed due to the large size (670 kDa) of the tetrameric thyroglobulin, which 
makes its migration on a 7.5% SDS-PAGE as well as the possibility of detecting 
variations on the apparent molecular weight upon peptide conjugation, very 
unpredictable. GluCla3B and 3A peptide coupling reactions were analysed by SDS- 
PAGE (Fig. 2.8).
Fig. 2.8- Coupling analysis of GluCla3A and 3B peptides to thyroglobulin.
7.5% (w/v) SDS-PAGE stained with Coomasie Blue solution. Lane 1, BSA. Lanes 2 & 6 
BSA cross-linked to MBS. Lanes 3 & 7, BSA-MBS-GluCla3B and BSA-MBS-GluCla34 
conjugates, respectively. Lanes 4 & 8, thyroglobulin (Thyr) crosslinked to SMCC. Lanes 5 8 
9, Thyr-SMCC-GluCla3B and Thyr-SMCC-GluCla3A conjugates, respectively. A: Rainbow 
(Amersham) and B: BioRad wide range molecular weight markers with relevant bands notec 
on the side. The arrow indicates the peptide-Thyr conjugates.
Both conjugates Thyr:GluCla3A and Thyr:GluCla3B showed a decrease in their 
migration profiles in comparison to Thyr-SMCC before being coupled, indicating 
that the reaction was successful (lanes 8 & 9 and 4 & 5 respectively). The 
difference in kDa was not estimated due to the molecular weight of these proteins 
were higher than the markers used in the SDS-PAGE. It is possible though that the 
band above 250 kDa corresponds to thyroglobulin. Of the control reactions only 
BSA coupled to the GluCla3B peptide showed a slightly decrease in the migration 
profile, which was difficult to estimate in kDa because of the characteristic fuzzy 
band obtained.
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2.3 .2.3  Immunisation and Determination of Antiserum Titres
For each antigen, two rabbits or rats were immunised with the thyroglobulin-peptide 
conjugates mixed with the adjuvants TiterMax® Gold (water in oil formulation) for 
the GluCla3A and a3B or Imject® Alum (aluminum hydroxide) for the GluClp 
conjugates. Test bleeds were taken the day 0 (pre-immune serum) and 14 days 
after injections. Immunisation timings were determined according to serum titres 
measured by the enzyme linked immunosorbent assay (ELISA). Monitoring sera 
titres between injections prevented boosts from being given when sera titres were 
still high.
2.3.2.3a GluCla3A and 3B antisera
Rabbits injected with Thyr: GluCla3A and Thyr: GluCla3B conjugates were boosted 
2 and 8 weeks after the primings. ELISA analyses of sera collected from the rabbits 
with the highest antisera titres (rabbits 264 and 263 respectively) are shown in 
figure 2.9. Antibody titre was determined by plotting absorbance at 450 nm (A450) 
vs. antiserum dilution. The inflection point of the immune data when interpolated by 
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Fig. 2.9 Sera response to GluCla3A and GluCla3B peptides
ELISA readings on GluCla3A (A) and GluCla3B (B) peptide-coated plates analysing sera 
collected during the immunisation protocols with the GluCla3A and 3B antigens respectively. 
Data was ploted using the mean and standard error for duplicates. Dashed lines indicate the 
highest titres, achieved after the second boost: 1:153,600 in A and 1:25, 600 in B.
The antibody titre for both peptides reached the highest level after the second boost 
with a half-maximal response at 1:153,600 dilution for GluCI3A (rabbit 264) and 
1:25,600 dilution for GluCla3B (rabbit 263) (Fig. 2.9, dashed lines). These rabbits
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received a third and last boost 7 weeks later. In contrast to the GluCla3B antiserum 
which titre remained the same, the GluCla3A titre dropped to 1:51,200 after the 
third boost (Fig. 2.10), therefore rabbits were soon terminated. For each rabbit, 40 
ml serum was extracted from the collected blood and aliquots of 7 ml were stored at 
-20  °C.
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Fig. 2.10 Sera response to GluCla3A and GluCla3B peptides after the third boost.
Comparison of GluCla3A (A) and GluCla3B (B) antisera titres measured by ELISA on 
GluCla3A (A) and GluCla3B (B) peptide-coated plates, collected after the second, third 
boost and just before the final bleed. Dashed lines indicate the titres achieved after the third 
boost: 1:51,200 in A and 1:25,600 in B.
2.3.2.3b HcGluCip antiserum
As an anti-HcGluCIa serum raised in rabbits was already available in our 
laboratory, producing an anti-HcGluCip serum in a different animal species would 
allow to perform double labelling immunocytochemistry in H. contortus. Therefore, 
two rats were immunised with the Thyr-GluClp mixture. After the first boost, only the 
serum of one animal showed immunoreactivity to GluClp peptide. Hence, further 
boosts, monitored by ELISA, were given just to the immunoreactive rat two weeks, 
a month and four months after the priming. The ELISA analyses of the sera 
collected are shown in figure 2.11. The antibody titre for GluClp peptide reached the 
highest level after the third boost with a half-maximal response at 1:6400 dilution. 
The animal was finally bled two weeks after this boost. Five ml of serum were 











Fig. 2.11 Immune response to GluClp peptide.
ELISA readings from sera collected during the immunisation protocol for the anti-GluClp rat 
sera on a GluClp peptide-coated plate. The dashed line indicates the highest titre 
(1:64,000), achieved after the third boost.
2.3.2.4 Antibody purification
Specific antibodies represent at most 20-30 % of the antisera immunoglobulins. 
Using total sera may reduce antibody efficiency and lead to high background in 
immunocytochemistry assays. To overcome these features, affinity purification of 
polyclonal antibodies was preformed. Anti-peptide antibody purification allows only 
the antibodies that bind to the antigen to be collected. In this work polyclonal 
antibodies were raised against thyroglobulin-peptides conjugates. Therefore, affinity 
purification of anti-peptide antibodies reduces the possibility of anti-thyroglobulin 
antibodies cross-reacting.
Anti-peptide antibodies can be purified straight from the immune sera or from total 
IgG. Isolation of IgG antibodies not only provides an enriched fraction of high affinity 
antibodies (IgG class), but also reduces the amount of non-specific serum proteins 
that would be recycled through the peptide-affinity column, which may interfere with 
the antibody binding to the column. However, antibody elution occurs at high pH 
and the more an antibody is exposed to high pH, the more it might be inactived. 
Therefore, both approaches were tried in this work. For the HcGluCla3A, 3B and 
HcGluCIa immune sera, total IgG were firstly purified on Protein A Sepharose CL- 
4B columns. For the HcGluCip rat antiserum, this additional step was not included.
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Protein A, a constituent of the cell wall of the bacteria Staphylococcus aureus, binds 
to the Fc domain of IgG immunoglobulins with high affinity and this reaction is pH 
dependent.
2.3.2.4a HcGluCla3A and a3B  anti-peptide antibodies
Five ml serum samples extracted soon after titres reached the highest levels (on 
the second boost for HcGluCla3A and 3B and third boost for the GluCIa antisera), 
were diluted 1/10 in PBS and recycled through 5 ml Protein A Sepharose columns 
(one per antisera). IgG antibodies were eluted with 35 mM NaCI / 35 mM 
diethylamine pH 11.5 and neutralised by dialysis against PBS. Antisera were 
recycled and eluted three times. Eluted samples were pooled and recycled through 
the respective peptide-coupled Sepharose columns. Anti-peptide antibodies were 
then purified on peptide-affinity cyanogen bromide activated Sepharose 4B column 
with 50 mM diethylamine pH 11.5. Samples were neutralised in the same way as 
for the IgG and concentrated to 0.5 mg/ml. Affinity purified antibodies were tested 
by ELISA and the highest titres were: 1:4,800 for GluCla3A, obtained on the first 
elution and 1:3,200 for GluCla3B, obtained on the second peak of the first elution 
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Fig. 2.12 Antibody titres from GluCla3A and GluCla3B affinity purified antibodies.
Anti GluCla3A (A) and anti GluCla3B (B) affinity purified antibodies were analysed by 
ELISA on GluCla3A (A) and a3B (B) peptide-coated plates. The highest titres, indicated by 
a dashed line, were reached at elution 1 for both anti-peptide antibodies. Square symbol 
plots show non-cross reactivity of the anti GluCla3B Ab with the GluCa3A peptide or the 
anti GluCla3A Ab with the GluCla3B peptide.
These were the antibodies used in immunocytochemistry experiments (chapter 3). 
The anti-GluCla3B antibody showed no cross-reactivity with the GluCla3A peptide,
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as assayed by ELISA, nor did the anti-GluCla3A antibody cross-react with the 
GluCla3B peptide (Fig. 2.12, plots on square symbols).
2.3.2.4b GluCIa and GluClp anti-peptide antibodies
An anti-GluCIa immune serum obtained previously in our lab by S. Jagannathan 
was affinity purified. Serum titres against the GluCIa peptide reached the highest 
level after the third boost (S. Jagannathan, personal communication) with a titre of 
1:25,600 (Fig. 2.13A, red plot). Five ml of this antiserum were used to purify total 
IgG, in the same way as for the GluCla3 antisera (see above). GluCIa anti-peptide 
antibodies were subsequently purified on a GluCla-affinity cyanogen bromide 
activated Sepharose 4B column with 50 mM diethylamine pH 11.5, neutralised on 
the same way than for the IgG and concentrated to 0.5 mg/ml. Anti-peptide 
antibodies were purified in just one elution step and the titre measured by ELISA 
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Fig. 2.13 Antibody titres from GluCIa and GluClp affinity purified antibodies.
Anti-GluCIa (A) and anti-GluCip (B) antibodies analysed by ELISA on GluCIa (A) and 
GluClp (B) peptide-coated plates. The anti-GluCIa antibodies were eluted in one step but 
the anti-GluCip in three cycles. The highest titres, indicated by a dashed line, were 1:12,800 
and 1:1,600 respectively. Square symbol plots show non-cross reactivity of the anti GluCIa 
Ab with the GluClp peptide or the anti GluClp Ab with the GluCIa peptide.
The GluClp rat antiserum achieved an acceptable high titre after the third boost 
(section 2.3.2.3b). Five ml of this serum diluted 1/10 in PBS were recycled through 
a GluCip-affinity cyanogen bromide activated Sepharose 4B column. Affinity 
purified antibodies were obtained from three cycles of antisera recycling and were 
eluted with 50 mM diethylamine pH 11.5. Collected fractions were neutralised by
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dialysis against PBS, concentrated to 0.5 mg/ml and tested by ELISA. Anti GluClp 
antibodies were eluted in three steps and showed a titre of 1:1,600 (Fig. 2.13B).
The specificity of the HcGluCIa and p antibodies was tested by ELISA. The 
HcGluCIa antibodies did not show cross-reactivity with the GluClp peptide nor did 
the rat anti HcGluCip antibodies (elution 1 samples) cross-react with the GluCIa 
peptide (Fig. 2.13, plots on square symbols). These antibodies were used in 
immunocytochemistry assays (chapter 3).
2.3.2.5 HcGluCla3B antibody recognition of the GST:GluCla3B 
protein
In order to demonstrate that anti GluCla3B antibodies would recognise the 
HcGluCla3B protein, a western blot assay against the recombinant protein 
GST:GluCla3B was performed (the production of the GST:GluCla3B protein was 
described in section 2.3.1). This protein consists of the GluCla3B intracellular loop 
between the transmembrane domains III and IV, the region where the GluCla3B 
peptide was designed to, expressed as a fusion protein with the S. japonicum GST. 
After induction with IPTG, bacteria transformed with the pGEX:GluCla3B plasmid 
were lysed, the proteins separated on a SDS-PAGE and blotted onto nitrocellulose. 
The affinity purified anti HcGluCla3B antibodies that reached the highest tires (Ab 
from elution 1 peak 2) were used at a 1:200 dilution in blocking solution. These 
antibodies recognised a 32 kDa protein on the IPTG induced extract, coinciding 
with the predicted size for the fusion protein (Fig. 2.14, lane 1). The antibodies did 







Fig. 2.14 Immunoreactivity of the anti-GluCla3B purified antibody to GST:GluCla3B
Cell lysates of E.coli BL21 transformed with pGEX:GluCla3B plasmid, separated on a 12% 
(w/v) SDS-PAGE and blotted on a nitrocellulose membrane. Lanes 1, pre-sonicated extract of 
0.1 mM IPTG-induced cells. Lane 2, soluble fraction of uninduced cells. Blot probed with 
1:200 dilution of the affinity purified anti GluCla3B antibody (elution 1 peak 2), followed by 
incubation with a 1:1000 goat anti-rabbit horseradish peroxidase-conjugated antibody. 
Chemiluminescence was detected using the ECL reagents after 5 min of exposure on X-ray 
film. The point arrow indicates the 32 kDa protein recognised by the antibody. Relevant 
molecular weight marker bands are noted on the side.
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2.4 Conclusions
Specific polyclonal antibodies were produced to study the localisation of the GluCI 
subunits in H. contortus.
A recombinant protein consisting of the intracellular TM lll-TM IV region of the 
HcGluCla3B subunit fused to the S. japonicum GST protein (GST:GluCla3B) was 
expressed in E. coli. The fusion protein resulting was insoluble, which is a 
possibility when overexpressing foreign proteins into a prokaryotic system. It was 
then solubilised using a non-ionic detergent. However, the purification of the protein 
was unsuccessful as the majority of the protein did not adsorb to the column and 
the small fraction that eluted was contaminated with other bacterial proteins. 
Although the non-denaturing method used to solubilise the recombinant protein 
should not interfere with the binding of the protein to the glutathione-agarose affinity 
column, this possibility cannot be ignored. Because of this, synthetic peptides were 
chosen to raise polyclonal antibodies against the GluCla3A, a3B, a and p subunits. 
The selected peptide sequences were specific to their respective subunits. Also, the 
predicted hydrophilicity and antigenic index gave good scores, predicting high 
chances for the peptides to be exposed on the native protein and hence available 
for antibody recognition.
Antisera produced against the HcGluCla3 peptides reached the highest titres after 
the second boost and for the GluClp peptide, after the third boost. The GluClp 
antiserum was raised in rats to allow purified antibodies to be used with the rabbit 
anti-GluCIa antibodies in double labelling immunocytochemistry in H. contortus. 
Antibodies were purified on peptide-affinity columns. Titres of the immune sera and 
the purified antibodies dropped significantly for the anti GluCla3A and GluCla3B 
antibodies from 1:153,600 to 1:4,800 and from 1:25,600 to 1:3,200, respectively. 
However, when the GluCIa and p antisera were affinity purified, only the titres for 
the GluCIa antibodies showed a minor reduction from 1:25,600 on the immune 
serum to 1:12,000 on the purified fraction. In contrast, the titres for the GluClp 
antibodies pre- and post-purification remained unchanged. A drop in antibody titres 
is normally expected during antibody purification procedures. One explanation for 
these low anti-peptide antibody titres is that the affinity of the antibodies for their
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respective peptides is so high that with the elution conditions used, a vast majority 
of antibodies remain bound to the column. For testing this, different elution reagents 
such as low pH, high salt buffers, ionic detergents, dissociating agents or a 
combination of them could have been used to find out the better elution conditions 
for these antibodies. However, eluting antibodies with harsh treatments often 
denatures the antigen and the antibody leaving both inactive. It is also possible that 
anti-peptide antibodies had passed through the affinity column on the first column 
wash, before even interacting with the peptides or if they did, it is also possible that 
the antigen-antibody interactions were weak and the antibodies got detached during 
the column washes. Finally, other possibilities are that a large fraction of the 
GluCla3A and a3B anti-peptide antibodies might be wasted on the washes steps 
during the isolation of total IgG, previous to the antibodies affinity-purification. It is 
noteworthy that the calculation of the antibody titres was performed as an 
estimation of the inflexion point of the immune graphs. Therefore, intrinsic variations 
of the method might result in differences of Ab titres. Another possible way to 
calculate antibody-titres is using the IC50 value of the graphs. This method did not 
show significant differences with the employed in the present study (data not 
shown). On the ELISAs for the GluCIa, a3A and a3B antibodies, the shift to the left 
observed between the immune sera and the affinity-purified antibody graphs, 
indicated a drop in the titre for the affinity-purified antibodies. Despite this drop, the 
levels reached post purification were satisfactory.
The peptide sequences chosen during the peptide design were subunit-specific and 
this was confirmed by a BLAST search. Cross-reactivity between the GluCla3 
antibodies and between the GluCIa and p antibodies was tested by ELISA. None of 
the affinity purified antibodies showed cross-reactivity with any of the peptides 
tested, reacting only with the peptide to which the antiserum was raised. This gave 
confidence that each antiserum would be specific when used in 
immunocytochemical assays.
Binding of peptides to microtiter plates could be a problem in ELISAs in that the 
peptide may not bind or may bind in a configuration that masks or distorts the 
epitopes so, they may not be recognised by the antibodies. However, all the anti­
peptides antibodies in this work recognised their respective peptides by ELISA. 
Confirmation that the GluCla3B antibodies would recognise the intracellular TM MI-
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TM IV region of the HcGluCla3B subunit was achieved by Western blotting of the 
anti GluCla3B antibodies to the GST:GluCla3B recombinant protein.
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CHAPTER 3
IMMUNOLOCALISATION OF GLUTAMATE-GATED 




The glutamate-gated chloride channels (GluCIs) are the target sites for the 
avermectin/milbemycin (AMs) anthelmintics, drugs that cause paralysis of the 
somatic and pharyngeal muscles in nematodes. In order to study the composition of 
the avermectin receptor of H. contortus and to better understand the mechanism of 
action of the AMs, the distribution of all the currently known H. contortus GluCI 
subunits was studied in adult worms. This chapter introduces a brief review of the 
methods used, and describes the immunolocalisation of the HcGluCIa, p, a3A and 
a3B subunits, using subunit-specific antibodies (see chapter 2).
3.1.1 Immunocytochemistry
Immunocytochemistry is the union of microscopy and immunology and exploits the 
very specific binding of an antibody for its antigen. Unlike promoter/reporter gene 
constructs and RNA in-situ hybridisation studies, which provide information on the 
transcription products and possibly transcriptional regulation of particular genes, the 
main advantage of protein immunocytochemistry is that it reveals where the 
majority of the protein is actually localised and presumably functions. In some 
cases, striking differences between the two patterns have been shown in C. 
elegans arising from post-transcriptional regulatory mechanisms (Evans et al., 
1994) or secretion of the protein product (Sharrock, 1984). Immunocytochemistry is 
also a highly specific and relatively sensitive technique. In addition, it allows the 
detection of antigens at the cellular and subcellular levels and, when necessary, 
immuno-electron microscopy can provide additional resolution on the subcellular 
localisation of antigens.
3.1.1.1 Tissue fixation
The process of fixation is crucial to maintain the morphology of the tissue. The 
choice of fixation method represents a compromise between optimally preserving 
ultrastructural elements, while also allowing the antibody to penetrate the specimen 
and to bind to the fixed antigen.
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Fixation methods fall generally into two classes: organic solvents and cross-linking 
reagents. Organic solvents such as alcohols and acetone remove lipids and 
dehydrate the cells, precipitating the proteins on the cellular architecture. Cross- 
linking reagents such as glutaraldehyde and paraformaldehyde form intermolecular 
bridges, normally through free amino groups, creating a network of linked antigens 
(Harlow and Lane, 1999). Choosing between these methods is empirical. Fixation 
of H. contortus works better with aldehydes, particularly with paraformaldehyde 
since glutaraldehyde causes a higher degree of auto-fluorescence in the worms 
(Skinner, 1997).
3.1.1.2 Permeabilisation
Staining worms can be a difficult procedure due to the surface cuticle, which is 
composed of covalently cross-linked soluble and insoluble structural proteins 
(collagens and cuticulins respectively), other minor proteins, lipids and 
carbohydrates. The major function of this structure is to act as a barrier to the 
environment. It also allows movement via opposed muscles, acts as a 
hydroskeleton, determines body shape and permits growth through the larval 
moults (Page, 2001).
Nematode cuticle varies throughout the developmental stages and also between 
free-living and parasitic species. A few methods have been developed in 
nematodes for gaining antibody access through the cuticle. In C. elegans, 
permeabilisation has been achieved by a freeze-crack approach whereby cuticles 
from specimens fixed to subbed slides are physically broken through the force of 
quickly popping off a frozen coverslip from the slide (Miller and Shakes, 1995). 
Cuticle permeabilisation has also been achieved by enzymatic treatment of 
nematode collagens combined with reduction of disulphide bonds, cross-linkers of 
collagen fibres. This latter approach potentially ensures uniform permeability of the 
cuticle and it has been used to study the distribution of neuronal proteins on whole 
mount preparations of C. elegans (Hekimi, 1990; Mclntire et al., 1992) and H. 
contortus (Keating et al. 1995; Skinner et al., 1998, Delany et al., 1998, 
Jagannathan et al., 1999). Nematode body wall consists of the cuticle and the 
hypodermis in which the nervous system is embedded. In A. suum collagenase 
treatment has been used to dissociate the muscle cells, which then separate from
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the body wall to expose the neurons (Johnson and Stretton, 1987; Skinner et al., 
1998).
3.1.1.3 Antibody binding and detection: direct and indirect 
immunocytochemistry
Antibodies that are specific to the antigen of interest (primary antibodies) are 
purified and labelled with an easily detected label. In this work I used anti-peptide 
antibodies raised in rabbits and rats, purified by affinity chromatography (chapter 2). 
Primary antibodies are added to the fixed and permeabilised samples prepared as 
described above, and their localisation in the tissue is determined by detection of 
the label. The antibodies can be labelled directly or they can be detected indirectly 
by using a labelled secondary reagent. The indirect detection method is the most 
frequently used for several reasons: it is versatile, cost effective and saves the time 
to label each preparation of primary antibody. There are three labelled reagents: 
protein A, protein G and anti-immunoglobulin antibodies (secondary antibodies), 
available from commercial suppliers and all bind with high affinity and specificity to 
the primary antibodies. In this work, secondary antibodies were preferred because, 
in contrast to protein A and G that bind to only one site on the primary antibody, 
they can bind to multiple sites and thus would give a stronger signal.
As far as labelling is concerned, there is a wide choice of labelled reagents. The 
detection methods use enzymes or fluorochromes. Enzyme-linked detection works 
by modifying a chemical agent included in the reaction mixture so that it becomes 
coloured and insoluble. The insoluble product precipitates at the site of the antigen- 
antibody-secondary reagent complex (Nakane and Pierce, 1967). This method 
provide high sensitivity, only light microscope is needed and the staining is 
permanent. However, the resolution is low, endogenous enzyme activity might 
occur, some substrates are toxic and performing double staining is difficult. An 
alternative method is immunofluorescence microscopy.
3.1.1.4 Immunofluorescence microscopy
This method consists of the staining of a fixed tissue with a fluorescent-labelled
antibody and visualisation by epifluorescence microscope. It became a widely used
method for identifying the subcellular location of antigens in the early 1950s, when
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the immunocytochemistry method was modified to include fluorochrome-linked 
secondary reagents to determine the site of antibody binding. For this method, 
samples are examined under light of a specific wavelength. Absorbing radiation of 
the appropriate wavelength causes the electrons of the fluorochrome to be raised to 
a higher energy level. As these electrons return to their ground state, light of a 
different wavelength is emitted forming the fluorescent image seen with the 
microscope (Harlow and Lane, 1999). Individual fluorochromes have discrete and 
characteristic excitation and emission spectra. Because some of them have 
emission spectra that do not overlap, multiple labelling is possible. Fluorescence 
detection also provides high-resolution power over the enzyme-linked method. 
When using conventional light microscopy, the resolution of immunofluorescent 
images is limited by stray light from fluorescent objects out of the plane of focus. In 
contrast, confocal scanning microscopy uses a laser to precisely scan a single 
optical section, increasing resolution in the z axis which eliminates out of focus 
fluorescence such that significantly crisper images can be obtained. Also, the 
confocal optical sections are ideal for three-dimensional reconstruction from a serie 
taken at successive focal levels. Since the images produced by the confocal system 
are held in a digital frame store, they are readily available for computer analysis.
Due to the relative transparency and small size of adult H. contortus (males -  15 
mm, females ~ 27 mm), specimen anatomy can be clearly observed in whole mount 
preparations. As it was mentioned above, the coupling of immunofluorescence 
staining to confocal microscopy has been already used for detecting neuronal 
proteins in whole mount preparations of H. contortus. Therefore, it was chosen in 
this work to study the distribution of the HcGluCIa, p, a3A and a3B subunits in adult 
worms, using subunit-specific antibodies (chapter 2). Secondary antibodies 
conjugated to the fluorescent probes tetramethylrhodamine isothiocyanate (TRITC) 
and fluorescein isothiocyanate (FITC) were chosen in the following set of 
experiments.
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3.2 Materials and Methods
3.2.1 Materials
PBS tablets supplied by OXOID (Basingstoke, UK).
All chemicals used were of analytical grade and obtained from Sigma Chemical 
Company Ltd. (Poole, UK) and BDH chemicals (Poole, UK). Plasticware was 
Sterilin (Bibby Sterilin Ltd., Stone, UK), Nunc (Life Technologies Ltd), Paisley, UK) 
and Falcon (Falcon, New Jersey, USA). Sources from other products will be 
indicated in the following sections.
3.2.2 Adult Worm Collection
A sheep infected with 5000 L3 larvae of ivermectin-suceptible Haemochus 
contortus Weybridge strain, was slaughtered 3 weeks after infection. The 
abomasum was removed, rinsed with water, cut out and placed into an isolation 
apparatus in the presence of Dulbecco’s Modified Eagle Medium (DMEM) (GIBCO, 
Paisley, UK) (Gerald Coles, School of Veterinary Science, University of Bristol, UK). 
Worms were kept at 37°C by a heat-emitting lamp in the isolation apparatus, which 
consists of a funnel connected by 20 cm tubing to a 50 ml centrifuge tube. Live 
worms attached to the abomasum wall were directly picked with forceps and fixed 
(see section 3.2.3), or allowed to detach from the organ and collected on the 
centrifuge tube. To remove residual debris, worms were washed with DMEM kept at 
37°C before fixation.
3.2.3 Tissue Fixation and Permeabilisation
Adult H. contortus were incubated in freshly prepared fixative (4 % w/v 
paraformaldehyde in PBS) for 8 h at 4°C. Worms were washed three times in PBS 
and stored in 0.1 % w/v paraformaldehyde in PBS at 4°C for no more than 6 weeks. 
Worms were washed in PBS and the cuticle was permeabilised by incubating them 
in BME solution (5 % v/v 2-mercaptoethanol, 1 % v/v Triton X-100, 125 mM Tris- 
HCI pH 6.9) overnight at 37°C in a water bath. Finally, worms were briefly washed 
with PBS and transferred to Bijou tubes (Sterilin) where they were treated with 120 
collagen digestion units/ml of collagenase type IA (Sigma) in collagenase buffer (1
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mM CaCfe, 100 mM Tris-HCI pH 7.5) for either 8,10 to 24 h at 37°C in a water bath 
shaking at 100 rpm.
3.2.4 Immunofluorescence
Fixed and permeabilised worms were washed with PBS and four worms per Bijou 
tube (Sterilin) were incubated for 72 hours at 4°C with a 1:10 dilution of affinity 
purified antibodies in antibody diluent (0.1% (w/v) BSA, 0.5% (v/v) Triton X-100, 
0.05% (w/v) sodium azide in PBS). For the mouse anti-y-Aminobutyric Acid (GABA) 
monoclonal antibody (Sigma), dilutions of 1:10, 1:50 and 1:100 were used. 
Unbound antibodies were removed by three washes of one hour each with PBS 
and worms were treated overnight at 4°C with a 1:200 dilution of the appropriate 
secondary antibody: tetramethylrhodamine isothiocyanate (TRITC) -conjugated 
goat anti-rabbit IgG (Sigma), fluorescein isothiocyanate (FITC) -conjugated goat 
anti-mouse IgG (Jackson ImmunoResearch; West Grove, USA) or FITC-conjugated 
rabbit anti rat IgG (Vector Laboratories; Peterborough, UK). Worms were washed 
three times with PBS followed by a final overnight wash at 4°C with PBS / 0.1% 
(v/v) Triton X-100. They were mounted on microscope slides using Vectashield 
mounting media (Vector Laboratories), which reduces the effect of quenching of the 
fluorescence emission after exposure to excitation radiation and examined under a 
Zeiss LSM 510 confocal microscope (Zeiss, Germany). For the acquisition of 
images, filters and laser units were selected according to the fluorochrome used. 
FITC required a filter set 9 (blue excitation) and an argon laser (488 nm); TRITC a 
filter set 15 (green excitation) and a helium neon laser (543 nm). Transmitted-light 
observations were scanned using the argon laser (488 nm).
For each antibody, ten to twelve adult worms were treated on two or three different 
experiments. Controls included the omission of primary antibody and the use of 
peptide-adsorbed antibodies. In this case an excess of the appropriate peptide (20- 
40 pg/ml) was added to antibody working dilution and incubated at 37°C for 1 hour 
before been used for immunocytochemistry.
For double labelling of HcGluCIa and GABA or HcGluCIa and HcGluCip, 12 worms 
were treated as described above but co-incubated with both primary antibodies and 
then both secondary antibodies as required. Omission of primary antibodies was
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used as controls in these experiments. FITC and TRITC images were acquired 
separately and then the two scanned images were merged. All the antibodies used 




Whole mount adult H. contortus were immunostained with polyclonal anti- 
HcGluCIa, -p, -a3A and -a3B subunit specific antibodies, obtained as described in 
chapter 2, and with an anti-GABA antibody.
Staining results did not show differences when incubating the worms for 6 or 8 h in 
the concentrated fixative (4 % (w/v) paraformaldehyde (PAF) in PBS). However, 
worms kept in the storage fixative (0.1 % (w/v) PAF in PBS) for more than 6 weeks 
did not immunostain. In this latter case it is possible that over-fixation or under 
fixation conditions have masked or eliminated the epitope(s), preventing the 
antibodies from interacting with their antigen(s). As far as tissue permeabilisation is 
concerned, worms were incubated for 8, 10 and 24 h in 120 collagen digestion 
units/ml of collagenase in collagenase buffer. Reactions were terminated when 
worms became fragile and showed signs of cuticle degradation. Although this 
varied between different batches of worms, in most cases the best immunostaining 
was obtained from specimens exposed for 10 h to the collagenase treatment. 
Longer incubations often damaged the worms, causing the “heads” to break-off 
from the rest of the body.
In all cases pre-adsortion of the affinity-purified antibodies with the appropriate 
synthetic peptide blocked all specific staining, consistent with the immunoreactivity 
being due to the presence of the relevant GluCI subunit. With all the anti-HcGluCI 
affinity-purified antibodies (section 2.3.2.4) presented in this work, specific staining 
was obtained using antibodies at a dilution of 1:10 (~50 pg/ml) in antibody dilutent, 
followed by incubations with TRITC- or FITC-conjugated secondary antibodies at a 
1:200 dilutions. Similar staining was observed in female and male worms but the 
females seemed to stain better and therefore all the images are from females.
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Figure 3.1 Confocal images of anti-HcGluCIa antibody staining of H. contortus
Worms were incubated with 1:10 (v/v) dilution of anti-HcGluCIa antibody followed by 1:200 
(v/v) dilution of TRITC-conjugated secondary antibody. A: Lateral view from the anterior 
region of a female worm showing staining of motor neuron commissures (m). Orientation, 
anterior is top right. Scale bar 100 pm. B: High power magnification image of motor neuron 
commissures (m) projecting across the side of the worm (indicated by arrows) through the 
lateral cord (Ic). Scale bar 20 pm. -j Q2
When the anti HcGluCIa antibodies were used to immunostain adult worms, the 
HcGluCIa subunit was found to be present on H. contortus motor neuron 
commissures (Fig. 3.1 A). Specific staining was confined to the anterior part of the 
worm, below the pharynx to the anterior of the vulva. This result was very similar to 
that reported for the HcGluCip subunit (Delany et al., 1998) and suggested that the 
a- and p-subunits are co-expressed in H. contortus and might co-assemble to form 
the native GluCI. Commissures projecting from nerve cords and passing through 
the lateral cord could be discerned (Fig. 3.1B).
In addition, the HcGluCIa immunostaining was brighter where the motor neurons 
made contacts with nerve cords. No staining of pharyngeal muscle was observed. 
Motor neuron commissure staining was absent in worms incubated with peptide- 
adsorbed antibody, though non-specific staining was identified in the cuticle and in 
the intestine (Fig. 3.2A). Some general background fluorescence was observed in 
worms treated with pre-immune serum or with secondary antibody in the absence 
of primary antibody, as previously observed (Delany et al., 1998; Jagannathan et 
al.,1999). In these studies, pictures were obtained only from the anterior part of the 
worms but background fluorescence was observed all along the specimens (Fig. 
3.2B and C). Incubations in the presence of 10 % (v/v) serum from the same 
species in which the secondary antibody was raised, did not reduce the 
background.
A B
Figure 3.2 Negative controls of the HcGluCIa immunostaining
Confocal images of nematodes probed with 1:10 dilutions of HcGluCIa peptide (40 
jig/ml) -adsorbed antibody (A), pre-immune HcGluCIa serum (B) or in the absence of 
primary antibody (C). In all cases samples were incubated with 1:200 (v/v) dilution of 
dilution of TRITC-conjugated secondary antibody. A: lateral view of a mid-anterior region 
of a worm. B&C: head region, c: cuticle ridge; i: intestine.
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3.3.2.2 HcG luCIa and GABA
Nematodes posses distinct excitatory and inhibitory motor neurons that release 
acetylcholine or y-Aminobutyric Acid (GABA), respectively, at neuromuscular 
junctions (Stretton et al., 1985; Walrond et al., 1985). In order to determine on 
which type the HcGluCIa subunit is expressed, adult H. contortus were incubated 
with both anti-HcGluCIa and anti-GABA antibodies. All the GABA-ergic neurons in 
the anterior and middle part of the worm were also stained by the antibody to 





Figure 3.3 Confocal images of HcGluCIa and GABA dual immunostaining Lateral 
view from an anterior region of a female worm probed with 1:10 (v/v) dilution of the 
HcGluCIa antibody and 1:50 dilution (v/v) of an anti-GABA antibody, followed by 
incubation with 1/200 (v/v) dilution of TRITC- and FITC-conjugated secondary antibodies. 
A & B: Immunoreactivity to the HcGluCIa subunit and to GABA, respectively. The 
expression of the HcGluCIa subunit on GABA-ergic neurons is observed on the merged 






Is it also expressed on excitatory motor neurons? To date, none of the cholinergic 
marker genes, such as the vesicular acetylcholine transporter or choline acetyl 
transferase have been cloned from H. contortus. Attempts to immunostain H. 
contortus using polyclonal antibodies raised against C. elegans cholinergic markers 
were unsuccessful as these antibodies were incompatible with the fixation process 
used (data not shown). It is therefore not possible to determine whether or not 
excitatory motor neurons also express GluCI subunits.
3.3.2.3 HcGluCip
The similar expression patterns of HcGluCIa and HcGluCip suggested that in the 
motor nervous system which innervates body wall muscles of H. contortus, 
avermectin receptors might contain both of these subunits. In order to demonstrate 
this directly, rat antibodies to HcGluCip were produced (described in chapter 2). 
Immunofluorescence experiments showed that the rat HcGluCip affinity-purified 
antibodies also stained motor neuron commissures in H. contortus (Fig. 3.4). 
Background staining of the two ovaries wrapping the intestine shows that the 
staining corresponds to the mid-anterior region of a female worm. Different planes 
of focusing allowed me to distinguish lateral commissures projecting across the 
worm via lateral and sub-lateral cords (Fig. 3.4A,B). As with the HcGluCIa antibody, 
staining was brighter where the commissures made contact with nerve cords. In 
addition, the rat anti-HcGluClp antibody showed staining on possible sub-lateral 
and lateral nerve cords in the mid-anterior region of the worm (Fig. 3.4A, B), and 
this coincided with the area where the antibody stained motor neuron commissures. 
A rabbit antibody to HcGluCip has previously immunostained nerve cords in adult 
worms (Delany et al., 1998), however no distinction on the type of cord was 
described at that time.
The rat anti-HcGluClp antibody showed no staining of pharyngeal muscle, nor did 
the rabbit anti-HcGluClp antibody. Worms incubated only in the presence of 
secondary antibody, showed some fluorescence background in the ovaries and 
intestine (data not shown).
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Figure 3.4 Immunolocalisation of HcGluCip in H. contortus
Confocal images from the staining on the mid-anterior region of a female worm probed 
with 1:10 (v/v) dilution of the rat anti-HcGluClp antibody and 1:200 dilution of a FITC- 
conjugated secondary antibody, scanned on different focal levels (A & B). Motor neuron 
commissures (m) project laterally via the lateral (Ic) and sub-lateral nerve cords (sic). 
Orientation, right lateral side with the anterior towards the top right.
3.3.2.4 HcG luCIa and HcGluCip
Double labelling with the HcGluCI-a and p antibodies showed complete co­
localisation in motor neuron commissures in the anterior and middle part of H. 
contortus (Fig. 3.5), suggesting that at this site the avermectin receptor does 
contain both of these subunits.
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Figure 3.5 Confocal images of HcGluCIa and p dual-immunolabelling
Lateral view of the mid-anterior region of a female worm probed with 1:10 (v/v) dilutions of 
the rabbit anti-HcGluCIa and rat anti-HcGluClp antibody followed by incubation with 1/200 
(v/v) dilution of TRITC- and FITC-conjugated secondary antibodies. Immunoreactivity to 
the HcGluCIa (A) and HcGluCip (B) subunits was observed on motor neuron commissures 
(m). C: Overlay image of A and B. Orientation, anterior is top left.
3.3.3 Immunolocalisation of HcGluCla3A and HcGluCla3B
The alternatively-spliced products of the GluCI H. contortus avr-14 (gbr-2) gene, 
HcGluCla3A and a3B, were previously shown to be widely distributed in the adult 
nervous system of H. contortus (Jagannathan et al., 1999). In order to distinguish 
between the expression patterns of HcGluCla3A & a3B, peptide-specific antisera 
were produced in rabbits and the antibodies purified by affinity chromatography 
(described in chapter 2). Antibody specificities were demonstrated by ELISA 
assays, where the anti-GluCla3A antibody did not show any cross-reactivity with 
the GluCla3B peptide, nor did the anti-GluCla3B antibody cross-react with the 
GluCla3A peptide (section 2.3.2.4a).
Immunofluorescence experiments showed that the HcGluCla3 subunits are both 
expressed in motor neuron commissures in the anterior and middle region of H. 
contortus (Fig. 3.6A, B). The anti-GluCla3A antibody seemed to stain fewer 
commissures than the anti-GluCIa, p or GluCla3B antibodies did. Outside of these 
structures, the HcGluCla3A and 3B subunits are expressed in different regions of 
the worm nervous system. HcGluCla3B, but not a3A is expressed in nerve cords 
(Fig. 3.6B and C). Assuming that H. contortus neuroanatomy is similar to that 
described for C. elegans, the thick structure stained with the HcGluCla3B antibody 
in the figure 3.6B is probably the ventral nerve cord and the one parallel to it is the 
ventral sub-lateral cord. The punctate staining observed with the same antibody in 





Figure 3.6 Distribution of HcGluCla3A and a3B subunits in the motor nervous
system
Confocal images of lateral views from the middle region of worms probed with 1:10 (v/v) 
dilutions of the anti-HcGluCla3A (A) or anti-HcGluCla3B (B&C) antibodies, followed by 
incubation with 1:200 (v/v) of TRITC-conjugated secondary Ab. Both HcGluCla3A and a3B 
antibodies stained motor neuron commissures (m); but the HcGluCla3B also stained the 
ventral (vnc) and ventral sub-lateral (sic) nerve cords. Scale bars, A= 20 pM; B,C = 10 pM
In addition to the staining mentioned above, novel expression sites for the 
HcGluCla3A and -3B subunits were observed in the head of H. contortus. The anti- 
HcGluCla3A antibody stained a pair of lateral neurons in the anterior end (Fig. 
3.7A). A pair of nerve processes, emanating from their cell bodies can be
1 0 9
distinguished. These may correspond to sensory neurons from the amphids, the 




Figure 3.7 Immunolocalisation of HcGluCla3A in the head of H. contortus
Reconstruction from serial confocal sections of the staining on a female worm, probably on 
amphidial neurons. Worms were treated with 1:10 (v/v) dilutions of the anti-HcGluCla3A 
antibody (A), HcGluCla3A peptide (40 pg/ml)-adsorbed antibody (B) and pre-immune 
HcGluCla3A serum (C) followed by incubation with 1:200 (v/v) of TRITC-conjugated 
secondary antibody. Note nerve precesses (np) and cell bodies (cb). Orientations: the 
worm anterior end is top right in A, left bottom in B and right in C. A-C images were 
scanned keeping the same confocal settings. Scale bars, 10 pM.
The stained cell bodies were -  300 pm from the anterior tip of the worm. Since in H. 
contortus adult females the nerve ring has been located ~ 285 pm from the anterior 
end of the body (Veglia, 1915), it seems that the cell bodies stained with the 
HcGluCla3A antibody are located just behind the nerve ring, possibly in the lateral
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ganglion. In H.contortus L1 and L3 larva as in C. elegans, all receptor neurons of 
the amphid sensilla have their cell bodies in the lateral ganglia (Li et al., 2000 a & 
b). This specific neuronal staining was absent after treatment with HcGluCla3A 
peptide-adsorbed antibody or pre-immune sera, which detected only some non­
specific cuticle staining in both cases (Fig. 3.7B and C).
In the head, the anti-HcGiuCla3B antibodies reacted with three possible neuronal 
cell bodies situated ~ 500 pm from the anterior tip. These structures, arranged in a 
triangular disposition, one in one plane and two in a different focal plane, were in 
the region of the pharynx (Fig. 3.8A,B). They might correspond to pharyngeal motor 
neuron cell bodies, possibly the equivalents of the two M2 and single M1 neurons 
found in C. elegans (Albertson and Thomson 1976). The staining was absent in 
worms incubated with FlcGluCla3B peptide-adsorbed antibody or pre-immune sera, 
which again gave rise to non-specific staining of the cuticle (Fig. 3.8D, E).
A B
Figure 3.8 Immursolocalisation of HcGluCla3B in the pharynx of H. contortus
Worms were probed with 1:10 (v/v) dilutions of the anti-HcGluCla3B antibody (A-C), 
HcGluCla3B peptide (40 pg/ml)-adsorbed antibody (D) and pre-immune HcGluCla3B 
serum (E) followed by incubation with 1:200 (v/v) of TRITC-conjugated secondary 
antibody. A&B: Confocal images scanned in two different planes of focusing, merged with 
their DIC images. Note three cell bodies (cb) stained on the pharynx (ph). C: Low power 
magnification image; the arrow indicates the staining observed in A and B. Orientation, 
anterior is right. A-E images were scanned keeping the same confocal settings. Scale 
bars, panels A, B, D, E = 20 pM; C = 50 pM.
Taken together, these data allowed the description of the expression pattern of all 
the currently identified GluCI subunits in H. contortus (Table 3.1) and to draw some 
preliminary conclusions about the subunit compositions of the avermectin receptors 
in this organism.
Table 3.1. Location of avermectin subunits in H. contortus
GluCIa motor neuron commissures3 (Fig. 3.1, 3.3 & 3.5)
GluCip motor neuron commissures’3,3 (Fig. 3.4 & 3.5) and lateral
and sub-lateral nerve cords3 (Fig. 3.4)
GluCla3A amphidial neurons3 (Fig. 3.7) and motor neuron
commissures0,3 (Fig. 3.6A), nerve cords and nerve ring0
GluCla3B pharyngeal neurons3 (Fig. 3.8), motor neuron
commissures0, 3 (Fig. 3.6B), lateral and ventral nerve
cords0,3 (Fig. 3.6B,C), nerve ring0
3 current study; b Delany et al, 1998; 0 Jagannathan et al, 1999. Note that the
antibodies used in this work did not distinguished between the two alternative
spliced variants GluCla3A and 3B.
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3.4 Discussion
Specific antisera raised against the HcGluCIa, p, a3A and a3B subunits were used 
to study the distribution of the H. contortus avermectin receptor in adult worms. The 
data presented provide the first immunocytochemical evidence for the possible 
association of a and p subunits in native nematode GluCIs and reveal different 
expression sites for the alternatively spliced gene products of Hcgbr-2.
In general, good reproducibility of the results was seen between preparations and 
between individual worms within a preparation. However, some variation was seen. 
It is difficult to assess the biological significance of this, as it is necessary to almost 
completely destroy the cuticle in order to permit penetration of antibodies. Under­
digestion with collagenase results in no specific staining, whereas over-digestion 
produces extremely fragile worms that do not survive the antibody treatment and 
washes intact. The best results were obtained by halting the digestion just as the 
worms were about to disintegrate. Given the inherent biological variation in 
populations this inevitably means that some worms will be slightly over- or under­
digested in each preparation. In fact, the reason for obtaining better results with 
female worms is possibly due to a slightly different cuticle structure. Certain sites of 
expression may therefore not be available for detection using this protocol and for 
that reason, though the presence of specific immunoreactivity certainly implies 
expression of a particular subunit at a site, the absence of reactivity does not 
necessarily imply the absence of expression.
HcGluCIa and p
The expression pattern obtained for the HcGluCIa and p subunits shows that both 
co-localise in motor neuron commissures in adult H. contortus, strongly suggesting 
that these subunits are part of the same receptor. This expression of GluCIs in 
motor neurons is consistent with the paralysing effect of ivermectin on H. contortus 
somatic musculature (Gill et al., 1991; Geary et al., 1993). Since the HcGluCIa 
subunit binds ivermectin (IVM) with high affinity (Cheeseman et al., 2001; Forrester 
et al., 2002), it is possible that a HcGluCIa- and HcGluCip-containing receptor is 
responsible for at least part of the paralysing effects of the drug.
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The presence of GABA in the nematode motor nervous system has been 
demonstrated for both C. elegans and Ascaris suum, a large parasite of pigs 
(Johnson and Stretton 1987; Mclntire et al., 1993). The use of anti-HcGluCIa and 
anti-GABA antibodies showed that the HcGluCIa subunit, and therefore the ‘a + p’ 
receptor, is expressed on GABA-ergic motor neurons. This conclusion is supported 
by the data of Kass et al (1980) who found that avermectin inhibits transmission 
between inhibitory (VI) motor neurons and muscle in A. suum. Moreover, Davies 
(1998) showed that, in this parasite, the dorsal inhibitory motor neuron (Dl) exhibits 
a reversible glutamate-induced hyperpolarisation, an observation which could be 
explained by the presence of GluCIs on the GABA-ergic motor neurons.
The GluCIa and p immunostaining revealed commissures crossing lateral and sub­
lateral cords, as previously reported (Delany et al., 1998). GluCI immunoreactivity 
was stronger where the commissures make contacts with these nerve cords, 
suggesting a concentration of receptors at possible synaptic areas. Johnson and 
Stretton (1987) suggested that motor neurons may receive inputs from neurons in 
the lateral cords that are important for the control of movement in the right-left 
plane. GluCI subunits staining was found in motor neurons between the pharynx 
and the vulva, consistent with the IVM-induced paralysis of the mid-body region of 
adult H. contortus (Geary et al., 1993). In C. elegans this area contains neurons 
running in sub-lateral nerves as well as the ALM and AVM touch receptor neurons 
running in the lateral and ventral nerve cords, respectively (White et al., 1986). The 
expresssion of eat-4 (a glutamate transporter gene) in ALM and AVM suggested 
that these neurons are glutamatergic (Lee et al., 1999). Thus, it is tempting to 
speculate that the GluCI could be target sites for glutamatergic transmission from 
those neurons.
HcGluCla3A and a3B
Specific antibodies to HcGluCla3A and a3B allowed the distinction between the
expression patterns of these subunits. This work confirmed that both subunits are
expressed in motor neuron commissures, and, excluding this location, it does
suggest that the HcGluCla3A and a3B subunits are expressed in different regions
of the worm nervous system. HcGluCla3B, but not HcGluCla3A is expressed in
nerve cords. Indeed, ventral cord staining has already been described for the
HcGluCla3 subunits in H. contortus and for avr-14 in C. elegans (Jagannathan et
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al., 1999; Dent et al., 2000). However, neither the antibody used earlier in H. 
contortus nor the reporter gene construct used in C. elegans distinguished between 
the two gene products. More recently the HcGluCla3B antibody was used to 
immunostain C. elegans and in agreement with the data presented here, it showed 
immunoreactivity in the C. elegans motor nervous system (A. Cook and L. Holden- 
Dye, pers. commun.). Expression of HcGluCla3B in lateral cords might correspond 
to the touch receptor neuron ALM or interneurons, both with axons running laterally. 
In C. elegans the lateral interneuron SIADL receives in the nerve ring a synapse 
from the glutamatergic neuron ALM. It is possible that the SIADL or other(s) lateral 
interneurons express GluCIs and receive glutamatergic inputs, such as from ALM, 
not yet characterised. HcGluCip was also present on lateral cords but whether 
HcGluCla3B and HcGluCip are part of the same GluCI channel in the cords, is still 
unclear. In the present study, double labelling assays with both anti-peptide 
antibodies were inconclusive.
In the ventral cord, the anti-HcGluCla3B antibody might be staining motor neurons 
and or command interneurons. The punctate pattern obtained with this antibody 
suggests a post-synaptic role for the HcGluCla3B-containing GluCI in the ventral 
cord. C. elegans command interneurons control locomotion by receiving inputs from 
sensory neurons and synapsing onto motor neurons and other command 
interneurons along the ventral cord. Recently, a GFP-tagged version of the C. 
elegans GluCla3 was expressed in interneurons and localised to distinct synapses 
along the ventral nerve cord (Grunwalnd, 2001). In addition, indirect evidence from 
the sensory response to anterior touch behaviour in C. elegans, suggested the 
presence of the GluCla2 subunit in the AVB and PVC command interneurons (Lee 
et al., 1999). These interneurons control C. elegans forward locomotion and the 
AVA, AVD and AVE command interneurons backward movement (Chalfie and 
White, 1988). Very recently, a glutamate-gated chloride current has been detected 
in the AVA neuron, being suggested that the GluCIs may help to reestablish forward 
movement following a backwards one (Mellem et al., 2002). Therefore, the 
expression of GluCIs in possibly lateral and ventral cord interneurons may further 
contribute to the function of the GluCI receptor expressed in motor neuron 
commissures on the locomotory control in H. contortus.
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In the head, HcGluCla3A was found in a pair of probable sensory neurons. The 
distance from their cell bodies to the tip of the worm and the bilateral disposition of 
the neuronal processes suggested that they were amphidial neurons. Amphids, the 
main chemoreceptor sense organs from the anterior end of nematodes, are the 
largest sensilla located on each side of the mouth. The amphidial structure of the 
first stage larva of H. contortus has been described and is very similar to their 
counterparts in C. elegans (Li et al., 2000a). However, there is no information about 
the amphids in adult H. contortus making it difficult to determine which neurons are 
stained with the anti-HcGluCla3A antibody. In C. elegans, the orthologous avr-14 
gene is also expressed in extrapharyngeal neurons in the head of the worm as well 
as in other sensory neurons (Dent et al., 2000). Expression of GluCI subunits in 
these neurons has not been reported before and their function here is uncertain. It 
has been shown that HcGluCla3A, when expressed alone in a heterologous 
system, failed to form IVM binding sites and, presumably, functional receptors 
(Cheeseman et al., 2001). This suggests that other, as yet unidentified, GluCI 
subunits are likely to be expressed in H. contortus amphidial neurons.
The connectivity of C. elegans nervous system has been studied by electron 
microscopy reconstructions (White et al., 1986). As far as amphid neurons is 
concerned, there are several instances of neurons synapsing directly onto others, 
such as those of ASH onto ASK and ASK onto ASJ. Also, some of them synapse 
onto more than one other type of neuron, such as ASE onto AWC and AFD. 
Interestingly, the two pairs of ASH and ASK neurons (left and right) express the eat- 
4 glutamate transporter and hence, supposed to be glutamatergic (Lee, et al.1999). 
If this was the case for H. contortus, it is possible that the GluCla3A- containing 
receptor expressed in the amphids was the synaptic target for the ASH or ASK 
glutamatergic amphidial neurons. Chemical synapses in C. elegans and probably in 
H. contortus, occur en passant between neighbouring parallel processes. Since 
amphidial neurons run parallel into the amphidial channel, apart from the well- 
characterised outputs of those neurons described on the nerve ring area, synapses 
onto the distal nerve processes cannot be ruled out. This would explain the 
expression of GluCla3A in the anterior processes of H. contortus amphid neurons. 
It seems likely that amphid receptor-receptor connections facilitate the modulation 
of the activity of one receptor by another (White et al., 1986). GluCI channels have 
been implicated in the formation of inhibitory synapses (Dent et al., 1997). In this
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case amphid neurons expressing HcGluCla3A-containing receptors might modulate 
sensory modality inactivating chemical transmission.
Interestingly, a direct role for ligand-gated ion channels in chemosensation has 
been already reported for a nicotinic acetylcholine receptor in C. elegans (Yassin et 
al., 2001). This receptor (DEG-3/DES-2) was localised to sensory neurons in the 
head, probably IL2s and FLPs, and was preferentially activated by choline. Unlike 
the punctate staining typical of nematode synaptic proteins (Nonet et al., 1993), the 
antibody staining for the DEG-3 subunit was diffuse. The HcGluCla3A amphidial 
staining was also diffuse. This may be a result of receptor translocation 
intermediates. Alternatively, the glutamate HcGluCla3A-containing receptor might 
have a non-synaptic role in the amphids. It is tempting to speculate that expression 
of HcGluCla3A in amphidial neurons might modulate sensory signals; these 
neurons are very likely to play an important role in mediating the infective process, 
including host contact, host recognition, and initiation of parasitic growth and 
development (Ashton et al., 1999; Li et al., 2000b; Lopez et al., 2000). IVM would 
therefore be predicted to interfere with these processes and studies on Brugia 
pahangi (a filarial nematode) have indeed shown that the drug can block 
physiological responses to chemical stimuli (Perry, 2001; Rolfe et al., 2001). 
Interestingly, in C. elegans the entry of IVM into the nematode seems to be 
facilitated by amphidial neurons (Dent et al., 2000). This might also be the case in 
H. contortus but the link of this, if it is any, with the expression of HcGluCla3A is 
unclear.
Previous reports have shown that a major effect of the avermectin/mylbemycin
(AM) anthelmintics on parasitic nematodes is the paralysis of pharyngeal muscle
(Geary et al. 1993; Martin, 1996). Results presented here have now demonstrated
the expression of the HcGluCla3B subunit in pharyngeal cells. Expression of the
subunit was restricted to three cell bodies situated about 500 pm from the anterior
tip of the worm. The identity of these cells is still unknown. However, due to their
position in the pharynx, and assuming that the localisation of the cell bodies is
similar to that seen in C. elegans, the staining might correspond to pharyngeal
neurons M2 (right and left) and M1. This presynaptic localisation in pharyngeal
neurons suggests a modulatory effect of H. contortus GluCI on nematode feeding
and might explain the paralysing effect of IVM on this process. In C. elegans the
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HcGluCla3B antibody also stained pharyngeal neurons (A. Cook and L. Holden- 
Dye, pers. commun). Although the immunostaing appeared more widespread than 
observed in H. contortus, a triplet of neurons identified as M1 and M2 in the 
terminal bulb of the pharynx (Fig. 3.9), resembles the staining here reported in H. 
contortus. In C. elegans the M1 is a single motor neuron with unknown function 
whose cell body is in the anterior terminal bulb. It synapses to pharyngeal muscle 
(pm) 1, pm2 and pm3. The M2 motor neuron innervates pm4 and pm5 pharyngeal 
muscles. Interestingly, the GluCI genes glc-2 and avr-15 were expressed in the 
pm4 and the avr-15 was also expressed in the pm5 (Laughton et al., 1997b and 
Dent et al., 2000) (Fig. 3.9). Expression of GluCI subunits in nematode pharyngeal 
system, either in pharyngeal muscles for C. elegans or in pharyngeal neurons in 
both C. elegans and H. contortus, suggests an important role for GluCIs in 
controlling nematode feeding.
avr-15 mm glc-2 ^■G luC la3B i z i  eat-4
Fig. 3.9 C. elegans GluCI subunit staining in the pharynx
Lateral view of the pharynx showing in colour the muscles expressing reporter gene 
constructs for the avr-15 and glc-2 genes. In red, expression of the GluCla2A::GFP 
promoter fusion in the pharyngeal muscle cells 4 (pm4) and 5 (pm5) and in blue, the 
GluClp::lacZ construct expressed in the pm4. Small circles correspond to the cell bodies of 
pharyngeal motorneurons that synapse onto pharyngeal muscle. Notice the GluCla3B 
subunit expressed in M1, M2 and M3. Chemical synapses are indicated by arrows. Notice 
that the glutamatergic M3 motorneuron (which expresses eat-4) synapses onto pm4. 
References are mentioned in the discussion, a, anterior, p,posterior.
In contrast to early results obtained with the anti-HcGluCla3 antibodies 
(Jagannathan et al., 1999); none of the subunit-specific anti-HcGluCla3A or a3B 
antibodies stained the H. contortus nerve ring in the present work. This might be 
explained by differences in the affinities of the antibodies used or variation in tissue 
fixation and/or permeabilisation conditions.
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It is noteworthy that the results presented confirmed that the expression pattern of 
orthologous GluCI subunits is not conserved between C. elegans and H. contortus, 
as demonstrated earlier for the p-subunits (Laughton et al., 1997b; Delany et al.,
1998), though we have not yet identified the parasite orthologues, if any, of C. 
elegans glc-1 or avr-15 genes. There is, however, a strong correlation between the 
biological activity of IVM on C. elegans and H. contortus, with both pharyngeal 
pumping and motility being inhibited in both species (Bernt et al., 1989; Avery et al., 
1990; Geary et al., 1993; Arena et al., 1995). It seems that nematodes contain more 
than one type of GluCI, and it is possible that differences in the expression of 
individual subunit genes between nematode species reflect their adaptation to 
different life-styles. This would predict that the effects of the AM anthelmintics would 
vary in different species, reflecting the varying roles and subunit composition of the 
GluCI. A number of observations support this prediction; the avermectins (AVMs) 
have different effects on the development, fertility and somatic and pharyngeal 
musculature of different parasitic nematodes (Gill et al., 1998; Grant 2000). AVM 
effects on motility are critical for efficacy against H. contortus and Trichostrongylus 
colubriformis, whereas its effects on pharyngeal pumping are crucial for the 
elimination of Ostertagia circumcinta (Gill et al., 1998).
In summary, it was shown that H. contortus GluCIa and p subunits co-localise and 
probably co-assemble in motor neuron commissures in native glutamate gated- 
chloride channels. The expression of HcGluCla3 subunits in motor neurons was 
confirmed and their expression in nerve cords was dissected, identifying only the 
HcGluCla3B subunit in the sub-lateral and ventral cords. New expression sites for 
the HcGluCla3A and a3B subunits were detected in sensory and possibly 
pharyngeal neurons, respectively. These expression patterns suggest that the 
GluCIs have critical roles controlling locomotion, pharyngeal function and possibly 
sensory processing in parasitic nematodes. They also provide an explanation for 
the observed effects of the AMs anthelmintics on H. contortus and the different 
effects that are observed on different nematode species.
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CHAPTER 4
STUDY OF THE ROLES OF GLUTAMATE-GATED 




4.1.1 C. elegans behaviour
Behavioural studies have been important screening tools for the isolation of 
mutations in C. elegans (Brenner, 1974; Wood, 1988; Bargmann, 1993). The study 
of behavioural genetics in C. elegans, an organism in which the nervous system is 
small enough (302 neurons in the adult hermaphrodite) to theoretically allow the 
role of every neuron in a given behaviour to be known, has given unique insights 
into how genes contribute to behaviour in general. Laser ablation of identified 
neurons has allowed researchers to investigate the role of single neurons in specific 
behaviours (Chalfie et al., 1985), and once determined, the neuronal circuit can be 
used to explore the roles of other neurons that connect to the circuit in the same 
behaviour.
Naturally occurring behaviours in C. elegans can be divided into four classes: 1) 
sensory input: chemosensation, thermosensation and mechanosensation; 2 ) 
locomotion; 3) survival: foraging, feeding, defaecation and dauer larva formation, 
and 4) reproduction: egg laying and male mating. Other complex behaviours 
include: social behaviour, learning and memory (Rankin, 2002). General 
descriptions of the behaviours studied in the present work are described below.
4.1.1.1 Chemosensation
C. elegans sense different stimuli detected by the amphids and the inner labial 
sensilla in the anterior tip of the worm and by the phasmid sensilla at the posterior 
end of the animal (Bargmann and Horvitz, 1991a). The amphids and phasmids are 
considered to be the main chemoreceptive organs in C. elegans because their 
structure permits a group of nerve endings to be exposed to the external 
environment of the animal (White et al., 1986). Chemosensory functions have been 
identified for 11 pairs of amphid neurons. Each type of neuron has a particular 
sensory specificity and most of them recognise several different chemical cues. The 
chemical specificities of different neurons can overlap; for example: two types of 
neurons sense thiazole and four types sense salts. Also, some neurons respond to 
more than one type of stimulus (Bargmann and Mori, 1997). It is believed that 
behavioural specificity is probably encoded by synaptic connections between
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sensory neurons and their partners (interneurons) in the nerve ring. In brief, the 
stimuli detected by the sensory neurons are transmitted to interneurons, which 
synapse onto motor neurons such as those responsible for driving locomotion in the 
worm.
Although many genetic screens for C. elegans mutants unable to respond to 
chemicals have been conducted, they have generally not led to the identification of 
the receptors, with the exception of odr-10 (Sengupta et al., 1996). ODR-10, the 
receptor for diacetyl, is a G protein-coupled 7-transmembrane domain protein that 
localises to the cilia of the AWA neurons, where diacetyl detection is believed to 
occur. Identification of other chemosensory receptors as well as the events that 
occur downstream of the sensory neurons remain largely unsolved.
Chemotaxis
Chemotaxis represents a complex response of the animal to its environment. The 
animal must sense continuous changes in external conditions and convert sensory 
information into movement in a particular direction. C. elegans moves up gradients 
of attractive stimuli and moves down gradients of repellent stimuli. The C. elegans 
sensory neurons required for normal responses to a number of chemical attractans 
or repellents have been identified by laser ablation of particular cell types. In this 
way, Bargmann and Horvitz (1991a) found that the amphidial neuron ASE is the 
single most important chemosensory neuron for chemotactic responses to cAMP, 
biotin, Cl' and Na+. Chemical attractants and repellents for C. elegans have been 
identified by screening large numbers of volatile and non-volatile chemicals. Salts, 
some amino acids, some nucleotides and some vitamins act as water-soluble 
attractants (Ward, 1973; Dusenbery 1974; Bargmann and Horvitz, 1991a) as do 
many different volatile organic molecules (Bargmann et al., 1993). Although 
mutants worms that have specific chemotaxis defects have been isolated (Culotti 
and Rusell, 1978), the mechanism by which chemotaxis is accomplished is only 
partly understood. Chemotaxis towards water-soluble attractants requires the cyclic 
nucleotide-gated channel encoded by tax-2 and tax-4. TAX-2 and TAX-4 form a 
putative sensory transduction channel gated by cGMP, which is permeable to Na+ 
and Ca2+ (Komatsu et al., 1999). Recently, Yassin et al (2001) showed for first time 




High osmotic strength is repulsive to C. elegans. Detection of a high osmotic 
strength, low pH or octanol induces a rapid reversal response, which is followed by 
a change in direction (Culotti and Russell 1978; Troemel et al., 1995). The 
polymodal sensory neuron ASH seems to play the predominant role in detecting 
hyperosmolarity (Hart et al., 1999). It also mediates the responses to nose touch, 
volatile and water-soluble repellents (such as octanol and sodium dodecyl sulphate, 
respectively), with each of the three stimuli evoking backward locomotion 
(Bargmann et al., 1990; Kaplan and Horvitz, 1993; Troemel et al, 1995; Hilliard et 
al., 2002). It is believed that hyperosmolarity and touch are both detected by 
mechanically gated ion channels. In mammals, ubiquitous stretch-activated 
channels mediate osmosensation (Oliet and Bourque, 1993; 1996). However, it is 
unclear in C. elegans which receptor(s) respond(s) directly to the osmotic modality. 
The search for mutants defective only in ASH-mediated osmotic avoidance but 
normal for ASH-mediated nose touch sensitivity, resulted in the isolation of OSM-10 
(Hart et al., 1999). This is a cytosolic protein expressed in ASH, and in three other 
classes of sensory neurons required for osmosensory signalling. Recently, Mellem 
et al (2002) showed that ASH polymodal signalling in C. elegans occurs via 
differential activation of postsynaptic glutamate receptors. Particularly, osmotic 
signals activate non-NMDA (GLR-1 and GLR-2)- and NMDA (NMR-1)- dependent 
glutamate currents.
In this chapter, a new osmotic avoidance assay described by Hilliard et al (2002) 
was used in preference to the standard ring assay described by Culotti and Russell 
(1978). The reason for this, as recently suggested by Mellem et al (2002), is that 
the ring assay does not measure the immediate avoidance response to an osmotic 
stimulus and may reflect a variety of signalling processes including desensitization 
and adaptation. In this way, the drop assay described by Hilliard has just revealed 
that glr-1 mutant worms with a normal osmotic avoidance response assayed by the 
osmotic ring method (Maricq et al., 1995), were in fact defective compared to wild- 
type worms. These worms, showed a significant increase in the delay to the 
withdrawal response (Mellem et al., 2002).
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4.1.1.2 Locomotion
Locomotion in C. elegans is achieved by moving the body in sinusoidal waves. To 
generate this pattern, the contraction of the dorsal and ventral body muscles must 
be out of phase: to turn the body dorsally, the dorsal muscles contract while the 
ventral muscles relax. A pattern of altering dorsal and ventral contractions is 
produced by interactions between excitatory and inhibitory motor neurons (for 
details see chapter 1, section 1.5.3).
Circuit for forward and backward locomotion
In C. elegans the locomotory control circuit regulates movement in response to 
environmental stimuli. Forward and backward locomotion are regulated by several 
pairs of command interneurons (Chalfie et al., 1985). These are bilaterally 
symmetrical ventral cord neurons, whose axons run the entire length of the cord 
providing inputs to the ventral cord motor neurons: VA, VB, DA and DB. The 
command interneurons AVB and PVC activate forward movement and the AVA, 
AVD and probably AVE, backward movement (see figure 4.1). The command 
interneurons receive extensive input from sensory circuits, both directly from 
sensory neurons and indirectly through amphid interneurons and other nerve-ring 
interneurons. It is likely that the command interneurons integrate complex sensory 
information and direct appropriate locomotory responses. Also, the forward and 
backward interneurons have reciprocal connections, which could mediate 
coordination of opposing circuits (White et al., 1986).





Fig. 4.1 C. elegans motor circuitry
Backward and forward movement is mediated by the activation of excitatory motor 
neurons (grey circles) by their associated command interneurons (yellow rectangles). The 
GABA-ergic inhibitory motor neurons (red circles) receive their synaptic input from the 
other motor neuron classes. They coordinate the front and back movements synapsing 
onto muscles situated on the opposite side of those that are innervated by their 
presynaptic partners (indicated by capped lines). Cholinergic neuromuscular synapses 
are indicated by thin arrows. D: dorsal, V: ventral. Thick arrows: neuronal chemical 
synapses: straight connecting lines: gap junctions. Adapted from Chalfie and White, 
1988. a
4.1.2 Double strand RNA interference in C. elegans
RNA-mediated interference (RNAi) transiently inhibits or knocks-down the activity of 
a gene by the introduction of double-stranded RNA (dsRNA) sequences specific to 
the targeted gene (Fire et alM 1998). The specificity, potency and relatively easy 
methodology of RNAi, make it ideal for investigating gene function in C. elegans. 
RNAi is transmitted to the first generation (F1) progeny but in most cases complete 
recovery of wild-type gene activity occurs in the second (F2) generation (Fire et al., 
1998; Tabara et al., 1998; Timmons and Fire, 1998; Fraser et al., 2000). Although 
the mechanism of RNAi is not completely understood, current evidence favours a 
model in which RNAi blocks a posttranscriptional step in gene expression. It has 
been described that when dsRNAs enter the cell, they are cut up into short double 
stranded fragments during at least two steps of RNA silencing. First, dsRNA is 
processed into many short pieces of 21-22 nucleotides by a specific RNaselll-like 
nuclease. These fragments are then incorporated into a multi-subunit complex, 
which carries out the second RNA-degradation reaction. Apparently, the role of the 
22-nucleotide RNAs generated in the first step is to interact, by base pairing, with 
the target mRNA in which the sequence of nucleotides is the same as in the 
dsRNA. The short RNA molecules thus guide the RNases of the multi-subunit 
complex, ensuring specific degradation of those mRNA species related to the 
dsRNA (Baulcombe, 2001).
Initially, the introduction of dsRNA into C. elegans has been assayed by 
microinjection into the gonad of an adult hermaphrodite (Fire et al., 1998). Since 
RNA can be absorbed through the gut and distributed to somatic tissue and the 
germ line, it has also been possible to initiate RNAi by soaking worms in a solution 
of dsRNA (Tabara et al., 1998) or by feeding nematode larvae with E. coli 
expressing target gene dsRNA (Timmons and Fire, 1998). C. elegans normally feed 
on bacteria, ingesting and grinding them in the pharynx and subsequently 
absorbing bacterial contents in the gut. RNAi by feeding has been more used than 
the dsRNA soaking method and has several advantages over microinjection. It is 
less labour-intensive, is more convenient for performing RNAi on a large number of 
worms, and is less expensive than injection resulting in a durable reagent (a 
bacterial strain expressing dsRNA corresponding to a gene of interest) which can 
be reused to reproduce an RNAi phenotype easily (Kamath et al., 2000). For all
these reasons, the RNAi method by feeding was the one used in this work.
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4.1.3 GluCI subunits and behaviour studies
Previous data from our group suggested that C. elegans GluCI subunits participate 
in locomotion, egg laying and feeding behaviours (Aptel et al., 2002). Studies on 
avr-14 and avr-15 mutant worms showed a 50 % decrease in the duration of 
forward movement and about 60 % reduction in the progeny in these mutants, 
compared to wild-type worms. RNA interference experiments with avr-14 or avr-15 
in wild-type worms showed a similar reduction in the duration of the forward 
movements, confirming that this method can be used to study the effect of reducing 
the expression of GluCI genes for which no mutant alleles are yet available. As far 
as feeding is concerned, the avr-15 mutant but not the avr-14, showed a reduction 
in the pumping rate. The phenotypes observed in avr-14 and avr-15 mutant worms 
are in agreement with the biological effects of ivermectin in susceptible nematodes, 
such as the inhibition of: pharyngeal pumping, motility and fecundity. Also, and 
although no GluCI subunits have been found in the C. elegans reproductive system 
yet, there is a good correlation between the presence of GluCI subunits on neurons 
and muscle cells and the behavioural phenotypes found in GluCI mutant worms. 
Therefore, behavioural assays would also allow identify possible roles for the GluCI 
subunits whose expression patterns have not been described yet, such as the C. 
elegans GluClal encoded by the glc-1 gene. Besides, disrupting the expression of 
particular GluCI subunits, for example through RNAi assays in a wild- type and in a 
GluCI mutant background strain, might also help to dissect the contribution of 
different subunits to the function of the native GluCI receptor in C. elegans.
When considering that the biological effects of ivermctin on C. elegans and H. 
contortus are conserved between the two species and that the drug target sites, the 
GluCIs, are mainly expressed in the nervous system of these worms, studies in C. 
elegans could be used as a model to find out possible functions of the GluCI 
receptors in the parasitic nematode. Table 4.1 shows a comparison of the 
expression pattern between C. elegans and H. contortus. In particular, the 
distribution for the orthologous GluCla3 subunits is very similar in both nematodes, 
as indicated in Table 4.1 by the same font colours. Expression on the neuronal 
structures responsible for movement, nerve cords and motor neurons, correlates 
with the locomotion defects described for the avr-14 mutants, as mentioned above.
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Table 4.1. Comparison of the known expression patterns of the GluCI subunits in C. elegans and H. contortus
C. elegans H. contortus
GluCloc2
(avr-15)
pharyngeal muscle, some motor 
neurons in the head and ventral nerve ? ?
GluCla3
corda
extrapharyngeal neurons in the head, HcGluCla3A amphidial neuronsf and motor neuron
(avr-14) sensory neurons and commissures ,^ nerve cords and nerve
ventral nerve cord motor neurons® 
and interneurons9 HcGluCla3B
ringd
pharyngeal neuronsf, motor neuron
GluClp pharyngeal muscleb HcGluClp
commissuresd,f, lateral and ventral nerve 
cordsdf, nerve ringd
motor neuron commissures0* and lateral
(glc-2)
X
a r \ ___4 a  n n -7
X
bi__ l i ______ 4 . 1  a  C r - \ _ i_____a
HcGluCIa
d .__________ 4._______ 4
and sub-lateral nerve cordsf 
motor neuron commissuresf
a Dent et al., 1997. DLaughton et al., 1997a.cDelany et al, 1998.d Jagannathan et al, 1999. Note that the antibodies used in this work 
did not distinguish between the two alternative spliced variants HcGluCla3A and a3B. 6 Dent et al., 2000.fthis project (Figs. from 
chapter 3), 9Grunwald and Kaplan, 2001. ?=not yet identified; x=not present
The extrapharyngeal neurons expressing the C. elegans GluCla3 subunits 
correspond to neurons from the ring ganglia of the head (Dent et al., 2000), which 
contains cell bodies of sensory neurons, motor neurons and interneurons. 
Moreover, the H. contortus GluCla3A subunit was localised to possible amphidial 
neurons (sensory neurons in the head) (chapter 3, Fig. 3. 7). However to date, no 
data have been published linking nematode GluCI subunits to a chemosensory 
function.
The aim of the experiments described in this chapter was to further characterise the 
contribution of GluCI receptors into C. elegans behaviour. So far, the roles of 
GluCIs in locomotion have been analysed for all the C. elegans GluCI subunits 
except for the GluClal. Besides, the results obtained in chapter 3 showed that the 
H. contortus GluCla3A subunit is expressed in a pair of sensory neurons in the 
head and in motor neuron commissures. Therefore, the particular interest of this 
work was to investigate whether the GluClal subunit (glc-1) participates in C. 
elegans locomotion and to find out whether GluCla3 (avr-14), orthologous to 
HcGluCla3A in H. contortus, and GluCla2 (avr-15) have a role in the sensory 
behaviours, chemotaxis and osmosensation. This could then be used as an 
approach in the understanding of the function of these channels in H. contortus.
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4.2 Materials and Methods
4.2.1 C. elegans strains
Wild-type: N2, Bristol strain 
Mutant strains:
glr-1 (n2461): nonsense mutation in codon 807
avr-14 (ad1302)\ missense V60E mutation in an exon common to both transcripts of 
avr-14
avr-15 (ad1051): molecular null for avr-15
avr-14/avr-15 (ad1302/ad 1051): avr-14 and 15 double mutant
Wild-type and glr-1 mutant stocks were obtained from the Caenorhabditis Genetics 
Center (CGC) (University of Minnesota, USA), avr-14, avr-15 and avr14/avr15 
mutant stocks were provided by Leon Avery (Southwestern Medical Center, 
University of Texas, Dallas).
4.2.2 Bacterial strain genotypes
E. coli OP50: RecA1 endA1 gyr96 thi-1 hsdR17 (ricmk+) supE44 relA1 lac [F’ proAB 
la(?AM15Tr\10]. Obtained from CGC 
E. coll HTh5: F , mcrA, mcrB, IN(rrnD-rrnE)1, X-, rr\Cu':Tn10(DE3 lysogen:lacilV5 
promoter-T7 polymerase). Obtained from L. Holden-Dye (University of 
Southampton, UK)
4.2.3 Plasmids and clones
L4440, provided by L. Holden-Dye (University of Southampton, UK). This plasmid is 
designed for bi-directional transcription of the gene of interest by bacteriophage T7 
RNA polymerase; it has two T7 promoters in inverted orientation flanking the 
multiple cloning site. It also contains the p-lactamase gene, which confers the Ampr 
phenotype (Timmons and Fire, 1998).
L4440-unc22 clone, provided by L. Holden-Dye (University of Southampton, UK).
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L4440-glc-1 clone, obtained from N. Aptel (University of Bath, UK). The glc-1 insert 
is a 200 bp DNA, corresponding to the sequence encoding the intracellular loop 
between the transmembrane domains III and IV of the GluClal subunit.
4.2.4 Media
NGM (Nematode Growth Medium) agar. 3 g NaCI, 17 g agar, 2.5 g peptone, H20  
975 ml. Autoclaved; then 1 ml cholesterol (5 mg/ml in EtOH), 1 ml CaCI2 1 M, 1 ml 
MgS0 4  1 M and 25 ml potassium phosphate 1M (pH 6.0) were added.
LB agar: 10 g tryptone, 5 g yeast, 5 g NaCI, 15 g agar, H20  to 1 I. Autoclaved.
DYTbroth: 20 g Bacto-yeast, 10 g Bacto-tryptone, 5 g NaCI, H20  to 1 I. Autoclaved.
4.2.5 Reagents
L-glutamate USB (Ohio, USA)
All other chemicals used were of analytical grade and obtained from standard 
commercial sources such as Sigma Chemical Company Ltd. (Poole, UK), Difco 
laboratories (East Molesey, UK) and BDH chemicals (Poole, UK).
C.elegans Methods 
4.2.6 C. elegans culture
C. elegans was fed with E. coli OP50 grown on NGM agar plates. To prepare the 
bacterial food source, OP50 was streaked from a OP50-LB agar plate to generate 
single bacterial colonies. A single colony was used to inoculate a flask containing 5 
ml sterile DYT broth. This was incubated at 37°C overnight. The resulting culture 
was kept at 4°C for 2-3 weeks.
Nematode culturing was performed on Petri plates. The NGM agar was poured into 
60 mm or 90 mm diameter plates. The NGM agar OP50 plates were prepared using 
100 or 200 pi of E. coli OP50 liquid culture, respectively. Bacteria were spread 
creating a square lawn leaving the edges of the plate clear of bacteria. Plates were 
incubated overnight at 37°C and stored at 4°C. Nematodes were maintained at
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20°C on NGM OP50 plates by transferring them to new plates before they became 
starved, normally every 3-4 days. A wire bacteriological loop was used to pick 
worms under a dissecting inverted microscope (Zeiss, Germany). Normal bacterial 
sterile precautions at the open bench were adequate for these procedures. Worms 
were maintained as self-fertilising hermaphrodites.
4.2.7 Behavioural assays
4.2.7.1 Chemotaxis
Chemotaxis assays were based on those described by Bargmann and Horvitz 
(1991a) with some modifications. Assay plates (90 mm diameter) contained 5 mM 
potassium phosphate (pH 6 .0 ), 1 mM CaCI2, 1 mM MgS0 4 , and 2  % (w/v) agar. 
Agar plugs of about 6  mm diameter cut with a 200 pi yellow pipet tip a were soaked 
for 1 h in 50 pi of attractant (1M NaCI or 100 mM L-glutamate) or ddH2 0 . The 
gradient was produced by placing the plug saturated in attractant on the right side 
of an assay plate, 5-10 mm from the edge. A plug soaked in ddH20  was positioned 
at a point diametrically opposite the peak of the gradient (Fig. 4.2, step 1). Plates 
with both plugs soaked in ddH20  were included (negative control). Plates were left 
overnight (14-20 h) at 20°C. Shortly before the chemotaxis assay, the plugs were 
removed and 1 pi of 0.5 M NaN3 was spotted onto the same position to 
anaesthetise the animals on the peak of the gradient (Fig 4.2, step 2).
Non-starved C. elegans adults were washed twice with wash buffer (5 mM 
potassium phosphate (pH 6.0), 1 mM CaCI2, 1 mM MgS04) in 15 ml centrifuge 
tubes. Worms were allowed to decant and the supernatant, containing bacteria 
debris, was removed. After the second wash and just before starting the 
chemotaxis assay, a brief 120 xg spin was done. Approximately 100 worms were 
placed equidistant to the two plugs (start) and left to move freely on the assay plate 
for 40-50 min at room temperature (Fig 4.2, step 3). The assay plates were chilled 
to 4°C, and the chemotaxis index (Cl) determined. Cl was calculated as CI=(N+-N' 
)/(total number of animals on the plate), where N+ is the number of animals on the 
quadrant where the attractant was placed and N' on the control quadrant.
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vFig. 4.2 Configuration of the chemotaxis assay
4.2.7.2 Osm otic avoidance
The osmotic avoidance assay was based on the method described by Hilliard et al 
(2002). A young adult or adult worm was transferred without food to a 60 mm NGM 
agar plate and allowed to recover for 1 min. A ~ 5 nl drop of control buffer (30 mM 
Tris, pH 7.5, 100 mM NaCI, 10 mM KCI) or 1M fructose in control buffer, was placed 
in the path of the worm as it moved forward. Drops were delivered using glass 
capillaries (3.5 inches Drummond glass capillary tubes, Drummond Scientific 
Company, USA). To reduce the diameter of the tip, capillaries were pulled on a 
stationary coil Narishige microelectrode puller (Stutter Instrument Co., USA) and 
then the needle was gently broken with a pair of forceps under a binocular 
microscope. The capillaries were back filled with sterile mineral oil, attached to the 
plunger of a Drummond “Nanoject” microinjector (Broomhall, PA, USA) set up to 
inject ~ 5 nl drops, and front filled with 2 pi of the solution to be tested (control 
buffer or 1 M fructose). The response was analysed under a dissecting microscope 
and the time interval (delay) between the initial contact with the solution and the 
response (backward movement) was determined using a stopwatch. Individual tests 
were performed on 1 2  worms per experiment.
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4.2.7.3 RNA-mediated interference
RNA-mediated interference (RNAi) assays were based on those described by 
Kamath et al (2000). NGM agar plates (60 mm diameter) were prepared with 1 mM 
IPTG (IPTG stock: 100 mM in FfeO, sterilised by filtration through a 0.22 i^m filter 
and stored at -20°C). Single colonies of HTn5 bacteria transformed with the L4440 
plasmids (empty, or containing unc-22 or glc-1 DNA inserts), were picked and 
grown in culture in LB with 100 pg/ml Ampicillin. The HT115 strain expresses the T7 
polymerase gene from an inducible (Lac) promoter and is RNAase Ill-deficient, 
beneficial for RNAi by feeding. NGM IPTG agar plates were seeded in triplicates 
with the different bacterial cultures and incubated overnight at 37°C. L2-stage 
worms were placed onto these plates (5 per plate) and incubated for 48 h at 20°C. 
Once the twitching phenotype appeared on the unc-22 RNAi treated worms 
(positive control), L4 individuals but not the unc-22 dsRNA fed worms, were 
transferred to NGM off-food plates. Locomotion behaviour was assessed 12 or 24 h 
later. Twelve worms were analysed per condition, in each experiment.
4.2.7.4 Locomotion assays
The movement of RNAi treated worms was analysed on NGM agar off-food plates. 
Two different aspects of locomotion were quantified: the number of reversals and 
the duration of backward movements carried out per worm in 5 min. A reversal was 
measured each time a worm moving forward, stopped, went backwards and moved 
forward again but in a new direction. Backward locomotion was measured from the 
time a worm started a backward movement until it re-started moving forward. For a 
given experiment, in order to reduce possible variability in the data as a 
consequence of room temperature, humidity, dryness of plates, etc., all RNAi 
treated worms were scored on the same day.
4.2.7.5 Statistical analysis
Data represent the mean ± standard error of the mean (S.E.M), indicated by error 
bars, of at least 3 independent experiments. Statistical significance was determined 
using Mann-Whitney Rank Sum test or one-way ANOVA plus post hoc Tukey’s test, 




4.3.1 Chemotaxis to water-soluble chemicals
Chemotaxis towards NaCI and L-glutamate was assayed in C. elegans wild-type 
and avr-14/avr-15 mutant worms. Pictures taken from the NaCI and water (negative 
control) assay plates were used as examples to show typical chemoattraction 
behaviour (Fig. 4.3A). Figure 4.3B shows that both C. elegans strains chemotax 
towards NaCI and L-glutamate, but no differences in the responses were found 
between wild-type and avr-14/avr-15 mutant worms. Worms on the water plates, 
where water was used as substitute for the attractants, moved randomly showing 
no preference for the right or left side of the plates. Chemotaxis towards the 
attractants was evident 30 minutes after starting the experiments. The chemotaxis 
index (Cl) obtained to NaCI was 0.6 ±0 .12  for wild-type and 0.82 ± 0.05 for avr- 
14/avr-15 worms. These values are similar to the Cl described for C. elegans wild- 
type worms and some mutant strains that chemotax towards NaCI (Saeki et al., 
2001; Yassin et al., 2001). The Cl found for L-glutamate was 0.23 ± 0.04 for wild- 
type and 0.27 ± 0.06 for avr-14/avr-15 worms. These figures were not as high as 
the Cl for NaCI, but were significantly increased compared to the Cl obtained on the 
negative controls (0.03 ± 0.03 for wild-type and 0.06 ± 0.05 for avr-14/avr-15 
worms). Since the worms are exposed to a gradient of an attractant, the only 
concentration of the attractant that is known is the one at the peak of the gradient 
(100 mM for L-glutamate and 1 M of NaCI).
These results show that the avr-14/avr-15 mutant worms are not deficient to 
chemotax towards the compounds tested, suggesting that the GluCI subunits 
encoded by avr-14 and avr-15 are not involved in detecting NaCI or glutamate in C. 
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Fig. 4.3 Chemotaxis response of wild-type and avr-14/avr-15 worms to NaCI and L-
glutamate
Adult worms were collected, washed and assayed for 1M NaCI or 100 mM L-glutamate 
chemotaxis. Two agar plugs soaked in H20 or attractant, were placed on the surface of an 
assay plate; the plug with attractant was placed on the right. For the H20 plates, both 
plugs were soaked in H20  (negative control). The gradient was allowed to form for 20 h at 
20°C, the plugs were removed and 1pl of 0.5M NaN3 was spotted onto the place occupied 
for the plugs, as anaesthetic. A: Pictures from the H20 and NaCI plates, taken 40 min 
after placing -100 animals at the starting position (centre of the plate). Arrow heads 
indicate chemotaxis towards NaCI. B: Chemotaxis index (Cl) towards H20, 100 mM L- 
glutamate and 1M NaCI. The three conditions were tested in parallel. Values are means ± 
S.E.M of 3 independent experiments, each carried out in triplicate. Significantly different 




By placing a small drop of control buffer or buffer with the osmotic repellent (1 M 
fructose) in the path of a worm moving forward, it was possible to test the osmotic 
avoidance response (Fig. 4.4A). Wild-type and mutant worms that encountered the 
control buffer moved through the drop with no change in velocity or direction of 
movement (data not shown). In contrast, worms that encountered the fructose drop 
stopped their movement and initiated, after a brief delay, a backing response (Fig. 
4.4B). glr-1 and avr-14 mutants displayed defects in the osmotic avoidance 
behaviour. Both mutants showed an increase in the response delay after contacting 
1 M fructose compared to wild-type worms (glr-1: 1.58 ± 0.097 s; avr-14: 2.42 ± 
0.15 s and wild-type: 0.36 ± 0.016 s). Interestingly, the delay in the response 
observed in the avr-14 mutant was more severe than the observed in glr-1 mutants 
(p<0.01). glr-1 encodes an ionotropic glutamate receptor subunit, GLR-1, similar to 
the vertebrate non-NMDA glutamate subunits (Maricq et al., 1995). The response 
delay showed in the figure 4.4B for the glr-1 (n2461) mutant and wild-type worms is 
very similar to the data described by Mellem et al (2002) using the same osmotic 
avoidance method described here, but testing the glr-1 (ky176) mutant. Both mutant 
alleles (n2461 and ky176) cause loss of receptor function in glr-1 mutant animals. 
The glr-1 (ky176) mutants were also defective for osmotic avoidance and displayed 
a delay in the withdrawal response significantly increased compared to wild-type 
worms (~ 1.2 s and -  0.3 s, respectively). These results showed that the osmotic 
assay is working under the conditions set in the laboratory and validates the use of 
glr-1 (n2461) mutant worms as a positive control for the osmotic avoidance 
experiments.
Osmotic avoidance was also assessed in avr-15 mutants. Unlike avr-14 mutants, 
these mutants showed a normal response to osmotic stimuli (Fig. 4.4B), suggesting 
that avr-14 but not avr-15 GluCI containing receptor might be required for the 
osmotic avoidance response in C. elegans.
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wild-type glr-1 avr-14 avr-15
Fig. 4.4 C. elegans avr-14 but not avr-15 mutants are defective in osmotic
avoidance
A: Diagram of the osmotic avoidance assay. A drop of 1 M fructose is placed in the path 
of a worm moving forward on an off-food NGM agar plate. B: Time taken (response 
delay) for wild-type, glr-1 (n2461), avr-14 and avr-15 mutant worms to go backwards 
after contacting the fructose, s: seconds. Values are means ± S.E M of 3 independent 
experiments. In each assay, individual tests were carried out in 12 worms. Statistically 
different from wild-type, *p<0.001 and from glr-1, # p<0.01, Mann-Whitney Rank Sum 
test.
4.3.3 Locomotion behaviour
The expression of glc-1, which encodes the C. elegans GluClal subunit, was 
disrupted in wild-type and avr-14 mutant worms through RNAi assays. In all the 
experiments the following controls were included: L4440 (negative control) and unc- 
22 (positive control). The first one corresponds to worms fed from E. coli HTn5 (a 
RNAi feeding strain) carrying the L4440 empty vector. The unc-22 controls,
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corresponds to worms fed from E. coli HTi 15 transformed with a L4440-unc22 clone. 
unc-22 (unc: uncoordinated movement) encodes an abundant muscle filament 
protein (Benian et al., 1993). All worms treated with unc-22 RNAi produced a 
characteristic and uniform twitching phenotype, observed 40 hours post-feeding L2 
larvae.
In order to study whether silencing the GluClal subunit affects C. elegans 
locomotion, movement was assessed by quantifying the number of reversals 
performed per individual in 5 minutes. This approach was preferred to the 
quantification of the duration of forward locomotion, solely for the simplicity of the 
measurements. When searching for food, worms move in a regulated manner with 
fairly long forward runs interspersed with shorter periods of backward locomotion 
and turns. Reversals were considered when a worm moving forwards went 
backwards and moved forward again changing direction. In wild-type worms, glc-1 
RNAi showed a 92.6 % increase in the number of reversals compared to the L4440 
wild-type control (10 ± 0.57 and 5.4 ± 0.5, respectively) (Fig. 4.5A). Since previous 
studies showed no differences in locomotion between L4440 controls and animals 
from the same strain non-assayed for RNAi (N. Aptel, pers. commun.), it was 
assumed that the results obtained for the L4440 controls represent the regular 
phenotype of the assayed strains.
avr-14 mutants treated with the L4440 empty vector (negative control), showed an 
increase of reversals compared to wild-type, which was not significantly different 
from glc-1 RNAi treated wild-type worms (Fig. 4.5A). However, avr-14 mutants 
treated with glc-1 RNAi showed a 43 % reduction in the number of reversals 
compared to the L4440 avr-14 controls (4.9 ± 0.6 and 8 . 6  ± 0.6, respectively), 
reaching similar values to the wild-type L4440 control worms (4.9 ± 0.6 and 5.4 ± 
0.5 reversals in 5 minutes, respectively).
Qualitative observations showed that avr-14 mutant worms treated with glc-1 RNAi 
had a tendency for long backward movements, being defective in re-starting 
forward locomotion. These worms made a few attempts to go forward before 
actually achieving it. This phenotype was thus called hesitation. To further 
characterise this behaviour, the duration of backward movement was quantified in 
these worms.
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Fig. 4.5 Effects of glc-1 RNAi on the locomotion of wild-type and avr-14 worms
RNAi was carried out by feeding C. elegans L2 larvae with E. coli HT115 transformed with 
the control plasmid (L4440) or with the same vector containing a DNA fragment of glc-1 
(construct obtained by N. Aptel), for 48 h. L4 worms were transferred to NGM off-food 
plates and locomotion phenotypes were assessed 24 h later. At all times, unc-22 RNAi of 
wild-type worms was included as positive control and worms showed the twitching 
phenotype 40 h post-feeding. Locomotion behaviour was not assayed on these worms. A: 
glc-1 RNAi in wild-type and avr-14 worms. Data represent the number of times worms 
reverse direction in 5 minutes. B: glc-1 RNAi in avr-14 worms. The duration of the backward 
movement was measured as the time since a worm started a backward movement until it 
re-started moving forwards. s:seconds. Values are means ± S.E.M of 3 independent 
experiments, each carried out on 10-12 individuals. Significantly different from L4440 
control, *p<0.001, Mann-Whitney Rank Sum test.
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The effect of glc-1 RNAi on avr-14 mutants showed about a 140 % increase in the 
duration of backward movement compared to control worms (14.8 ± 1.7 s and 6.1 ± 
0.48 s, respectively) (Fig. 4.5B). This suggests that the reduction in the number of 
reversals found with these worms, might be the result of an impediment in re­
starting a forward movement.
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4.4 Discussion
Sensory and locomotion studies allowed the definition of possible functions of some 
of the GluCI subunits in C. elegans behaviour.
Chemotaxis
The chemotaxis response to NaCI and L-glutamate is not deficient in avr-14/avr-15 
mutants, suggesting that neither avr-14 nor avr-15 gene products are involved in 
detecting those attractants, or at least none of them seem to be crucial for that 
function. Preliminary results showed that the avr-14/avr-15 mutants also chemotax 
towards other water-soluble substances such as sodium acetate and ammonium 
chloride (N. Aptel, pers. commun.), in agreement with the results presented in this 
work. However, no final conclusion can be draw at this stage, as chemotaxis 
towards more water-soluble compounds and volatile attractants and/or repellents 
should be tested.
Although C. elegans chemotaxis to NaCI has been previously described (Saeki et 
al., 2001; Yassin et al., 2001) there was no previous data on the chemoattraction to 
glutamate. Since C. elegans chemotax towards other amino acids such as: lysine, 
cysteine and histidine (Ward, 1973; Dusenbery, 1974) and towards serotonin 
(Bargmann and Horvitz, 1991a), is not surprising that worms detect glutamate. 
However, the biological relevance of chemotaxis towards glutamate is unclear. In 
the soil, C. elegans lives at the air-water interface and is exposed to both liquid and 
airborne chemicals (Bargmann and Mori, 1997). Many of the attractants are by­
products of bacterial metabolism, so glutamate might be one of those chemicals 
present in the animal’s natural environment.
Osmotic avoidance
The sensory response to osmolarity is defective in avr-14 but seems normal in avr- 
15 mutant worms, which suggests a role for the avr-14 but not the avr-15 containing 
receptor in osmosensation. It is very unlikely that the avoidance behaviour 
observed in this work reflects a mechanosensory response to contact with the 
solution for the following reasons: first, wild-type worms did not respond to the drop 
of control buffer and second, worms that encountered the stimulus after the drop of
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fructose has been absorbed into the agar showed an avoidance response 
comparable to worms that contacted the fructose on the agar surface.
Excluding the expression in the ventral cord, avr-14 and avr-15 localised to different 
regions of the worm, avr-15 is expressed in pharyngeal muscle and head motor 
neurons (Dent et al., 1997), whereas avr-14 is expressed in extrapharyngeal 
neurons (which may be amphidial neurons) and mechanosensory neurons (Dent et 
al., 2000). avr-14 expression in extrapharyngeal neurons correlates with the 
possibility of having a role in a sensory function mediated, for example, by 
amphidial neurons, such as osmosensation. However, the way a GluCla3 subunit 
(encoded by avr-14) containing receptor might accomplish this function is unclear. 
A simple explanation would be that this receptor had a direct role in osmosensation 
through the amphids. However, this is improbable since the response to 
hyperosmolarity is thought to be mediated by mechanically gated ion channels. 
Alternatively, GluCIs might indirectly regulate high osmolarity responses in the 
amphids, through the activation of amphidial neurons that respond to osmotic 
avoidance. Interestingly, the delay in the response to fructose obtained in this work 
for the avr-14 mutants (~ 2.4 seconds) was very similar to that observed by Mellem 
et al (2002) in eat-4 mutants (~ 2.7 seconds). The mutant used was a null allele for 
the EAT-4, the C. elegans vesicular glutamate transporter (Lee et al., 1999). It 
seems that in the osmotic avoidance response, the absence of one of the GluCI 
genes, avr-14, is as severe as the lack of glutamatergic transmission. The 
amphidial neuron ASH seems to play the major role in hyperosmolarity (Hart et al.,
1999). ASH expresses eat-4 and is therefore supposed to be glutamatergic (Lee et 
al., 1999). It is possible then that avr-14 regulates the function of ASH in the 
osmotic avoidance function. If this is true, a GluCla3 containing receptor might act 
as an autoreceptor regulating glutamate release on the pre-synaptic ASH neuron. 
The fact that GluCIs might function as autoreceptors was suggested for avr-14 
expressed on the glutamatergic sensory neurons for the tap-withdrawal response in 
C. elegans: ALM, PLM and AVM (Steidl et al., 2002).
Interestingly, the fact that C. elegans GluCla3 seems to participate in 
osmosensation correlates with the presence of the orthologous H. contortus subunit 
(HcGluCla3A) in a pair of sensory neurons in the head of the worm, possibly 
amphidial neurons (chapter 3, figure 3.7). As it was discussed in chapter 3, the
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function of GluCIs in those neurons is uncertain. The results obtained on the 
present work for C. elegans, strongly suggest a sensory role for the HcGluCla3A 
containing receptor in H. contortus, possibly in osmosensation, though other roles 
cannot be ruled out.
Locomotion
The disruption of glc-1 expression through RNAi produced a locomotion defective 
phenotype. Previous data obtained in our group showed that RNAi can phenocopy 
the phenotype of avr-15 and avr-14 mutants. This gave us confidence that the 
phenotype obtained on the glc-1 RNAi experiments represented a specific effect of 
glc-1 RNAi in C. elegans.
Since a 50 % decrease on the duration of the forward movement has been 
described for GluCI avr-14, avr-15, glc-3 and glc-4 mutant worms compared to wild- 
type animals (Aptel et al., 2002), it is not surprising that wild-type glc-1 RNAi treated 
worms showed a 100 % increase in the number of reversals. Expression of avr-14 
and avr-15 in the ventral cord, which possesses motor neurons and interneurons 
responsible for driving nematode locomotion (for references see table 4.2), 
correlates with the movement defects previously observed on those mutants. 
Therefore, the results obtained in this work for glc-1 suggests that this GluCI gene 
might also be expressed in the neuronal tissue that controls C. elegans locomotion. 
As far as knocking-down glc-1 expression in avr-14 mutants is concerned, the glc-1 
RNAi worms were more defective in locomotion than the single knockouts. The 
observed increase in the duration of backward locomotion was the result of the 
‘hesitation’ phenotype detected in those worms for re-starting a forward movement. 
Therefore, the decrease in the number of reversals to values similar to wild-type 
worms seems to be a consequence of the long backward movements rather than a 
wild-type phenotype rescue. Finally, the additive defect in locomotion obtained with 
worms lacking the GluClal and GluCla3 subunits (encoded by glc-1 and avr-14, 
respectively), suggests that at least in some neurons responsible for nematode 
movement, these GluCI subunits might not be part of the same receptor.
The work presented in this section showed that the absence or disruption of GluCI 
subunit expression produces locomotion defects in C. elegans. How might this 
phenotype be achieved? As already mentioned in the discussion of chapter 3, an
143
inhibitory glutamate-gated chloride current has been recently detected in the AVA 
neuron (a command interneuron that controls backward movement) and it was 
suggested that the GluCIs may help to reestablish forward movement following 
backwards locomotion (Mellem et al., 2002). This would explain why in the absence 
of avr-14 or glc-1, worms tend to increase the number of reversals or the duration of 
backward locomotion.
Finally, it seems that three different GluCla3 subunit-containing receptors might be 
present in C. elegans: one regulating sensory behaviour, one modulating 
locomotion and a third one controlling feeding (the feeding behaviour was studied 
by Aptel et al (2002). This agrees with the expression pattern found in C. elegans 
for avr-14 and in H. contortus for the orthologous HcGluCla3A and a3B subunits 
(discussed in chapter 3). The behavioural phenotypes found in this work for the 
GluCI mutant or RNAi treated C. elegans, support the possible roles of H. contortus 





Antibodies raised against all the currently known H. contortus glutamate-gated 
chloride channel (GluCI) subunits allowed the mapping of their distribution in adult 
worms. The anti-HcGluClp antibody produced in this work confirmed the expression 
of this subunit in motor neuron commissures, as reported previously (Delany et al. 
(1998), but also detected expression in the lateral and sub-lateral nerve cords. 
HcGluCIa was localised to motor neuron commissures and double immunolabelling 
experiments showed that the a- and p-subunits co-localise to the same 
commissures in adult worms, suggesting that these subunits are part of the same 
receptor. Nematodes possess distinct excitatory and inhibitory motor neurons that 
release acetylcholine or GABA, respectively, at neuromuscular junctions (Stretton 
et al., 1985; Walrond et al., 1985). The anti-HcGluCIa subunit fluorescence 
overlapped with that produced by an anti-GABA antibody, suggesting that an ‘a+p’ 
containing receptor is expressed on GABA-ergic motor neurons.
Specific anti-peptide antibodies designed to HcGluCla3A and a3B allowed us to 
distinguish between the expression patterns of these subunits. They were 
previously shown to be localised to motor neuron commissures, nerve cords and 
the nerve ring of H. contortus (Jagannathan et al., 1999), but the antibody used in 
those experiments did not discriminate between the two subunits. The results 
presented in this project confirmed that the HcGluCla3A and a3B subunits are 
expressed in motor neuron commissures but that, outside of these cells, they were 
expressed in different regions of the worm nervous system. HcGluCla3B, but not 
HcGluCla3A, is expressed in nerve cords, in agreement with the results obtained 
with the HcGluCla3B antibody in C. elegans, which showed immunoreactivity in the 
worm motor nervous system (A. Cook and L. Holden-Dye, pers. commun.). New 
expression sites were also detected for both subunits in the head of H. contortus. 
HcGluCla3A was found in a pair of putative sensory amphid neurons and 
HcGluCla3B in three probable pharyngeal neurons, which may correspond to the 
M1 and M2 motor neurons. In C. elegans, avr-14 is also expressed in 
extrapharyngeal neurons in the head of the worm, in other sensory neurons and in 
the ventral cord (Dent et al., 2000). Recently, the HcGluCla3B antibody also 
seemed to stain the M1 and M2 pharyngeal neurons in C. elegans (A. Cook and L. 
Holden-Dye, pers. commun.), further supporting the results obtained in H. 
contortus.
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The expression pattern obtained in this study for all the currently identified GluCI 
subunits of H. contortus, was presented in a table format in chapter 4 (table 4.1), 
and is now summarised in the figure 5.1.
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Fig 5.1 Distribution of H. contortus GluCI subunits
A: Schematic representation of a mid-anterior portion of the right lateral side of a worm 
showing structures from the motor nervous system expressing HcGluCI subunits. Anterior 
is left. See key boxes to identify the location of each subunit, dnc: dorsal nerve cord; dslc: 
dorsal sub-lateral cord; mnc: motor neuron commissure; Ic: lateral cord; vslc: ventral sub- 
lateral cord and vnc: ventral nerve cord. B: Top view of the head showing the expression of 
the HcGluCla3 subunits. Green circles: cell bodies of 3 possible pharyngeal motorneurons 
that may correspond to C. elegans M1 and M2 left (I) and right (r). Yellow circles: cell 
bodies of possible amphidial neurons (A). Notice the anterior nerve processes (yellow 
lines) also containinq this subunit, p, pharynx.
These results strongly suggest that H. contortus contains more than one type of 
GluCI, distributed in distinct regions in the worm nervous system: 1) in the motor 
nervous system (motor neuron commissures and nerve cords); 2) in the pharyngeal 
nervous system and 3) in a pair of sensory, possibly amphid, neurons in the head. 
As the HcGluCIa and -p subunits showed complete co-localisation in motor neuron 
commissures, it is very tempting to think that these subunits probably co-assemble 
in motor neuron commissures in native GluCI receptors. It would obviously have
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been interesting to determine whether these motor neurons were the same as 
those expressing the HcGluCla3A and a3p subunits. Attempts to double-label adult 
H. contortus with the rat anti-HcGluCip and rabbit anti-HcGluCla3A or a3B 
antibodies showed some indications of co-localisation. However, the data were not 
conclusive and it does remain an obvious possibility that the native GluCI contains 
the a, one or both a3, and p-subunits. The same thought can be applied to the 
HcGluCip and a3B subunits, which are both expressed in the ventral sub-lateral 
cord. The present data suggest that the HcGluCla3-contaning receptors are the 
GluCI subunits most widely distributed in the H. contortus nervous system. Since 
the a3A and a3B are alternative spliced products from the avr-14 (gbr-2) gene, it is 
not surprising that they may contribute to increase the number of subunit 
combinations available to the worm and therefore, the diversity of GluCI receptors. 
Besides, the HcGluCla3B and a3A subunits seem also to be part of GluCIs 
expressed in pharyngeal neurons and in a pair of putative amphidial neurons, 
respectively. Considering that the GluCIs are thought to be heteromeric channels, 
the expression of the GluCla3 subunits in those structures suggest that other, as 
yet unidentified, GluCI subunits are likely to be expressed in H. contortus 
pharyngeal and sensory neurons.
The distribution of the H. contortus GluCI subunits suggests that the GluCIs have 
critical roles controlling pharyngeal function, locomotion, and possibly sensory 
perception and processing in the nematode. Does this distribution explain the mode 
of action of the AM anthelmintics? The observed inhibition of pharyngeal pumping 
may be explained by the presence of the AM-sensitive GluCIs on motor neurons 
innervating pharyngeal muscle in H. contortus. Based on the C. elegans motor 
circuitry (Chalfie and White, 1988), the expression of the H. contortus GluCIa, a3A, 
a3B and (3 subunits in motor neurons which innervate somatic muscle, strongly 
suggests that the GluCIs contribute to the control of movement. The presence of H. 
contortus GluCIs in GABA-ergic motor neurons also suggests that these receptors 
are involved in the co-ordination of forward and backward movements. This leads to 
a model for the paralysing effects of ivermectin and related drugs shown in figure 
5.2, where the drug inhibits the control interneurons and/or the inhibitory motor 
neurons, leading to a cessation of movement. This model predicts that the AMs 
have no direct effect on the muscle, but disrupt neuronal signalling to it. The results
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obtained in C. elegans from behavioural assays, together with previous studies 
(Aptel et al., 2002), further support the role of GluCIs in regulating locomotion. 
Knocking-out or knocking-down the expression of GluCI genes leads to changes in 
nematode locomotion, specifically an increased frequency of backward movements.
Forward C o-& K ^aJ^m  of Backward
locomotion frorjJfcS^ck locomotion
m ^ m e n fe v
AMs
Fig 5.2 Model for the effect of the AMs on locomotion in nematodes
GluCIs are expressed in the inhibitory motor neurons (red circles) and may also be 
present in the command interneurons (yellow octagons). Application of 
avermectin/milbemycin (blue arrows) will ‘irreversibly’ open these channels, 
preventing neurotransmission and hence inhibiting muscle contraction/relaxation. Grey 
circles represent excitatory motor neurons, black arrows indicate chemical synapses 
and straight connecting lines gap junctions. Diagram based on the circuitry described 
by Chalfie and White (1988).
As far as sensory perception is concerned, chemosensory assays performed in this 
work showed that neither the avr-14 nor avr-15 genes are involved in chemotaxis, 
at least for the chemicals tested. However, an a3- but not a2- containing receptor 
seems to have a role in osmosensation. Preliminary data from dye-filling assays 
with DiO (a fluorescent lipophilic dye), showed no clear differences between avr-14 
or avr-15 mutants compared to wild-type worms (Victoria Lumby, pers. commun.), 
suggesting that amphidial neuron structure is not altered in either of these mutants. 
Therefore, it is possible that the C. elegans GluCla3 subunits (encoded by avr-14)
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might regulate osmotic avoidance, functioning as autoreceptors on the 
glutamatergic ASH amphidial neurons, as discussed in chapter 4. What is the 
relevance of this result, if any, to H. contortus? Aspects of the biology of parasitic 
species are completely different to the free-living nematode C. elegans, making it 
difficult to correlate functions directly. However, it is tempting to speculate that H. 
contortus might sense osmolarity and or other stimuli in the host, and that 
HcGluCla3A-containing receptors expressed in putative amphidial neurons, might 
have a role in that sensory behaviour, but other roles cannot be ruled out. 
Alternatively, it seems likely that amphid receptor-receptor connections facilitate the 
modulation of the activity of one receptor (sensory neuron) by another (White et al., 
1986). GluCI channels have been implicated in the formation of inhibitory synapses 
(Dent et al., 1997). In this case, amphid neurons expressing GluCla3A containing 
receptors might modulate sensory modality by inactivating chemical transmission.
In summary, the distribution of the known GluCI subunits in H. contortus seems to 
correlate well with the observed actions of the AMs, providing further evidence that 
these receptors are the main drug targets in nematodes. One exception to this may 
be the effects of the anthelmintics on fecundity, as there is as yet no direct evidence 
for any role for the GluCIs in the reproductive system. The exact effect that the AMs 
have on the channels is still somewhat uncertain, as there are clear quantitative 
differences between the concentrations of drug required to eliminate parasites and 
those that directly activate recombinant C. elegans GluCIs expressed in Xenopus 
oocytes. The genetic molecular complexity and distribution of the GluCI family 
clearly indicates that there are multiple forms of the channel, and thus multiple AM 
targets, in these organisms. There are differences in the genetic make-up of the 
GluCI family between the two nematode species considered here, as well as in the 
expression patterns of some particular subunits. Given the close phylogenetic 
relationship between C. elegans and H. contortus (Blaxter et al., 1998), it would not 
be surprising if more extensive differences in the composition and function of the 
GluCI exist in more diverse species, such as the filaria. Such differences may well 
underlie the different effects the AM anthelmintics have on different parasites.
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Future directions
Studies using techniques such as co-immunoprecipitation, might help to further 
elucidate the composition of the H. contortus native GluCIs. Expression of the 
GluCIa and p subunits, as well as all the other GluCI subunits in the combinations 
mentioned above, and new ones, could be assessed in Xenopus oocytes and the 
relevant pharmacology carried out to prove that these subunits do form functional 
glutamate-gated chloride channels. However, this expression system has proved 
quite difficult to express for nematode GluCIs (D. Yates, pers. commun). In addition, 
attempts to establish H. contortus GluCI stable cell lines in a mammalian cell line 
(L929) proved unsuccessful (Cheeseman, 2001). Appendix 1 describes the results 
obtained from transient expressions of the HcGluCIa and HcGluCip subunits in 
mammalian (COS-7 and HEK-293) and insect cells (S2).
It would be of interest to find out whether there is any difference in the expression 
pattern found between IVM-sensitive and IVM-resistant worms. Previous studies 
have shown no differences either in the predicted amino-acid sequence of 
HcGluCIa, p or a3 subunits (Chesseman et al., 2001; Hejmadi et at., 2000), or on 
the expression pattern of the p and a3 between H. contortus IVM-sensitive and 
IVM-resistant isolates.
Finally, behavioural studies mentioned in this work could also be performed in the 
triple avr-14, -15 and glc-1 mutant worms. In addition, chemotaxis to other 
attractants and repellents could be assessed in avr-14/avr-15 mutant worms, as 
well as avoidance response assays to other high osmotic solutions in avr-14 and 
avr-15 mutant C. elegans.
The results shown in the present work provide additional evidence for the 
understanding of the action of the AMs, suggesting that the native avermectin/GluCI 
receptor seems to be composed of different types of GluCI subunits, which might 
form different types of receptors in different areas of the worm nervous system. 
Considering the therapeutic relevance of the GluCIs, this could help to develop a 
combination of novel, receptor-type specific AMs.
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APPENDIX 1
TRANSIENT EXPRESION OF H. CONTORTUS 
GLUCL SUBUNITS IN CELL LINES
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A1.1 Introduction
Heterologous expression of nematode GluCI subunits has been studied in 
expression systems such as Xenopus oocytes and mammalian cell lines. In 
particular, Haemonchus contortus GluCI subunits have been transiently expressed 
in the COS-7 mammalian cell lines (Cheeseman et al., 2001; Forrester et al., 2002). 
The expression of HcGluCIa in the mammalian COS-7 expression system 
produced high affinity binding for [3H]-ivermectin (IVM), suggesting that this subunit 
can form homomeric receptors in COS-7 cells. In contrast, the HcGluClp subunit 
expressed in the same system failed to bind [3H]-IVM, as predicted by functional 
data from the Caenorhabditis elegans orthologue. Radioligand binding data does 
not prove receptor functionality but provides an approach to study the receptor 
pharmacology. Considering that GluCIs belong to the superfamily of ligand-gated 
ion channels (LGIC), it is probable that they act as heteropentamers. Despite the 
progress in identifying individual HcGluCI subunits that bind [3H]-IVM, such as the 
HcGluCIa and HcGluCla3B, so far no combinations of putative subunits have been 
expressed in an in vitro system. Pharmacological studies on cell lines expressing 
homomeric and heteromeric GluCIs might also be used as a tool to investigate 
possible receptor-subunit combinations. Thus, this might provide an idea of the 
putative composition of the GluCI receptors.
It was described in chapter 3 that the HcGluCIa and p subunits co-localised in H. 
contortus motor neuron commissures. The aim of this part of the project was to find 
out whether the HcGluCIa and p subunits co-express in an in vitro system. If they 
do, they could then be used to assess the pharmacology of these receptors in vitro. 
This appendix describes the cloning of HcGluCIa and p into two different 
expression vectors required for gene expression into mammalian or insect cell 
lines, and the results obtained from transient expression of those constructs in the 
mammalian COS-7 and HEK-293 cells and in the Drosophila S2.
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A1.2 Materials and Methods
A1.2.1 Cells
Mammalian: COS-7: monkey kidney cell line, supplied by the European Collection 
of Cell Cultures (ECACC) Salisbury, UK. HEK293: Human embryonic kidney cell- 
line, supplied by the American Type Culture Collection (ATCC), USA.
Insect: Drosophila Schneider 2 Cells (S2 cells) (Invitrogen, Paisley, UK). Many 
features of the S2 cell line suggest that it is derived from a macrophage-like lineage 
(Schneider, 1972).
Bacteria: Escherichia coli TOP10 competent cells (Invitrogen)
A1.2.2 Plasmid DNA
Vectors: pCR®-Blunt II TOPO (Invitrogen); pCMV/myc (Invitrogen); pFLAG-CMV- 
5a (Sigma); pMetSV and pActSV obtained from M. Kapsetaki (IMBB, Iraklion, 
Greece). For restriction maps of the pMetSV and pActSV vectors see appendix 1.1. 
Clones: pcDNA3(-)HcGluCla and pcDNAHcGluCip obtained in our group by C. 
Cheeseman; pActSV-EGFP obtained from M. Kapsetaki (IMBB, Iraklion, Greece) 
(for restriction map see appendix 1.1); GFP-CD36, obtained from B.J Reaves 
(University of Bath); hTRPC3-c-myc and hTRPC1-FLAG, obtained from I. Franklin 
(University of Bath).
A1.2.3 Primers
All the primers were ordered from Life technologies Gibco BRL® (Paisley, UK) 
desalted and 50 nmol scale. Those used to sequence pCMV/myc and pFLAG-CMV 
vectors were the commercial ones recommended by the supplies.
Primers used for cloning the HcGluCIa and p subunits into pCMV/myc and pFLAG 
vectors
afull 5’ 5' NNNNNNCTGCAGATGTTCGCCTTAATTC 3’ *
afull 3’ 5' NNNNNNCTCGAGTTCCAACTGCGCTTG 3' *
pfull 5' 5' NNNNNNAAGCTTATGTCACAGTATATG 3' ♦
pfull 3' 5' NNNNNNCTGCAGGACTAGTCTTGAC 3’ *
Restriction sites underlined: *  Pst I, a Xho I, ♦ Hind III.
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Primers used for cloning HcGluCIa and p subunits into the pMet vector
aNhe 5’ 5’ NAAGCTAGCATGTTCGCCTTAATTC 3’ *
aPac 3’ 5’ NNTTAATTAATCACCCATTCAGATCC 3’ A
PMet 5’ 5’ NNNGTCGACATGTCACAGTATATGATGG 3’ ♦
pFIagNot 3’ 5’ NNGCGGCCGCCLACTTGTCATCGTCG 3’ *
PMet 5’ 5’ GCATCTGGCCAATGTG 3’
PMet 3’ 5’ TATGTTTCAGGTTCAGGGG 3’
PAct 5’ 5’ GCTGTGTGGATACTCCTCCC 3’
PAct 3’ 5’ TTATGTTTCAGGTTCAGGGG 3’
Restriction sites underlined: *  Nhe I, *  Pac I, ♦ Sal I, * Not I. In italic, stop codons. In bold, 
primers used to sequence DNA cloned into the pMet and pAct vectors.
A1.2.4 Antibodies
Primaries: Anti-Tags: anti c-myc: mouse anti-c-myc monoclonal antibody 
(CHEMICON International, Inc, Harrow, UK), anti FLAG: mouse anti-FLAG 
monoclonal antibody (Sigma) and chicken anti-DYKDDDDK polyclonal antibody 
(Aves Labs, Inc; Oregon , USA). Anti-HcGluCIa (obtained as described in chapter 
2).
Secondaries: anti-mouse FITC- and TRITC-conjugated antibodies and anti-rabbit 
TRITC-conjugated antibody purchased from by Jackson ImmunoResearch Lab. 
(West Grove, USA).
A1.2.5 Others
Cell culture reagents were purchased from Sigma Chemical Company Ltd. (Poole, 
UK). FuGENE™6 transfection reagent was purchased from Roche (Lewes, UK). 
PBS tables were supplied by OXOID (Basingstoke, UK). General chemicals were of 
analytical grade and obtained from Sigma Chemical Company Ltd. (Poole, UK) and 
BDH chemicals (Poole, UK). Plasticware was Sterilin (Bibby Sterilin Ltd., Stone, 
UK), Nunc (Life Technologies Ltd), Paisley, UK) Falcon (Falcon, New Jersey, USA) 
and Greiner Labortechnik Ltd. (Stonehouse, UK).
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A1.2.6 Expression constructs
PCR and DNA cloning were performed as described in chapter 2 (sections 2.2.5 & 
2.2.9). For preparing the HcGluCla-c-myc and HcGluCip-FLAG constructs, 
HcGluCIa and p cDNA full-length clones were used as templates for PCR. The 
resultant constructs were later used as templates for PCR to clone the tagged a 
and p subunits into the pMet vector. PCR cycling conditions consisted of 94°C for 3 
min, followed by 35 cycles of 94°C for 1 min, 55°C for 1 min and 72°C for 1 min, 
terminating with 5 min at 72°C. A first step cloning in pCR®-Blunt II TOPO vector 
(Invitrogen) was done following the manufacturer instructions recommendations. 
Then the HcGluCIa cloned product was sub-cloned into PCMV/myc vector 
linearised with Pst I and Xho I and the HcGluClp into pFLAG linearised with Hind III 
and Pst I enzymes. The HcGluCla-cmyc and HcGluClp-FLAG subunits were cloned 
into the multiple cloning site of the pMet expression vector between the following 
restriction sites: Nhe I and Pac I for the a, and Sal I and Not I for the p subunit. E. 
coli TOP 10 competent cells were used for transformations.
A1.2.7 Cell culture
A1.2.7.1 Mammalian cell culture
COS-7 or HEK-293 cells were cultured in 75 cm2 vented flasks containing 12 ml of 
DMEM (Dulbecco's Modified Eagle’s Medium) supplemented with 2 mM L- 
glutamine, 10 % (v/v) heat inactivated foetal bovine serum (treated for 30 min at 
56°C) and 1 % (v/v) penicillin-streptomycin stabilised solution. Cells were incubated 
at 37°C with 5 % CO2 . At approximately 80 % confluence cells were washed with 
PBS and harvested with 1 ml 10 X trypsin-EDTA for 10 minutes at 37°C. Cells were 
split 1:10 to reach 80% confluency after 48-72 hours. HEK-293 cells used had 19- 
22 passages.
A1.2.7.2 Insect cell culture
S2 cells grow at room temperature without CO2 as a loose, semi-adherent 
monolayer in tissue culture flasks and in suspension in spinners and shake flask. In 
this work cells were incubated in a 22-24°C incubator. They were cultured in 75 cm2 
screw capped flasks (Greiner Labortechnik Ltd.) containing 12 ml of Shields and
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Sang M3 insect medium (Sigma; Cat. N° S-8398). This is a powdered M3 medium 
that was prepared in Milli-Q water following the manufacturer instructions with the 
exception that only 0.5 g/l and not extra NaCI, were added during its preparation. 
The optimal pH is 6.5 but as it increases slightly with sterilisation by filtration, the pH 
was adjusted to 0.2-0.5 units below the optimum. Medium was supplemented with 
12.5 % (v/v) heat inactivated foetal bovine serum and 50 pg/ml gentamycin. For 
general maintenance, cells were passed when cell density was about 6 to 20 X 106 
cells/ml and split at a 1:2 to 1:5 dilution. Cells were collected by centrifugation at 
1000 x g for 4 min., the medium was removed and cells were washed in PBS 
centrifuged as above, and then resuspended in fresh medium.
A1.2.8 Transient expression in ceil lines
A1.2.8.1 Preparation of cell cultures for trasfection
Mammalian cells
Prior to transfection a 80-90 % confluency cell culture was split 1:10 in DMEM and 
about 6 drops of the diluted culture were then plated drop-wise onto coverslips in 6 
well plates. Cells were allowed to adhere to the coverslip for 90 min before 2 ml of 
DMEM were added to each well. Cells were incubated at 37°C with 5 % CO2 until 
they reached 20-30 % confluency for the HEK-293 cells (normally 24h) and 40-50 
% confluency for the COS-7 cells (overnight), before transfection. Coverslips used 
for growing HEK-293 cells were pre-treated with Polyethylenimine (see below).
Treatment of coverslips with Polvethvlenimine (Polv-E)
One gram of Poly-E (50 % (w/v) aqueous solution) was diluted in 9 ml of ddH20 and 
sterilised with a 0.22pM filter (stock solution). A 1:100 dilution from the stock was 
prepared in sterile 0.1 M Borax and 2ml were added on to coverslips in 6 well 
plates. Plates were incubated for at least 2h at 37°C. Finally the Poly-E solution 
was removed and the dishes were washed 2 or 3 times with PBS. HEK-293 cells 
were plated onto the coverslips as described above.
Insect cells




COS-7 and HEK-293 cells were transiently transfected using a lipophilic 
transfection reagent, FuGENE™6 , or calcium phosphate. FuGENE™ 6  was used at 
a ratio of 3pl of reagent / pg of DNA, following the manufacturer instructions. Cells 
were incubated for 48 hours and assayed for gene expression.
The Calcium Phosphate transfection methodology was used to introduce DNA into 
COS-7, HEK-293 and S2 cells.
Calcium Phosphate transfection of COS-7 and HEK-293 cells 
The medium was changed 3 to 4 hours prior to transfection. For transfecting cells 
on coverslips, 2-4 pg DNA were thoroughly mixed with 12 pi 2M CaCI2 in a 1.5 ml 
microcentrifuge and sterile H2O was added up to 100 pi total volume. In co­
transfections, half of the DNA used for single transfections was used for each DNA 
assessed. The DNA solution was added dropwise to 100 pi 2X HEPES Buffered 
Saline (HBS; 140 mM NaCI, 1.5 mM Na2 HP04- 2H2 0 , 50 mM HEPES, pH 7.05) 
shaking the tube vigorously between additions for 1 - 2  min to maximise aeration, 
promoting the formation of a calcium phosphate-DNA precipitate. The mixture was 
left for 30-40 min at RT to allow DNA precipitation to occur. For combined volumes 
of over 500 pi, 15 ml centrifuge tubes were used. Following this time the precipitate 
was added drop-wise to the cells. The final volume of DNA-CaCI2 did not exceed 
1/10 of the volume of medium in which the cells were plated. The cells were then 
left to incubate overnight at 37°C with 5 % C 02. The following day the cells were 
washed twice with 1X PBS in order to remove the precipitate and 2 ml of fresh 
medium were added. The cells were incubated for a further 24-48 hours at 37°C 
with 5 % C 0 2 and assayed for gene expression (section A1.2.8.3).
To monitor expression conditions and levels, the following control samples were 
included. COS-7 cells were transfected with a GFP-CD36 construct, and HEK-293 
cells were transfected with hTRPC3-c-myc and hTRPC1-FLAG constructs. These 
myc- and FLAG- tagged constructs also allowed for the monitoring of 
immunodetection conditions. As in HcGluCla-myc and p-FLAG, expression of the 
mentioned constructs was driven by a constitutive promoter (CMV).
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Calcium Phosphate transfection of S2 cells
The procedure described above for the mammalian cells was used in S2 with some 
modifications based on the Invitrogen protocol (see http://www.invitrogen.com). Ten 
to 19 jj.g of DNA were used per well in a 6  well plate. Expression driven under the 
methallothionein (Met) promoter was induced 3 days after transfection, using 0.5 
mM CUSO4 . Transient expression was analysed by immunofluorescence detection, 
3 days after induction. At this step, cells were placed onto a PE-treated coverslip, 
cells were allowed to set for 1 hour and immunostaining was carried out as 
described in section A1.2.8.3. Transfections in S2 cells were monitored for 
efficiency by investigating the expression of a costitutive pActGFP construct in 
control samples.
A1.2.8.3 Immunofluorescence
Cells cultured on coverslips in 6  well plates were washed 3 times in PBS and fixed 
in 2 ml of 4 % (v/v) paraformaldehyde in PBS for 20 minutes at room temperature 
(RT). After 3 washes in PBS, cells were permeabilised with 0.1 % (v/v) Triton X-100 
in PBS for 5 minutes at RT (in some experiments this step was omitted). After one 
wash with PBS cells were incubated in blocking solution (0.2 % (w/v) BSA in PBS) 
for 30 minutes at RT. Coverslips were inverted first onto 70 jllI of primary Ab and 
then onto the same volume of secondary Ab for 1 hour and 20 minutes respectively. 
Antibody dilutions were carried out in blocking solution. Two washes of 5 minutes 
each with blocking solution and PBS were carried out after antibody incubations. 
Cells were placed back into the dishes and washed twice with blocking solution and 
twice with PBS. Incubations and washes with the secondary antibody were 
performed in the dark. Coverslips were mounted onto a drop of Mowiol mounting 
medium (prepared as described by Harlow and Lane, 1988b) on a coverslide and 
dried overnight at RT. Results were analysed under a Zeiss LSM 510 confocal 
microscope using the settings according to the fluorochrome-conjugated secondary 
antibody used in the assay. Images obtained for the negative controls 
(untransfected cells incubated only with the secondary antibody) were scanned 




A1.3.1 Expression of HcGluCIa and p in mammalian cells
A1.3.1.1 Cloning of the a and p subunits into expression vectors
The HcGluCIa and p subunits were C-terminal tagged with the c-myc and FLAG 
epitopes respectively. Full-length HcGluCIa and HcGluCip subunit cDNAs, with the 
exception of their stop codons, were amplified by PCR and cloned into pCMV/myc 
and pFLAG vectors respectively. Endonuclease restriction of all the transformants 
analysed shown a fragment of the expected size (1.3 Kb) (Fig. 1). The sequence of 
clones N°1 from the HcGluCIa and p constructs confirmed the identity of the 
sequences with the expected ones as well as the conservation of their open reading 
frames with the tag protein's sequences. These clones were used for transfections.
A B
1 2  3 4 5 6 7 8 9  ,
4 -
Fig. 1 Restriction analysis of plasmid DNA from HcGluCla-myc (A) and HcGluClp- 
FLAG (B) mammalian expression constructs
1 % (w/v) agarose gel in TBE. Lane 1, 1Kb DNA ladder (Promega). Lane 2, uncut DNA 
from clone 1. Lane 3, clone 1 digested. Lanes 4-9 clones 2 to 7. Clones in A were 
digested with Pst I and Xho I; in B with Hind III and Pst I. The arrows indicate the 
fragment of about 1.3 Kb released from the clones.
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A1.3.1.2 Transfection and immunodetection
Receptor subunits were then transiently expressed in COS-7 and HEK-293 cells 
and any expression analysed by immunofluorescence. COS-7 cells were also 
transfected with pcDNA3-HcGluCla construct, obtained by C. Cheeseman 
(University of Bath). The results described below were achieved using the calcium 
phosphate transfection method, which gave me better results than using the 
FuGENE™ reagent.
Immunostaining for the a subunit was detected using the anti-HcGluCIa and an 
anti-c-myc antibody. The two antibodies showed cytoplasmic staining in 
permeabilised cells (Fig. 2). The staining seemed to be located possibly in the 
endoplasmic reticulum (ER) and in cytoplasmic vesicules. Intracellular staining was 
also detected in non-permeabilised cells and rarely expression was detected in the 
plasma membrane (data not shown). The staining observed in COS-7 or HEK-293 
cells was very bright, but the expression level in terms of the proportion of cells that 
stained was very low (about 10 cells were stained on a coverslip of about 80 % 
confluency of cells). The high proportion of stained cells showed in figure 2.A, was 
very rare to obtain. From here onwards, the term ‘expression level’ will be 
considered in terms of percentage and not intensity of staining, which will be 
mentioned separately. No staining was detected either in COS-7 untransfected cells 
probed only with the TRITC- or FITC-conjugated secondary antibodies (Fig. 2E,F) 
nor in HEK-293 untransfected cells probed only with the FITC-conjugated antibody 
(Fig. 3E).
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Fig. 2 Expression of HcGluCIa in COS-7 and HEK-293 cells
Confocal images of transient expression of HcGluCIa in COS-7 cells (A, B), myc-tagged 
HcGluCIa in COS-7 (C) and HEK-293 cells (D) probed with 1:10 dilution of anti-HcGluCIa Ab 
(A, B) and 1:200 dilution of mouse anti-c-myc Ab (C, D), followed by 1:200 dilution of TRITC- 
(in red) and FITC- (in green) conjugated secondary Abs. B: fluorescence obtained in A 
merged with it transmitted image. E & F: non-transfected COS-7 cells probed with TRITC- 
and FITC-conjugated secondary, respectively. Immunostaining was carried out in cells 
permeabilised with 0.1 % (v/v) Triton X-100 in PBS. Scale bars, panels A, B, D, E, F = 10 
pm, panel C = 20 pm.
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Expression of the GluClp subunit was studied in COS-7 (Fig. 3A) and in HEK-293 
cells (Fig. 3B-E). Staining, using a mouse anti-FLAG antibody, was detected in the 
cytoplasm for both cell types in permeabilised cells (Fig. 3A,B) and also at the 
plasma membrane under non-permeable staining conditions (Fig. 3C,D). The best 
expression level for the p subunit was about 30 % reached in HEK-293 cells 48h 
post transfection with 7 pg of DNA per coverslip. No staining was detected in non­
transfected cells probed only with the secondary antibody (Fig. 3E).
Co-transfection experiments with the a and p subunits did not produce any cells 
expressing both in the same cell. Different transfection conditions were assayed 
such as varying the concentration of DNA and the expression timing, but they did 
not make any difference. It was then decided to test a different expression system, 
the Drosophila S2 cell line. Since in mammalian cells the GluCIa and p proteins 
were expressed mainly in the cytoplasm, which could be a side effect of constitutive 
expression driven by the CMV promoter, this time the a  and p subunits were cloned 
under an inducible promoter (methallothionein (Met) promoter) (section A1.3.2).
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Fig. 3 Expression of HcGluClp in COS-7 and HEK-293 cells
Confocal images of transient expression of HcGluClp-FLAG in COS-7 (A) and HEK-293 
(B-D) cells probed with 1:1000 dilution of mouse anti-FLAG Ab followed by 1:200 dilution 
of FITC-conjugated secondary Ab. A, B, E : cells permeabilised with 0.1 % (v/v) Triton X- 
100 in PBS. C-D, non-permeabilised cells. E : non-transfected HEK-293 cells probed with 
FITC-conjugated secondary. In C, arrows indicate plasma membrane staining. Scale bars, 
panels A-C, E = 10 nm, panel D = 5 ^m.
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A1.3.2 Expression of HcGluCIa and (3 in S2 insect cells
A1.3.2.1 Cloning of the a and (3 subunits into an inducible 
expression vector
The GluCla-myc and GluCip-FLAG sequences were amplified by PCR using as 
templates plasmid DNA from the clones used for transient expression in 
mammalian cell lines described above. Bands of the expected size (about 1.3 Kb) 
were obtained (Fig. 4 lanes 1 & 3).
L 1 2 3 4
turn
Fig. 4 PCR amplification of GluClac-myc and GluClpFLAG DNA
1 % (w/v) agarose gel in TBE. L, 1Kb DNA ladder (Promega). Lanes 1 & 3, PCR products 
for GluClp-FLAG & GluCla-myc DNAs respectively. Lane 2 & 4, no template controls. The 
arrow indicates the products of about 1.3 Kb.
The excised bands were cloned separately into the pCR®-Bluntll TOPO® vector as 
a previous step before the cloning into the insect expression vector pMet (vector 
map is shown in Appendix 2). HcGluCla-c-myc was cloned into the Nhe I and Pac I 
sites of the pMet vector and HcGluClp-FLAG into Sal I and Not I. Seven pMet 
transformants were isolated per construct type and digested with the relevant 
enzymes (Fig. 5B). The sequence from clone N°1 & 7 for HcGluCla-c-myc and N°1 
and 2 for HcGluClp-FLAG constructs was confirmed as well as the conservation of 
the open reading frame with the tagged sequences. From those, clone 7 and 2 
were the ones used for transfections.
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Fig. 5 Restriction analysis of plasmid DNA from HcGluCla-myc (A) and HcGluCip- 
FLAG (B) insect expression constructs. 1 % (w/v) agarose gel in TBE. L, 1Kb DNA
ladder. 1-7, different clones digested (d) in A with Nhe I and Pac I and in B with Sal I and 
Not I. The arrows indicate the fragment of about 1.3 Kb released from the clones.
A1.3.2.2 Transfection and immunodetection
HcGluCIa and p, c-myc and FLAG tagged respectively, were transiently expressed 
in S2 cells and expression was analysed by immunofluorescence. Mouse 
antibodies to the c-myc and FLAG proteins showed cytoplasmic staining in 
permeabilised cells (Fig. 6A-E). Immunostaining under non-permeable conditions 
was hardly observed (not shown). No staining was detected in untransfected cells 
probed with the TRITC- conjugated antibodies (Fig. 6F,G). The expression levels 
obtained for the a or p subunits were about 10 %. Besides, within the same 
preparation fluorescence detected in some cells was brighter than others. Co­
transfection experiments with these subunits did not show cells expressing both 
proteins in the same cell. Different rations of DNA such as 1:1, 1:5 and 1:10 were 






Fig. 6 Expression of HcGluCIa and HcGluClp in S2 cells
Confocal images of transient expression of HcGluCla-c-myc (A, B) and HcGluClp-FLAG 
(C-E) induced with 0.5 mM CuS04. Cells were probed with 1:200 dilution of anti-c-myc Ab 
(A,B) or 1:1000 dilution of anti-FLAG Ab (C-E), followed by 1:200 dilution of TRITC- 
conjugated secondary Ab. B & D: fluorescence obtained in A & C merged with their 
respective transmitted images. E: zoom-in image of a section from C. F & G: non­
transfected S2 cells probed with TRITC-conjugated secondary Ab. G is the transmitted 
image of F. Scale bars, 5 pm.
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A.1.4 Discussion
Two different expression systems were assessed to transiently express the 
HcGluCIa and HcGluClp subunits in vitro. These subunits were c-myc and FLAG- 
tagged and successfully expressed in mammalian and insect cells. COS-7 and 
HEK-293 were used to express the a and p subunits under a constitutive promoter 
(CMV) whereas a Drosophila S2 cell line was used to express these subunits under 
an inducible promoter (methallothionein promoter).
In mammalian cells, with the exception of the p subunit which was also localised at 
the plasma membrane, the a and p subunits were expressed intracellularly. As far 
as the a subunit is concerned, the incorporation of the c-myc tag peptide at the C- 
terminus of the protein seemed not to interfere with the expression pattern of this 
subunit in COS-7 cells. The expression detected using two different constructs (c- 
myc tagged and a non-tagged) and two different antibodies (anti-c-myc and anti 
HcGluCIa), was very similar and showed cytoplasmic and perinuclear staining. As 
expression was only analysed 48 hours after transfection some of the intracellular 
staining might be explained by over-expression of those subunits. Hence, they 
might be stacked in the cytoplasm either during protein synthesis pathways and/or 
recycling endosome pathways. Alternatively, as has been described for other 
members of the LGIC superfamily (Gorrie et al., 1997; Taylor et al., 2000; Kittler et 
al., 2000), GluCI subunit co-assembly and receptor targeting to the plasma 
membrane may require the presence of multiple subunits. This theory together with 
the putative staining of the ER detected for the HcGluCIa subunit in mammalian 
cells, are supported by studies carried out by Connolly et al (1999) who showed 
that GABAa receptor subunits expressed alone are ER retained. In contrast, when 
a1p2 subunits are co-expressed they co-assemble, localise on the cell surface and 
form functional receptors. If this were the situation for the HcGluCIa and p subunits, 
co-expressing both might result in functional receptors expressed on the cell 
surface. Unfortunately, co-expression experiments did not show cells expressing 
both subunits in the same. This could be explained simply because they may not 
co-express in vitro, at least under the conditions used in these experiments. Also, it 
may be the result of the low expression levels obtained for these proteins, 
particularly for the a subunit in mammalian cells, which may reduce the chances of
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finding a and p co-expression. Alternatively, these two subunits might require 
additional(s) GluCI subunits (s) for a and p co-expression. Ultimately, absence of 
staining cannot be considered lack of expression. It is possible then that the method 
used in this work was not sensitivity enough to detect lower protein concentration.
Inducible expression of HcGlucIa and p subunits in S2 cells also showed a 
cytoplasmic distribution of the proteins, supporting the idea discussed above about 
the necessity of additional GluCI subunits to target the receptor to the plasma 
membrane. The same theories about the lack of a  and p co-expression discussed 
for the expression in mammalian cells could be applied to the S2 cells. It is worth 
mentioning that, although the expression levels, as counted by the number of 
immunolabelled cells, for the a subunit in S2 was about 10 % this figure is much 
higher than that detected in mammalian cells where no more than 10 cells per 
coverslip expressed the a subunit. Moreover, preliminary data obtained from the 
expression of HcGluCla-GFP in S2 cells driven by the constitutive insect promoter 
Act5c, resulted in about 15-20 % level of expression 48 h post trasfection. The 
expression pattern for this GFP-tagged a subunit was cytoplasmic (Fig. 7), very 
similar to the observed with the c-myc tagged a subunit under the inducible 
promoter (Fig. 6A,B). Considering that the level of expression detected for the 
control vector (pActSV-EGFP) was about 30 %, the constitutive expression of 
HcGluCla-GFP in S2 seems to be the better choice to express this subunit in vitro 
for future studies.
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Fig. 7 Expression of HcGluCla-GFP in S2 cells
Confocal images of transient expression of HcGluCla-GFP cloned into the pActSV insect 
vector for constitutive expression in S2 cells. B & D: fluorescence obtained in A & C 





This section includes the restriction maps of the vectors used for transient 
expression of in Drosophila S2 cells, supplied by M. Kapsetaki (IMBB, Iraklion, 
Greece). Single restriction sites are indicated in brown and enzymes that cut twice 
are indicated in black. These vectors derive from the LITMUS 28 cloning vector, 
supplied by NEB (Hitchin, UK). The polylinker was modified and the promoters and 
SV40 polyA termination signal were added. The SV40 signal was cloned between 
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Fig. A1.1 1 Restriction map of pMetSV vector
This vector contains a methallothionein (Met) promoter, cloned between EcoR I and BamH 
I sites as indicated in purple. It gets induced with 0.5 mM CuS04 in cell culture medium. 
The Xba I (77) site is methylated. Restriction sites highlighted in yellow were the selected 
for HcGluCla-cmyc cloning and in pink for HcGluClp-FLAG cloning as described in 
appendix 1.
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Fig. A1.1 2 Restriction map of pActSV-EGFP vector
This vector contains a constitutive (Act5c) promoter, as indicated in purple. The EGFP 
sequence was cut from the pEGFP-1 vector (CLONTECH, Palo Alto, USA) and cloned 
into the BamH I and Not I restriction sites. This vector was used to monitor transfection 
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Fig. A1.1 3 Restriction map of pActSV vector
It contains a constitutive (Act5c) promoter, as indicated in purple.
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